FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Cirne-Santos, CC
   Barros, CD
   de Oliveira, MC
   Rabelo, VWH
   Azevedo, RC
   Teixeira, VL
   Ferreira, DF
   Paixao, ICND
AF Cirne-Santos, Claudio Cesar
   Barros, Caroline de Souza
   de Oliveira, Mariana Cavalcante
   Rabelo, Vitor Won-Held
   Azevedo, Renata Campos
   Teixeira, Valeria Laneuville
   Ferreira, Davis Fernandes
   Nunes de Palmer Paixao, Izabel Christina
TI In vitro Studies on The Inhibition of Replication of Zika and
   Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus
   cervicornis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANTIVIRAL ACTIVITY; BROWN ALGA; TRANSMISSION; DITERPENES; PROFILE;
   DRUGS; EGCG
AB The lack of vaccines and antiviral treatment, along with the increasing number of cases of Zika virus (ZIKV) and Chikungunya virus (CHIKV) infections, emphasize the need for searching for new therapeutic strategies. In this context, the marine brown seaweed Canistrocarpus cervicornis has been proved to hold great antiviral potential. Hence, the aim of this work was to evaluate the anti-ZIKV and anti-CHIKV activity of a marine dolastane isolated from brown seaweed C. cervicornis and its crude extract. Vero cells were used in antiviral assays, submitted to ZIKV and CHIKV, and treated with different concentrations of C. cervicornis extract or dolastane. The crude extract of C. cervicornis showed inhibitory activities for both ZIKV and CHIKV, with EC50 values of 3.3 mu g/mL and 3.1 mu g/mL, respectively. However, the isolated dolastane showed a more significant and promising inhibitory effect (EC50=0.95 mu M for ZIKV and 1.3 mu M for CHIKV) when compared to both the crude extract and ribavirin, which was used as control. Also, the dolastane showed a very potent virucidal activity against CHIKV and was able to inhibit around 90% of the virus infectivity at 10 mu M. For the ZIKV, the effects were somewhat lower, although interesting, at approximately 64% in this same concentration. Further, we observed that both the extract and the dolastane were able to inhibit the replication of ZIKV and CHIKV at different times of addition post-infection, remaining efficient even if added after 8hours post-infection, but declining soon after. A synergistic effect using sub-doses of the extract and isolates was associated with ribavirin, inhibiting above 80% replication even at the lowest concentrations. Therefore, this work has unveiled the anti-ZIKV and CHIKV potential of C. cervicornis crude extract and an isolated dolastane, which, in turn, can be used as a preventive or therapeutic strategy in the future.
C1 [Cirne-Santos, Claudio Cesar; Barros, Caroline de Souza; de Oliveira, Mariana Cavalcante; Rabelo, Vitor Won-Held; Nunes de Palmer Paixao, Izabel Christina] Univ Fed Fluminense, Dept Biol Celular & Mol, Programa Posgrad Ciencias & Biotecnol, Inst Biol,Lab Virol Mol & Biotecnol Marinha, Niteroi, RJ, Brazil.
   [Barros, Caroline de Souza; Teixeira, Valeria Laneuville] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Prod Nat Algas Marinhas ALGAMAR, Niteroi, RJ, Brazil.
   [Azevedo, Renata Campos; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, Rio De Janeiro, Brazil.
   [Teixeira, Valeria Laneuville] Univ Fed Estado Rio De Janeiro, Inst Biociencias, Programa Posgrad Biodiversidade Neotrop, Lab Biol & Taxon Algas LABIOTAL, Rio De Janeiro, RJ, Brazil.
RP Cirne-Santos, CC; Paixao, ICND (corresponding author), Univ Fed Fluminense, Dept Biol Celular & Mol, Programa Posgrad Ciencias & Biotecnol, Inst Biol,Lab Virol Mol & Biotecnol Marinha, Niteroi, RJ, Brazil.
EM claudiocirne@gmail.com; izabeluff@gmail.com
RI Rabelo, Vitor W/D-9812-2019; Cirne-Santos, Claudio/T-4009-2019
OI Rabelo, Vitor W/0000-0001-5303-6814; Cirne-Santos,
   Claudio/0000-0001-8376-1830; Teixeira, Valeria
   Laneuville/0000-0003-4962-6912
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7, 304070/2014-9]; FAPERJ (Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.442/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.344/2016];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowships to ICNPP and VLT (443930/2014-7 and 304070/2014-9). ICNPP
   and VLT (E-26/201.442/2014) also thank the FAPERJ (Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro) for the Cientista do Nosso Estado
   Fellowship. CCCS thanks to CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) for the Postdoc fellowship and CSB thanks
   FAPERJ for the Postdoc fellowship (E-26/201.344/2016). The postgraduate
   program in sciences and biotechnology of UFF (PPBI-UFF). This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Arora N, 2016, FUTURE VIROL, V11, P395, DOI 10.2217/fvl-2016-0048
   Atta-ur-Rahman F., 2016, STUDIES NATURAL PROD
   Barrios C, 2016, J AM SOC NEPHROL, V27, P933, DOI 10.1681/ASN.2015010109
   Barros CD, 2017, J APPL PHYCOL, V29, P769, DOI 10.1007/s10811-016-0865-9
   Barros CD, 2016, J APPL PHYCOL, V28, P2523, DOI 10.1007/s10811-015-0776-1
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Cavalcanti LPD, 2017, MEM I OSWALDO CRUZ, V112, P583, DOI 10.1590/0074-02760160537
   de Oliveira A, 2015, ANTIVIR RES, V118, P56, DOI 10.1016/j.antiviral.2015.03.009
   Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gulland A, 2016, ZIKA VIRUS IS GLOBAL
   Levi J, 2017, ISBT SCI SERIES, V12, P233, DOI [10.1111/voxs.12334, DOI 10.1111/VOXS.12334]
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Masmejan S., 2018, EXPERT REV ANTIINFEC
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14
   Pemovska T, 2018, CURR OPIN PHARMACOL, V42, P102, DOI 10.1016/j.coph.2018.07.008
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rebensburg S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20394
   Siddharta A, 2017, J INFECT DIS, V215, P902, DOI 10.1093/infdis/jix046
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   TEIXEIRA VL, 1986, J NAT PROD, V49, P570, DOI 10.1021/np50046a002
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Vallim MA, 2010, J MED PLANTS RES, V4, P2379
   Vasilakis N, 2016, AM J TROP MED HYG, V95, P488, DOI [10.4269/ajtmh.16-0281, DOI 10.4269/AJTMH.16-0281]
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 38
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2020
VL 10
IS 1
DI 10.1038/s41598-020-65357-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY5KL
UT WOS:000540568100056
PM 32427940
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Azevedo, RC
   Cardoso, MCA
   Caldas, LA
   Werneck, CLV
   Cohen, CN
   Yamamoto, KA
   Meira, GLS
   de Meneses, MDF
   Erthal, MC
   de Sa, PG
   Migowski, E
   de Souza, W
   Schmidt-Chanasit, J
   Hernandez, R
   Ferreira, DF
AF Azevedo, Renata Campos
   Cardoso, Maria Cecilia A.
   Caldas, Lucio Ayres
   Vieira Werneck, Caio Luis
   Cohen, Cristiane Napoleao
   Yamamoto, Kristie Aimi
   Silva Meira, Guilherme Louzada
   Ferreira de Meneses, Marcelo Damiao
   Erthal, Maria Cecilia
   de Sa, Paulo Gallo
   Migowski, Edimilson
   de Souza, Wanderley
   Schmidt-Chanasit, Jonas
   Hernandez, Raquel
   Ferreira, Davis Fernandes
TI The impact of Zika virus infection on human semen: a case study
SO FUTURE VIROLOGY
LA English
DT Article
DE assisted reproduction; Flavivirus persistence; immunofluorescence;
   longitudinal study; semen; semen donor; sexually transmitted virus;
   super-resolution microscopy; virus clearance; Zika virus
ID EPIDEMIC; OUTBREAK; BRAZIL; RNA
AB The outbreak of Zika virus (ZIKV) in Brazil and in many countries was marked by the occurrences of fetal malformations and neurological effects upon infection of pregnant women. Like other members of the Flaviviridae family, ZIKV in semen is infectious and sexually transmitted. Viral persistence in the male genital tract is unresolved and still needs further understanding. A regular semen donor was followed from the acute phase of ZIKV infection, up to 8 months after ZIKV in his body fluids became undetected. Immunofluorescence assay was performed in semen samples before and after the infection. A significant decrease in sperm concentration and in the percentage of progressive motility of sperm was observed. The methodology adopted for clearance of sexually transmitted viruses decreased virus load, but the complete clearance of ZIKV from semen was not achieved.
C1 [Azevedo, Renata Campos; Yamamoto, Kristie Aimi; Silva Meira, Guilherme Louzada; Ferreira de Meneses, Marcelo Damiao; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Cardoso, Maria Cecilia A.; Vieira Werneck, Caio Luis; Cohen, Cristiane Napoleao; Erthal, Maria Cecilia; de Sa, Paulo Gallo] Fertil Ctr, Vida Assisted Reprod Lab, Av Amer 6-205, BR-22793080 Rio De Janeiro, RJ, Brazil.
   [Caldas, Lucio Ayres; de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Cellular Ultrastruct Hertha Meyer, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Caldas, Lucio Ayres; de Souza, Wanderley] Ctr Nacl Biol Estrutural & Bioimagem CENABIO, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [de Sa, Paulo Gallo] Univ Fed Rio de Janeiro, Dept Gynecol & Obstet, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Migowski, Edimilson] Univ Fed Rio de Janeiro, Inst Pediat & Puericulture Martagao Gesteira, Rua Bruno Lobo 50, BR-21941912 Rio De Janeiro, RJ, Brazil.
   [Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Hernandez, Raquel; Ferreira, Davis Fernandes] North Carolina State Univ, Dept Mol & Struct Biochem, 128 Polk Hall, Raleigh, NC 27695 USA.
RP Caldas, LA (corresponding author), Univ Fed Rio de Janeiro, Lab Cellular Ultrastruct Hertha Meyer, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.; Caldas, LA (corresponding author), Ctr Nacl Biol Estrutural & Bioimagem CENABIO, Av Carlos Chagas Filho 373, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM lucio@biof.ufrj.br
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E26/201.840/2017]; Instituto Nacional de Ciencia e
   Tecnologia para Biologia Estrutural e Bioimagem-INBEB
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro-FAPERJ (grant number E26/201.840/2017) and Instituto
   Nacional de Ciencia e Tecnologia para Biologia Estrutural e
   Bioimagem-INBEB. The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bradshaw D, 2015, J INFECT DIS, V211, P736, DOI 10.1093/infdis/jiu550
   Caldas LA, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw108
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Jindal SK, 2016, REPROD BIOMED ONLINE, V33, P121, DOI 10.1016/j.rbmo.2016.04.015
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Whelan DR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07924
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 0
Z9 0
U1 0
U2 0
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JAN
PY 2020
VL 15
IS 1
BP 5
EP 12
DI 10.2217/fvl-2019-0159
PG 8
WC Virology
SC Virology
GA NC6NU
UT WOS:000561335000002
DA 2020-10-30
ER

PT J
AU Mello, MVP
   Domingos, TFS
   Ferreira, DF
   Ribeiro, MMJ
   Ribeiro, TP
   Rodrigues, CR
   Souza, AMT
AF Mello, Marcos V. P.
   Domingos, Thaisa F. S.
   Ferreira, Davis F.
   Ribeiro, Mariana M. J.
   Ribeiro, Thayssa P.
   Rodrigues, Carlos R.
   Souza, Alessandra M. T.
TI Antiviral Drug Discovery and Development for Mayaro Fever - What do we
   have so far?
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Mayaro virus; mayaro fever; alphavirus; antivirals; tropical infectious;
   arboviruses
ID LOUIS-ENCEPHALITIS-VIRUS; HUMAN-DISEASE AGENT; MATO-GROSSO; BIOLOGICAL
   EVALUATION; PROSTAGLANDIN A(1); ZIKA VIRUS; SAO-PAULO; DERIVATIVES;
   INFECTION; BRAZIL
AB Tropical infectious diseases cause millions of deaths every year in developing countries, with about half of the world population living at risk. Mayaro virus (MAYV) is an emerging arbovirus that causes Mayaro fever, which is characterized by fever, headache, diarrhea, arthralgia, and rash. These symptoms can be clinically indistinguishable from other arboviruses, such as Dengue, Zika, and Chikungunya, which makes the diagnosis and treatment of the disease more difficult. Though, the Mayaro virus is a potential candidate to cause large-scale epidemics on the scale of ZIKV and CHIKV. Despite this, there is no licensed vaccine or antiviral for the treatment of Mayaro fever and most arboviruses, so the design and development of candidates for antiviral drugs are urgently needed. In this context, this mini-review aims to provide an overview of studies of anti-MAYV derivatives and highlight the importance of the discovery and development of promising drug candidates for Mayaro fever.
C1 [Mello, Marcos V. P.; Domingos, Thaisa F. S.; Ribeiro, Mariana M. J.; Ribeiro, Thayssa P.; Rodrigues, Carlos R.; Souza, Alessandra M. T.] Univ Fed Rio de Janeiro, Fac Pharm, Lab Mol Modeling & QSAR ModMolQSAR, Rio De Janeiro, RJ, Brazil.
   [Mello, Marcos V. P.] Fed Fluminense Univ, Chem Inst, Niteroi, RJ, Brazil.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Paulo de Goes Microbiol Inst, Dept Virol, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis F.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC USA.
RP Souza, AMT (corresponding author), Univ Fed Rio de Janeiro, Fac Pharm, Lab Mol Modeling & QSAR ModMolQSAR, Rio De Janeiro, RJ, Brazil.
EM amtsouza2@yahoo.com.br
RI Palmeira-Mello, Marcos V./M-3659-2014; Souza, Alessandra M.
   T./R-5628-2016
OI Palmeira-Mello, Marcos V./0000-0003-2550-5315; Souza, Alessandra M.
   T./0000-0001-9986-405X
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   AITKEN THG, 1960, SCIENCE, V131, P986, DOI 10.1126/science.131.3405.986
   Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Aly HM, 2011, EUR J MED CHEM, V46, P4566, DOI 10.1016/j.ejmech.2011.07.035
   Amorim R, 2017, ARCH VIROL, V162, P1577, DOI 10.1007/s00705-017-3261-0
   Anderson R., 1957, ISOLATION BLOOD OFPA, V6, DOI DOI 10.4269/AJTMH.1957.6.1012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Bernardino Alice Mr, 2012, Org Med Chem Lett, V2, P3, DOI 10.1186/2191-2858-2-3
   Burlandy FM, 2001, INTERVIROLOGY, V44, P344, DOI 10.1159/000050069
   Caldas LA, 2018, REV SOC BRAS MED TRO, V51, P584, DOI 10.1590/0037-8682-0235-2018
   Camini FC, 2018, ANTIVIR RES, V158, P8, DOI 10.1016/j.antiviral.2018.07.023
   Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P215, DOI 10.1590/S0036-46652015000300006
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   DEMELLO H, 2004, ANTILEISHMANIAL PYRA, V47, P5427, DOI DOI 10.1021/JM0401006
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   FARIA NR, 2016, PLOS CURR, V8, DOI DOI 10.1186/S13073-016-0356-2
   Ferraz AC, 2019, ANTIVIR RES, V168, P76, DOI 10.1016/j.antiviral.2019.05.008
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hayakawa I, 2004, BIOORG MED CHEM LETT, V14, P3411, DOI 10.1016/j.bmcl.2004.04.079
   Ishimaru D, 1998, BRAZ J MED BIOL RES, V31, P1119, DOI 10.1590/S0100-879X1998000900003
   Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k
   Leal B, 2008, BIOORGAN MED CHEM, V16, P8196, DOI 10.1016/j.bmc.2008.07.035
   Lin Liang-Tzung, 2014, J Tradit Complement Med, V4, P24, DOI 10.4103/2225-4110.124335
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Lourenco AL, 2017, EUR J MED CHEM, V135, P213, DOI 10.1016/j.ejmech.2017.04.023
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Michailidou M, 2016, EUR J MED CHEM, V121, P143, DOI 10.1016/j.ejmech.2016.05.035
   Ministerio da Saude, SIT EP DAD
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI [10.1590/S0037-86822011005000041, 10.1590/s0037-86822011005000041]
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Orlikova B, 2014, EUR J MED CHEM, V85, P450, DOI 10.1016/j.ejmech.2014.08.008
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parvez MK, 2017, INTERVIROLOGY, V60, P1, DOI 10.1159/000478729
   Pauvolid-Correa A, 2010, MEM I OSWALDO CRUZ, V105, P829, DOI 10.1590/S0074-02762010000600017
   Pena-Garcia VH, 2017, CURR CLIN MICROBIOL, V4, P208, DOI 10.1007/s40588-017-0076-4
   Pinheiro F. P., 1988, The arboviruses: epidemiology and ecology. Volume III., P137
   Pinheiro L, 2012, J MICROBIOL ANTIMICR, V4, P32, DOI DOI 10.5897/JMA11.109
   Queiroz MJRP, 2010, EUR J MED CHEM, V45, P5628, DOI 10.1016/j.ejmech.2010.09.014
   Redwan EM, 2014, CR BIOL, V337, P581, DOI 10.1016/j.crvi.2014.08.003
   Bernardino AMR, 2007, MED CHEM RES, V16, P352, DOI 10.1007/s00044-007-9035-6
   Bernardino AMR, 2006, BIOORGAN MED CHEM, V14, P5765, DOI 10.1016/j.bmc.2006.03.013
   Saito MS, 2016, J ENZYM INHIB MED CH, V31, P1591, DOI 10.3109/14756366.2016.1158712
   SANTORO M G, 1990, P27
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva TB, 2016, BIOORGAN MED CHEM, V24, P4492, DOI 10.1016/j.bmc.2016.07.049
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Spindola KCW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0537-z
   Fantinato FFST, 2016, EPIDEMIOL SERV SAUDE, V25, P683, DOI [10.5123/S1679-49742016000400002, 10.5123/s1679-49742016000400002]
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Weaver S., 2005, 8 INT COMM TAX VIR L, P999
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 2017, GLOB VECT CONTR RESP
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 71
TC 0
Z9 0
U1 2
U2 2
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PY 2020
VL 20
IS 10
BP 921
EP 928
DI 10.2174/1389557520666200316160425
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LU0BK
UT WOS:000537428600008
PM 32178610
DA 2020-10-30
ER

PT J
AU Cirne-Santos, CC
   Barros, CD
   Nogueira, CCR
   Azevedo, RC
   Yamamoto, KA
   Meira, GLS
   de Vasconcelos, ZFM
   Ratcliffe, NA
   Teixeira, VL
   Schmidt-Chanasit, J
   Ferreira, DF
   Paixao, LCND
AF Cirne-Santos, Claudio Cesar
   Barros, Caroline de Souza
   Richter Nogueira, Caio Cesar
   Azevedo, Renata Campos
   Yamamoto, Kristie Aimi
   Silva Meira, Guilherme Louzada
   Meira de Vasconcelos, Zilton Farias
   Ratcliffe, Norman Arthur
   Teixeira, Valeria Laneuville
   Schmidt-Chanasit, Jonas
   Ferreira, Davis Fernandes
   Nunes de Palmer Paixao, Lzabel Christina
TI Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients
   in a Recent Disease Outbreak in Rio de Janeiro
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE chikungunya; arbovirus; seaweed; antiviral; crude extracts
ID AVIAN RETINAL NEURONS; ZIKA VIRUS; SURVIVAL; SEAWEED;
   DOLABELLADIENETRIOL; ANTI-HSV-1; ACTIVATION; ANTIVIRALS; EXPRESSION;
   DISCOVERY
AB Chikungunya virus (CHIKV) infection is one of the most challenging re-emergent diseases caused by a virus, and with no specific antiviral treatment it has now become a major public health concern. In this investigation, 25 blood samples were collected from patients with characteristic CHIKV symptoms and submitted to a virus isolation protocol, which detected 3 CHIKV isolates. These samples were evaluated by sequencing for the characterization of the strains and any homology to viruses circulating in Brazil during a recent outbreak. These viruses were used for the development of antiviral assays. Subsequently, the inhibitory effects of seaweed extracts on CHIKV replication were studied. The marine species of algae tested were Bryothamnion triquetrum, Caulerpa racemosa, Laurencia dendroidea, Osmundaria obtusiloba, Ulva fasciata, and Kappaphycus alvarezii, all of which are found in different countries including Brazil. The results revealed high levels of CHIKV inhibition, including extracts of O. obtusiloba with inhibition values of 1.25 mu g/mL and a selectivity index of 420. Viral inhibition was dependent on the time of addition of extract of O. obtusiloba to the infected cells, with the optimal inhibition occurring up to 16 h after infection. Neuron evaluations with O. obtusiloba were performed and demonstrated low toxicity, and in infected neurons we observed high inhibitory activity in a dose-dependent manner. These results indicate that the algal extracts may be promising novel candidates for the development of therapeutic agents against CHIKV infections.
C1 [Cirne-Santos, Claudio Cesar; Barros, Caroline de Souza; Richter Nogueira, Caio Cesar; Nunes de Palmer Paixao, Lzabel Christina] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Lab Virol Mol & Biotecnol Marinha,Programa Posgra, Niteroi, RJ, Brazil.
   [Cirne-Santos, Claudio Cesar] Univ Salgado Oiiveira, Curso Farm, Dept Ensino, Niteroi, RJ, Brazil.
   [Richter Nogueira, Caio Cesar; Teixeira, Valeria Laneuville] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Prod Nat Algas Marinhas ALGAMAR, Niteroi, RJ, Brazil.
   [Azevedo, Renata Campos; Yamamoto, Kristie Aimi; Silva Meira, Guilherme Louzada; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes IMPPG, Rio De Janeiro, Brazil.
   [Meira de Vasconcelos, Zilton Farias] Fundacao Oswaido Cruz Fiocruz, IFF, Rio De Janeiro, Brazil.
   [Ratcliffe, Norman Arthur] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales.
   [Teixeira, Valeria Laneuville] Univ Fed Estado Rio de Janeiro, Inst Biociencias, Programa Posgrad Biodiversidade Neotrop, Lab Biol & Taxon Algas LABIOTAL, Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Ferreira, Davis Fernandes] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Paixao, LCND (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Lab Virol Mol & Biotecnol Marinha,Programa Posgra, Niteroi, RJ, Brazil.; Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes IMPPG, Rio De Janeiro, Brazil.; Ferreira, DF (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
EM davisf@micro.ufrj.br; izabeluff@gmail.com
RI Barros, Caroline/S-7840-2019; Azevedo, Renata/V-3130-2019; Cirne-Santos,
   Claudio/T-4009-2019; Paixao, Izabel/AAM-1668-2020
OI Cirne-Santos, Claudio/0000-0001-8376-1830; Barros,
   Caroline/0000-0002-4678-3093
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7, 304070/2014-9]; FAPERJ (Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.442/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.344/2016];
   postgraduate program in sciences and biotechnology of UFF (PPBI-UFF)
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowships to IP and VT (443930/2014-7 and 304070/2014-9). IP and VT
   (E-26/201.442/2014) also thank the FAPERJ (Fundacao de Amparo a Pesquisa
   do Estado do Rio de Janeiro) for the Cientista do Nosso Estado
   Fellowship. CC-S thanks CAPES (Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior) for the Postdoc fellowship and CB thanks FAPERJ for
   the Postdoc fellowship (E-26/201.344/2016). Support also came from the
   postgraduate program in sciences and biotechnology of UFF (PPBI-UFF).
CR Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   ADLER R, 1984, J CELL BIOL, V99, P1173, DOI 10.1083/jcb.99.3.1173
   Ahmadi A, 2016, RSC ADV, V6, P69421, DOI 10.1039/c6ra16640g
   Ahmadi A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825203
   Anccasi RM, 2013, PURINERG SIGNAL, V9, P15, DOI 10.1007/s11302-012-9324-5
   Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606
   Barros CD, 2017, J APPL PHYCOL, V29, P769, DOI 10.1007/s10811-016-0865-9
   Bourjot M, 2012, J NAT PROD, V75, P2183, DOI 10.1021/np300637t
   Brasil, 2018, B EPIDEMIOLOGICO
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Ching KC, 2015, J MED CHEM, V58, P9196, DOI 10.1021/acs.jmedchem.5b01047
   Cirne-Santos Claudio C, 2018, J MED PLANTS RES, V12, P387, DOI [10.5897/JMPR2018.6624, DOI 10.5897/JMPR2018.6624]
   Cirne-Santos CC, 2008, ANTIVIR RES, V77, P64, DOI 10.1016/j.antiviral.2007.08.006
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   Dash PK, 2007, VECTOR-BORNE ZOONOT, V7, P519, DOI [10.1089/vbz.2006.0648, 10.1089/vbz.2007.7272]
   de Alencar DB, 2016, ASIAN PAC J TROP MED, V9, P363, DOI 10.1016/j.apjtm.2016.03.015
   Carvalho Luciana Retz de, 2006, Braz. J. Bot., V29, P453, DOI 10.1590/S0100-84042006000300012
   De Souza Barros C., 2018, J MED PLANTS RES, V12, P217
   de Souza LM, 2012, MAR DRUGS, V10, P918, DOI 10.3390/md10040918
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009
   dos Santos AO, 2010, MAR DRUGS, V8, P2733, DOI 10.3390/md8112733
   Ferreira JM, 2001, BRAIN RES, V900, P169, DOI 10.1016/S0006-8993(01)02279-X
   Lira ML, 2016, J APPL PHYCOL, V28, P591, DOI 10.1007/s10811-015-0538-0
   Galabov A. S., 2007, GMS KRANKENHAUSHYG I, V2, P1
   Garrido V, 2017, REGUL TOXICOL PHARM, V86, P193, DOI 10.1016/j.yrtph.2017.03.007
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4
   Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000
   Mejia-Garcia TA, 2007, J NEUROCHEM, V100, P382, DOI 10.1111/j.1471-4159.2006.04244.x
   Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001
   Montagnier L, 2010, VIROLOGY, V397, P248, DOI 10.1016/j.virol.2009.10.045
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Paes-de-Carvalho R, 2003, NEUROCHEM RES, V28, P1583, DOI 10.1023/A:1025686812298
   Perez MJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14030052
   Macedo NRPV, 2012, REV BRAS FARMACOGN, V22, P861, DOI 10.1590/S0102-695X2012005000072
   Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Rocha FD, 2007, PHYTOTHER RES, V21, P170, DOI 10.1002/ptr.2038
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Sokoloski KJ, 2013, J VIROL, V87, P12216, DOI 10.1128/JVI.02437-13
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tan Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006670
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Pinto AMV, 2012, REV BRAS FARMACOGN, V22, P813, DOI 10.1590/S0102-695X2012005000060
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
NR 52
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 24
PY 2019
VL 10
AR 2426
DI 10.3389/fmicb.2019.02426
PG 11
WC Microbiology
SC Microbiology
GA JL2RG
UT WOS:000495378900001
PM 31708898
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Gonzaga, DTG
   Gomes, RSP
   Marra, RKF
   da Silva, FC
   Gomes, MWL
   Ferreira, DE
   Santos, RMA
   Pinto, AMV
   Ratcliffe, NA
   Cirne-Santos, CC
   Barros, CS
   Ferreira, VF
   Paixao, ICNP
AF Gonzaga, Daniel T. G.
   Gomes, Rafaela S. P.
   Marra, Roberta K. F.
   da Silva, Fernando C.
   Gomes, Max W. L.
   Ferreira, Davis E.
   Santos, Raissa M. A.
   Pinto, Ana M., V
   Ratcliffe, Norman Arthur
   Cirne-Santos, Claudio C.
   Barros, Caroline S.
   Ferreira, Vitor F.
   Paixao, Izabel Christina N. P.
TI Inhibition of Zika Virus Replication by Synthetic Bis-Naphthoquinones
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Article
DE Zika virus; Flavivirus; arbovirus; antiviral; bis-naphthoquinones
ID IN-VITRO; INFECTION; SCREEN; TYPE-2; DRUGS; RNA
AB Zika virus (ZIKV) is a mosquito-borne pathogen which is a current global public health concern. There are currently no approved vaccines or antivirals against ZIKV infection. Taking into account that naphthoquinones have shown promising antiviral activity, the aim of this study was to describe the screening of two bis-naphthoquinones series against ZIKV. Twenty seven compounds were evaluated against ZIKV using Vero cells. The findings showed that among the compounds analyzed four were promising. Compound 3.3' -((2-nitrophenyl)methylene)bis(2-hydroxynaphthalene-1,4-dione) containing the nitro group at the ortho position showed the best selectivity index, followed by compound 3,3'-(4-chlorophenylmethylene)bis(naphthalene-1,2,4-triyl triacetate) with the chlorophenylmethylene radical. These results demonstrate that these bis-naphthoquinones are largely effective in inhibiting the replication of ZIKV.
C1 [Gonzaga, Daniel T. G.; Marra, Roberta K. F.; da Silva, Fernando C.; Santos, Raissa M. A.; Ferreira, Vitor F.] Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.
   [Gonzaga, Daniel T. G.] Ctr Univ Estadual Zona Oeste, Inst Biomed, BR-23070200 Rio De Janeiro, RJ, Brazil.
   [Gomes, Rafaela S. P.; Gomes, Max W. L.; Cirne-Santos, Claudio C.; Barros, Caroline S.; Paixao, Izabel Christina N. P.] Univ Fed Fluminense, Inst Biol, BR-24020141 Niteroi, RJ, Brazil.
   [Ferreira, Davis E.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941599 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis E.] North Carolina State Univ, Dept Mol & Struct Biochem, 120 W Broughton Dr, Raleigh, NC 27607 USA.
   [Pinto, Ana M., V] Univ Fed Fluminense, Unidade Farm, BR-24210130 Niteroi, RJ, Brazil.
   [Ratcliffe, Norman Arthur] Swansea Univ, Coll Sci, Dept Biociences, Swansea SA2 8PP, W Glam, Wales.
RP Ferreira, VF (corresponding author), Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ, Brazil.; Paixao, ICNP (corresponding author), Univ Fed Fluminense, Inst Biol, BR-24020141 Niteroi, RJ, Brazil.
EM vitorferreira@id.uff.br; izabeluff@gmail.com
RI Paixao, Izabel/AAM-1668-2020; Cirne-Santos, Claudio/T-4009-2019; Paixao,
   Izabel/S-7490-2019; Pinto, Ana Maria Viana/AAH-2080-2019; de Carvalho da
   Silva, Fernando/E-3408-2014; Barros, Caroline/S-7840-2019
OI Cirne-Santos, Claudio/0000-0001-8376-1830; de Carvalho da Silva,
   Fernando/0000-0002-2042-3778; Barros, Caroline/0000-0002-4678-3093
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPESCAPES
FX The authors thank the Brazilian agencies CNPq, CAPES, and FAPERJ and
   FIOCRUZ for the HRMS. V. F. F., F. C. S. and I. C. N. P. P. are
   recipients of CNPq research fellowships; D. T. G. G., R. K. F. M. and N.
   A. R. received FAPERJ research fellowships. C. C. C. S. thanks to CAPES
   for the Postdoc fellowship and C. S. B. thanks FAPERJ for the Postdoc
   fellowship. The authors would like to acknowledge for the technical
   support of Thereza Elizabeth P. P. Garcia.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   [Anonymous], 2002, GRAPHPAD INST VERS 3
   Azarudeen R. M. S. T., 2016, J CLUST SCI, V20, P359
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brahmachari G, 2015, ACS SUSTAIN CHEM ENG, V3, P2058, DOI 10.1021/acssuschemeng.5b00325
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao S, 2014, CURR ORG CHEM, V18, P70, DOI 10.2174/138527281801140121123221
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng HY, 2004, J ANTIMICROB CHEMOTH, V53, P577, DOI 10.1093/jac/dkh136
   Crosby IT, 2011, BIOORG MED CHEM LETT, V21, P1644, DOI 10.1016/j.bmcl.2011.01.109
   da Costa ECB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082504
   da Silva FD, 2016, CURR ORG SYNTH, V13, P334, DOI 10.2174/1570179412666150817220343
   de Araujo MV, 2014, MOLECULES, V19, P15180, DOI 10.3390/molecules190915180
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Lieberherr C, 2017, PLANTA MED, V83, P232, DOI 10.1055/s-0042-111825
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira DRM, 2015, J ENZYM INHIB MED CH, V30, P615, DOI 10.3109/14756366.2014.958083
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7
   Ogura Takahiro, 2015, BMC Res Notes, V8, P644, DOI 10.1186/s13104-015-1627-5
   Pinto AMV, 2014, ARCH VIROL, V159, P1827, DOI 10.1007/s00705-014-1989-3
   Pires M. C., 2015, ANTIVIR THER, V21, P507
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Salam AP, 2017, ANN INTERN MED, V166, P725, DOI [10.7326/M16-2530, 10.7326/m16-2530]
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Silva TL, 2016, CHEMELECTROCHEM, V3, P2252, DOI 10.1002/celc.201600504
   Tisseh ZN, 2009, DYES PIGMENTS, V83, P258, DOI 10.1016/j.dyepig.2008.09.003
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 44
TC 1
Z9 1
U1 1
U2 1
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD AUG
PY 2019
VL 30
IS 8
BP 1697
EP 1706
DI 10.21577/0103-5053.20190071
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA IK5IZ
UT WOS:000476620200014
OA DOAJ Gold
DA 2020-10-30
ER

PT J
AU Pato, TP
   Souza, MCO
   Mattos, DA
   Caride, E
   Ferreira, DF
   Gaspar, LP
   Freire, MS
   Castilho, LR
AF Pato, Tania P.
   Souza, Marta C. O.
   Mattos, Diogo A.
   Caride, Elena
   Ferreira, Davis F.
   Gaspar, Luciane P.
   Freire, Marcos S.
   Castilho, Leda R.
TI Purification of yellow fever virus produced in Vero cells for
   inactivated vaccine manufacture
SO VACCINE
LA English
DT Article
DE Yellow fever virus (YFV); Downstream processing; Virus purification;
   Inactivated vaccine; Chromatographic techniques
ID INFLUENZA-A; IMMUNOGENICITY; CHROMATOGRAPHY; PROTEINS; VECTORS; CAPTURE
AB Yellow fever (YF) is a high-lethality viral disease, endemic in tropical regions of South America and Africa, with a population of over 900 million people under risk. A highly effective attenuated vaccine, produced in embryonated eggs, has been used for about 80 years. However, egg-based production limits manufacturing capacity, and vaccine shortage led to the emergency use of a fractional dose (1/5) by the WHO in an outbreak in Africa in 2016 and by Brazilian authorities during an outbreak in 2018. In addition, rare but fatal adverse events of this vaccine have been reported since 2001. These two aspects make clear the need for the development of a new vaccine. In an effort to develop an inactivated YF vaccine, Bio-Manguinhos/FIOCRUZ started developing a new vaccine based on the production of the attenuated 17DD virus in serum-free conditions in Vero cells propagated in bioreactors, followed by chromatography-based purification and beta-propiolactone inactivation.
   Virus purification was studied in this work. Capture was performed using an anion-exchange membrane adsorber (Sartobind (R) Q), resulting in a virus recovery of 80.2 +/- 4.8% and a residual DNA level of 1.3 +/- 1.6 ng/dose, thus in accordance with the recommendations of the WHO (<10 ng/dose). However, the level of host cell proteins (HCP) was still high for a human vaccine, so a second chromatography step was developed based on a multimodal resin (Capto (TM) Core 700). This step resulted in a virus recovery of 65.7 +/- 4.8% and decreased HCP levels to 345 +/- 25 ppm. The overall virus recovery in these chromatography steps was 52.7%. SDS-PAGE of the purified sample showed a band with molecular mass of 56 kDa, thus consistent with the virus envelope protein (E) and corresponding to 96.7% of identified proteins. A Western blot stained with an antibody against the E protein showed a single band, confirming the identity of the sample. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Pato, Tania P.; Souza, Marta C. O.; Mattos, Diogo A.; Caride, Elena; Gaspar, Luciane P.; Freire, Marcos S.] Biomanguinhos, Oswaldo Cruz Fdn FIOCRUZ, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Pato, Tania P.; Castilho, Leda R.] Fed Univ Rio de Janeiro UFRJ, Inst Chem, Biochem Program, Av Athos Silveira Ramos 149,Bl A, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis F.] Fed Univ Rio de Janeiro UFRJ, Inst Microbiol, Virol Dept, Av Carlos Chagas 373,Bl 1, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Castilho, Leda R.] Fed Univ Rio de Janeiro UFRJ, COPPE, Cell Culture Engn Lab, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
RP Pato, TP (corresponding author), Biomanguinhos, Oswaldo Cruz Fdn FIOCRUZ, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM tania@bio.fiocruz.br
FU FaperjCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); CapesCAPES
FX The authors wish to thank the Brazilian research funding agencies
   Faperj, CNPq and Capes for financial support.
CR Blom H, 2014, VACCINE, V32, P3721, DOI 10.1016/j.vaccine.2014.04.033
   BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Caufour PS, 2001, VIRUS RES, V79, P1, DOI 10.1016/S0168-1702(01)00273-8
   CDC, 2018, YELL FEV MAPS
   Chagas MP, 2013, THESIS
   FDA, 2010, CHAR QUAL CELL SUBST
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   GE HEALTHCARE, 2012, 28998307 AA GE HEALT
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Kalbfuss B, 2007, J MEMBRANE SCI, V299, P251, DOI 10.1016/j.memsci.2007.04.048
   Mattos DA, 2015, VACCINE, V33, P4288, DOI 10.1016/j.vaccine.2015.04.050
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/erv.12.6, 10.1586/ERV.12.6]
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Morenweiser R, 2005, GENE THER, V12, pS103, DOI 10.1038/sj.gt.3302624
   Nestola P, 2015, BIOTECHNOL BIOENG, V112, P843, DOI 10.1002/bit.25545
   Ohtake S, 2015, WILEY SER BIOTECHNOL, P287
   PAHO, 2018, BRAZ LAUNCH WORLDS L
   PATH Vaccine and Pharmaceutical Technologies Group, 2012, SUMM STAB DAT INV FO
   Pato TP, 2014, VACCINE, V32, P2789, DOI 10.1016/j.vaccine.2014.02.036
   Pato TP, 2014, THESIS
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Peixoto C, 2008, BIOTECHNOL PROGR, V24, P1290, DOI 10.1002/btpr.25
   Pereira RC, 2015, VACCINE, V33, P4261, DOI 10.1016/j.vaccine.2015.03.077
   Souza MCO, 2009, VACCINE, V27, P6420, DOI 10.1016/j.vaccine.2009.06.023
   Vicente T, 2009, GENE THER, V16, P766, DOI 10.1038/gt.2009.33
   Vicente T, 2008, J MEMBRANE SCI, V311, P270, DOI 10.1016/j.memsci.2007.12.021
   Wang X, 2009, BIOTECHNOL BIOENG, V103, P446, DOI 10.1002/bit.22304
   Weigel T, 2014, J VIROL METHODS, V207, P45, DOI 10.1016/j.jviromet.2014.06.019
   WHO, 2019, YELL FEV BRAZ
   WHO, 2013, YELL FEV VACC BOOST
   WHO, 2007, STUD GROUP CELL SUBS
   WHO, 2018, EL YELL FEV EP EYE S
   World Health Organization, 2016, 14 WHO
   World Health Organization, 2017, 32 WHO
NR 35
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 27
PY 2019
VL 37
IS 24
BP 3214
EP 3220
DI 10.1016/j.vaccine.2019.04.077
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA IA9UZ
UT WOS:000469903700012
PM 31047674
DA 2020-10-30
ER

PT J
AU Hernandez, R
   Glaros, T
   Rizzo, G
   Ferreira, DF
AF Hernandez, Raquel
   Glaros, Trevor
   Rizzo, Gabrielle
   Ferreira, Davis F.
TI Purification and Proteomic Analysis of Alphavirus Particles from Sindbis
   Virus Grown in Mammalian and Insect Cells
SO BIO-PROTOCOL
LA English
DT Article
DE Sindbis virus; Mass spectrometry; Virus proteome; Virus purification;
   Alphavirus; Proteomics
ID PROTEIN; IDENTIFICATION
AB Current mass spectrometry (MS) methods and new instrumentation now allow for more accurate identification of proteins in low abundance than previous protein fractionation and identification methods. It was of interest if this method could serve to define the virus proteome of a membrane-containing virus. To evaluate the efficacy of mass spec to determine the proteome of medically important viruses, Sindbis virus (SINV), the prototypical alphavirus was chosen for evaluation. This model system was chosen specifically because the alphaviruses contain members which are human pathogens, this virus is well defined biochemically and structurally, and grows to high titers in both vertebrate and non-vertebrate host cells. The SINV proteome was investigated using this method to determine if host proteins are specifically packaged into infectious virions. It was also of interest if the SINV proteome, when grown in multiple host cells representing vertebrate and mosquito hosts, incorporated specific host proteins from all hosts. Observation of recurrent or distinctive proteins in the virus proteome aided in the determination of proteins incorporated into the virion as opposed to those bound to the particle exterior. Mass spectrometry analysis identified the total protein content of purified virions within limits of detection. The most significant finding was that in addition to the host proteins, SINV non-structural protein 2 (nsP2) was detected within virions grown in all host cells examined. This analysis identified host factors not previously associated with alphavirus entry, replication, or egress, identifying at least one host factor integrally involved in alphavirus replication. Key to the success of this analysis is the method of virus purification which must deliver measurably infectious virus free of high levels of contaminants. For SINV and other members of the alphavirus family, this is accomplished by isopycnic centrifugation through potassium tartrate, followed by a high salt wash.
C1 [Hernandez, Raquel; Ferreira, Davis F.] North Carolina State Univ, Dept Mol & Struct Biol, Raleigh, NC 27695 USA.
   [Glaros, Trevor] US Army Combat Capabil Dev Command CCDC, Chem Biol Ctr, Aberdeen Proving Ground, MD 21010 USA.
   [Rizzo, Gabrielle] Excet Inc, 6225 Brandon Ave,Suite 360, Springfield, VA 22150 USA.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
RP Hernandez, R (corresponding author), North Carolina State Univ, Dept Mol & Struct Biol, Raleigh, NC 27695 USA.
EM Raquel_Hernandez@ncsu.edu
FU Clayton Foundation for Research; Carson City NV; College of Agriculture
   and Natural Sciences, North Carolina State University; U.S. Army Combat
   Capabilities Development Command (CCDC) Chemical Biological Center
FX RH and DF were supported by the Clayton Foundation for Research, Carson
   City NV and the College of Agriculture and Natural Sciences, North
   Carolina State University. TG and GR were supported by the U.S. Army
   Combat Capabilities Development Command (CCDC) Chemical Biological
   Center through an internal basic research grant. The opinions presented
   here are those of the authors and are not the official policy of the
   U.S. Army, CCDC, or the U.S. Government. Information in this report is
   cleared for public release and distribution is unlimited. This protocol
   is adapted from the publication. Schuchman R, Kilianski A, Piper A,
   Vancini R, Ribeiro JMC, Sprague TR, Nasar F, Boyd G, Hernandez R, Glaros
   T. 2018. Comparative Characterization of the Sindbis Virus Proteome from
   Mammalian and Invertebrate Hosts Identifies nsP2 as a Component of the
   Virion and Sorting Nexin 5 as a Significant Host Factor for Alphavirus
   Replication. J Virol 92.
CR Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   COOMBS K, 1987, VIRUS RES, V7, P131, DOI 10.1016/0168-1702(87)90075-X
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Glaros TG, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9079-4
   Hernandez R, 2014, ADV VIROL, V2014, DOI 10.1155/2014/259382
   Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525
   Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194
   Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x
   Rumble J.R., 2005, CRC HDB CHEM PHYS
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Vancini R, 2013, J VIROL, V87, P4352, DOI 10.1128/JVI.03412-12
   Wilkins M, 2009, EXPERT REV PROTEOMIC, V6, P599, DOI 10.1586/EPR.09.81
   Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
NR 18
TC 0
Z9 0
U1 1
U2 3
PU BIO-PROTOCOL
PI SUNNYVALE
PA PO BOX 2073, SUNNYVALE, CA 94087 USA
EI 2331-8325
J9 BIO-PROTOCOL
JI Bio-protocol
PD MAY 20
PY 2019
VL 9
IS 10
AR e3239
DI 10.21769/BioProtoc.3239
PG 33
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HZ1DO
UT WOS:000468586700008
OA Other Gold
DA 2020-10-30
ER

PT J
AU Caldas, LA
   Ferreira, DF
   Freitas, TRP
AF Caldas, Lucio Ayres
   Ferreira, Davis Fernandes
   Pereira Freitas, Tania Rosaria
TI Prostaglandin A(1) triggers Mayaro virus inhibition and heat shock
   protein 70 expression in an epithelial cell model
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Mayaro virus; Prostaglandin A; Heat shock proteins
ID VESICULAR STOMATITIS-VIRUS; AEDES-ALBOPICTUS CELLS;
   HUMAN-IMMUNODEFICIENCY-VIRUS; SHOCK PROTEIN-SYNTHESIS; HUMAN-DISEASE
   AGENT; CYCLOPENTENONE PROSTAGLANDINS; VERO CELLS; REPLICATION; BRAZIL;
   INDUCTION
AB Introduction: The Mayaro virus (MAYV), which is an arbovirus closely related to the Chikungunya virus, causes a dengue-like acute illness that is endemic to Central and South America. We investigated the anti-MAYV activity of prostaglandin A(1) (PGA(1)), a hormone which exhibits antiviral activity against both ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) viruses. Further, we examined the effects of inducting the stress protein HSP70 following PGA(1) treatment. Methods: Hep-2 cells infected with MAYV were treated with PGA(1) (0.1- 6 mu g/ml) 12h before infection and for different periods post-infection. Inhibition of viral replication inhibition was analyzed via viral titer determination, whereas the effect of PGA(1) on viral morphogenesis was examined via transmission electron microscopy (TEM). Autoradiography (with S-35 methionine labeling) and western blotting were used to assess the effect of PGA(1) treatment on viral and cellular protein synthesis, and on HSP70 induction, respectively. Results: PGA(1) strongly reduced viral replication in Hep-2 cells, particularly when added during the early stages of viral replication. Although PGA(1) treatment inhibited viral replication by 95% at 24 hours post-infection (hpi), viral structural protein synthesis was inhibited only by 15%. TEM analysis suggested that PGA(1) inhibited replication before viral morphogenesis. Western blot and densitometry analyses showed that PGA(1) treatment increased HSP70 protein levels, although this was not detectable via autoradiography. Conclusions: PGA(1) inhibits MAYV replication in Hep-2 cells at early stages of viral replication, prior to production of viral structural proteins, possibly via HSP70 induction.
C1 [Caldas, Lucio Ayres] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis Fernandes] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC USA.
   [Pereira Freitas, Tania Rosaria] Minist Agr Pecuaria & Abastecimento, Lab Nacl Agr, Pedro Leopoldo, MG, Brazil.
RP Caldas, LA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
EM lucio@biof.ufrj.br
OI Caldas, Lucio Ayres/0000-0002-1187-557X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   ANKEL H, 1991, J GEN VIROL, V72, P2797, DOI 10.1099/0022-1317-72-11-2797
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   BADER T, 1990, J GEN VIROL, V71, P2823, DOI 10.1099/0022-1317-71-12-2823
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   BARBOSA JA, 1995, BRAZ J MED BIOL RES, V28, P27
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Burlandy FM, 2001, INTERVIROLOGY, V44, P344, DOI 10.1159/000050069
   CARVALHO MGC, 1987, BRAZ J MED BIOL RES, V20, P857
   Casseb Alexandre do Rosario, 2013, Veterinaria e Zootecnia, V20, P391
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Conti C, 1996, ANTIMICROB AGENTS CH, V40, P367, DOI 10.1128/AAC.40.2.367
   De Campos RM, 2003, ACTA VIROL, V47, P113
   De Marco A, 1998, EUR J BIOCHEM, V256, P334, DOI 10.1046/j.1432-1327.1998.2560334.x
   de Meneses MDF, 2001, Z NATURFORSCH C, V56, P298
   DINARELLO CA, 1982, AM J MED, V72, P799, DOI 10.1016/0002-9343(82)90548-4
   Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313
   Freitas TRP, 1998, MEM I OSWALDO CRUZ, V93, P815, DOI 10.1590/S0074-02761998000600021
   FUKUSHIMA M, 1989, ADV PROSTAG THROMB L, V19, P415
   FUKUSHIMA M, 1991, EICOSANOIDS, V4, P119
   FUKUSHIMA M, 1990, EICOSANOIDS, V3, P189
   Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hamel L, 2000, CELL STRESS CHAPERON, V5, P121, DOI 10.1379/1466-1268(2000)005<0121:IOHSPB>2.0.CO;2
   HOLBROOK NJ, 1992, MOL CELL BIOL, V12, P1528, DOI 10.1128/MCB.12.4.1528
   Ishimaru D, 1998, BRAZ J MED BIOL RES, V31, P1119, DOI 10.1590/S0100-879X1998000900003
   Johnston R.E., 1996, FIELDS VIROLOGY, P843
   MACEJAK DG, 1992, J VIROL, V66, P1520, DOI 10.1128/JVI.66.3.1520-1527.1992
   MASTROMARINO P, 1993, ANTIVIR RES, V20, P209, DOI 10.1016/0166-3542(93)90021-A
   PARKER J, 1995, ANTIVIR RES, V26, P83, DOI 10.1016/0166-3542(94)00067-I
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pena-Garcia VH, 2017, CURR CLIN MICROBIOL, V4, P208, DOI 10.1007/s40588-017-0076-4
   Pica F, 1996, ANTIVIR RES, V29, P187, DOI 10.1016/0166-3542(95)00834-9
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   REBELLO MCS, 1993, ACTA VIROL, V37, P223
   Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520
   ROSSI A, 1994, ANN NY ACAD SCI, V744, P326, DOI 10.1111/j.1749-6632.1994.tb52754.x
   SANTORO MG, 1983, J GEN VIROL, V64, P2797, DOI 10.1099/0022-1317-64-12-2797
   SANTORO MG, 1989, J GEN VIROL, V70, P789, DOI 10.1099/0022-1317-70-4-789
   SANTORO MG, 1994, EXPERIENTIA, V50, P1039, DOI 10.1007/BF01923459
   Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3
   Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4
   Santoro MG, 1996, STRESS INDUCIBLE CEL, P336
   SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4
   Sugiyama R, 2011, J BIOL CHEM, V286, P10051, DOI 10.1074/jbc.M110.166108
   Superti F, 1998, J INFECT DIS, V178, P564, DOI 10.1086/517475
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 54
TC 4
Z9 5
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2018
VL 51
IS 5
BP 584
EP 590
DI 10.1590/0037-8682-0235-2018
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GW0WU
UT WOS:000446591400004
PM 30304262
OA DOAJ Gold
DA 2020-10-30
ER

PT J
AU Schuchman, RM
   Vancini, R
   Piper, A
   Breuer, D
   Ribeiro, M
   Ferreira, D
   Magliocca, J
   Emmerich, V
   Hernandez, R
   Brown, DT
AF Schuchman, Ryan M.
   Vancini, Ricardo
   Piper, Amanda
   Breuer, Denitra
   Ribeiro, Mariana
   Ferreira, Davis
   Magliocca, Joseph
   Emmerich, Veronica
   Hernandez, Raquel
   Brown, Dennis T.
TI Role of the vacuolar ATPase in the Alphavirus replication cycle
SO HELIYON
LA English
DT Article
DE Virology; Cell biology
ID SEMLIKI-FOREST-VIRUS; PROTEIN-PROTEIN INTERACTIONS; FOLIMYCIN
   CONCANAMYCIN-A; BACTERIOPHAGE T7 DNA; CELL-CELL-FUSION; SINDBIS VIRUS;
   NONSTRUCTURAL PROTEIN; ESCHERICHIA-COLI; PLASMA-MEMBRANE; V-ATPASE
AB We have shown that Alphaviruses can enter cells by direct penetration at the plasma membrane (R. Vancini, G. Wang, D. Ferreira, R. Hernandez, and D. Brown, J Virol, 87: 4352-4359, 2013). Direct penetration removes the requirement for receptor-mediated endocytosis exposure to low pH and membrane fusion in the process of RNA entry. Endosomal pH as well as the pH of the cell cytoplasm is maintained by the activity of the vacuolar ATPase (V-ATPase). Bafilomycin is a specific inhibitor of V-ATPase. To characterize the roll of the V-ATPase in viral replication we generated a Bafilomycin A1(BAF) resistant mutant of Sindbis virus (BRSV). BRSV produced mature virus and virus RNA in greater amounts than parent virus in BAF-treated cells. Sequence analysis revealed mutations in the E2 glycoprotein, T15I/Y18H, were responsible for the phenotype. These results show that a functional V-ATPase is required for efficient virus RNA synthesis and virus maturation in Alphavirus infection.
C1 [Schuchman, Ryan M.; Vancini, Ricardo; Piper, Amanda; Breuer, Denitra; Ribeiro, Mariana; Ferreira, Davis; Magliocca, Joseph; Emmerich, Veronica; Hernandez, Raquel; Brown, Dennis T.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, RJ, Brazil.
RP Brown, DT (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
FU Clayton Foundation for Research, Carson City, NV; North Carolina
   Agriculture Research Service
FX This work was supported by the Clayton Foundation for Research, Carson
   City, NV; and by the North Carolina Agriculture Research Service.
CR Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y
   ALONSO MA, 1982, EUR J BIOCHEM, V127, P567
   Andoh T, 1998, J NEUROVIROL, V4, P627, DOI 10.3109/13550289809114229
   ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Camacho LAB, 2005, REV SAUDE PUBL, V39, P413, DOI 10.1590/S0034-89102005000300012
   de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X
   DING MX, 1989, VIROLOGY, V171, P280, DOI 10.1016/0042-6822(89)90539-4
   DOXSEY SJ, 1987, CELL, V50, P453, DOI 10.1016/0092-8674(87)90499-5
   Duan XQ, 2008, BIOCHEM BIOPH RES CO, V373, P319, DOI 10.1016/j.bbrc.2008.06.041
   EDWARDS J, 1986, J GEN VIROL, V67, P377, DOI 10.1099/0022-1317-67-2-377
   GARCIA LR, 1995, J BACTERIOL, V177, P4066, DOI 10.1128/jb.177.14.4066-4076.1995
   Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239
   Glomb-Reinmund S, 1998, J VIROL, V72, P4281, DOI 10.1128/JVI.72.5.4281-4287.1998
   Guzman-Grenfell AM, 2000, BBA-BIOMEMBRANES, V1464, P188, DOI 10.1016/S0005-2736(99)00247-3
   HAHN YS, 1989, J VIROL, V63, P1194, DOI 10.1128/JVI.63.3.1194-1202.1989
   HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989
   HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47
   HELENIUS A, 1982, CIBA F SYMP, V92, P59
   Hernandez R., 2005, CURR PROTOC MICROB B, V15B, P1
   Hunt SR, 2011, J VIROL, V85, P1257, DOI 10.1128/JVI.01864-10
   Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348
   Irurzun A, 1997, VIROLOGY, V227, P488, DOI 10.1006/viro.1996.8340
   Kemp P, 2004, MOL MICROBIOL, V53, P1251, DOI 10.1111/j.1365-2958.2004.04204.x
   KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7
   Kim KH, 1996, J VIROL, V70, P5533, DOI 10.1128/JVI.70.8.5533-5540.1996
   Koschinski A, 2005, J GEN VIROL, V86, P3311, DOI 10.1099/vir.0.81096-0
   LAAKKONEN P, 1994, J VIROL, V68, P7418, DOI 10.1128/JVI.68.11.7418-7425.1994
   LANZREIN M, 1993, VIROLOGY, V196, P541, DOI 10.1006/viro.1993.1509
   LEMM JA, 1990, J VIROL, V64, P3001, DOI 10.1128/JVI.64.6.3001-3011.1990
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   LI GP, 1990, VIROLOGY, V179, P416, DOI 10.1016/0042-6822(90)90310-N
   MARSH M, 1984, BIOCHEM SOC T, V12, P981, DOI 10.1042/bst0120981
   MARSH M, 1982, P NATL ACAD SCI-BIOL, V79, P5297, DOI 10.1073/pnas.79.17.5297
   MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311
   MI S, 1991, VIROLOGY, V184, P423, DOI 10.1016/0042-6822(91)90862-6
   MOFFATT BA, 1988, J BACTERIOL, V170, P2095, DOI 10.1128/jb.170.5.2095-2105.1988
   Mukhopadhyay S, 2006, STRUCTURE, V14, P63, DOI 10.1016/j.str.2005.07.025
   MUROI M, 1993, BIOCHEM BIOPH RES CO, V193, P999, DOI 10.1006/bbrc.1993.1724
   MUROI M, 1993, CELL STRUCT FUNCT, V18, P139, DOI 10.1247/csf.18.139
   OMAR A, 1988, VIROLOGY, V166, P17, DOI 10.1016/0042-6822(88)90141-9
   Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199
   PERANEN J, 1988, J GEN VIROL, V69, P2165, DOI 10.1099/0022-1317-69-9-2165
   Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6
   PRESSMAN BC, 1982, ANNU REV PHARMACOL, V22, P465, DOI 10.1146/annurev.pa.22.040182.002341
   RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994
   Rossmann MG, 2004, CURR OPIN STRUC BIOL, V14, P171, DOI 10.1016/j.sbi.2004.02.001
   SAWICKI DL, 1990, VIROLOGY, V174, P43, DOI 10.1016/0042-6822(90)90052-S
   SCHEIDEL LM, 1991, VIROLOGY, V181, P490, DOI 10.1016/0042-6822(91)90881-B
   Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304
   Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x
   Stiles KM, 2016, J VIROL, V90, P4289, DOI 10.1128/JVI.00018-16
   STRAUSS EG, 1992, VIROLOGY, V191, P932, DOI 10.1016/0042-6822(92)90268-T
   Sun-Wada GH, 2007, CELL TISSUE RES, V329, P239, DOI 10.1007/s00441-007-0421-7
   Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234
   Vancini R, 2015, PROG MOL BIOL TRANSL, V129, P33, DOI 10.1016/bs.pmbts.2014.10.002
   Vancini R, 2013, J VIROL, V87, P4352, DOI 10.1128/JVI.03412-12
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wang GB, 2007, VIROLOGY, V362, P461, DOI 10.1016/j.virol.2006.12.036
   Wang HL, 1996, VIROLOGY, V217, P527, DOI 10.1006/viro.1996.0147
   Wengler G, 2004, J GEN VIROL, V85, P1695, DOI 10.1099/vir.0.79845-0
   Wengler G, 2003, J GEN VIROL, V84, P173, DOI 10.1099/vir.0.18696-0
   WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273
   Whitehurst CB, 2007, J VIROL, V81, P6231, DOI 10.1128/JVI.02859-06
   Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   ZAVRIEV SK, 1982, NUCLEIC ACIDS RES, V10, P1635, DOI 10.1093/nar/10.5.1635
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 71
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD JUL
PY 2018
VL 4
IS 7
AR e00701
DI 10.1016/j.heliyon.2018.e00701
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP0UQ
UT WOS:000440526400009
PM 30094371
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Salles, TS
   Sa-Guimaraes, TD
   de Alvarenga, ESL
   Guimaraes-Ribeiro, V
   de Meneses, MDF
   de Castro-Salles, PF
   dos Santos, CR
   Melo, ACD
   Soares, MR
   Ferreira, DF
   Moreira, MF
AF Salles, Tiago Souza
   Sa-Guimaraes, Thayane da Encarnacao
   Lima de Alvarenga, Evelyn Seam
   Guimaraes-Ribeiro, Victor
   Ferreira de Meneses, Marcelo Damiao
   de Castro-Salles, Patricia Faria
   dos Santos, Carlucio Rocha
   do Amaral Melo, Ana Claudia
   Soares, Marcia Regina
   Ferreira, Davis Fernandes
   Moreira, Monica Ferreira
TI History, epidemiology and diagnostics of dengue in the American and
   Brazilian contexts: a review
SO PARASITES & VECTORS
LA English
DT Review
DE Dengue virus; Dengue history; Dengue epidemiology; Diagnostics of
   dengue; Serotyping
ID PCR ASSAY; VIRUSES; AMPLIFICATION; EMERGENCE; PRIMERS; DETECT
AB Dengue virus (DENV), an arbovirus transmitted by mosquitoes, has become a major threat to American human life, reaching approximately 23 million cases from 1980 to 2017. Brazil is among the countries most affected by this terrible viral disease, with 13.6 million cases. DENV has four different serotypes, DENV1-4, which show a broad clinical spectrum. Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector control strategies, early disease diagnostics and the development of vaccines and antiviral drugs are priorities. In this study, we present the probable origins of dengue in America and the trajectories of its spread. Overall, dengue diagnostics are costly, making the monitoring of dengue epidemiology more difficult and affecting physicians' therapeutic decisions regarding dengue patients, especially in developing countries. This review also highlights some recent and important findings regarding dengue in Brazil and the Americas. We also summarize the existing DENV polymerase chain reaction (PCR) diagnostic tests to provide an improved reference since these tests are useful and accurate at discriminating DENV from other flaviviruses that co-circulate in the Americas. Additionally, these DENV PCR assays ensure virus serotyping, enabling epidemiologic monitoring.
C1 [Salles, Tiago Souza; Sa-Guimaraes, Thayane da Encarnacao; Lima de Alvarenga, Evelyn Seam; Guimaraes-Ribeiro, Victor; do Amaral Melo, Ana Claudia; Soares, Marcia Regina; Moreira, Monica Ferreira] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, RJ, Brazil.
   [Salles, Tiago Souza; Ferreira de Meneses, Marcelo Damiao; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [de Castro-Salles, Patricia Faria] Hosp Vitoria, Amer Med City, Amil, Pediat, BR-22775001 Rio De Janeiro, RJ, Brazil.
   [dos Santos, Carlucio Rocha] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [do Amaral Melo, Ana Claudia; Moreira, Monica Ferreira] Inst Nacl Ciencia & Tecnol Entomol Mol, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Ferreira, Davis Fernandes] North Carolina State Univ, Dept Mol & Struct Biochem, 120 W Broughton Dr, Raleigh, NC 27695 USA.
RP Moreira, MF (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, BR-21941909 Rio De Janeiro, RJ, Brazil.; Moreira, MF (corresponding author), Inst Nacl Ciencia & Tecnol Entomol Mol, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM monica@iq.ufrj.br
RI Moreira, Monica F./J-4507-2016; Melo, Ana Claudia do Amaral/K-1048-2013;
   Melo, Ana Claudia do Amaral/Y-9734-2019
OI Moreira, Monica F./0000-0002-3720-415X; Melo, Ana Claudia do
   Amaral/0000-0003-0686-7089; Melo, Ana Claudia do
   Amaral/0000-0003-0686-7089; Salles, Tiago/0000-0002-5822-1426
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia em Entomologia
   Molecular (INCT-EM/CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-18/2015, 221797]
FX This study was financially supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de
   Ciencia e Tecnologia em Entomologia Molecular (INCT-EM/CNPq), and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ) -Edital: E-18/2015 pedido: 221797.
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   CHANG GJJ, 1994, J CLIN MICROBIOL, V32, P477, DOI 10.1128/JCM.32.2.477-483.1994
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Ghosh D, 2008, DRUG DISCOV TODAY, V13, P619, DOI 10.1016/j.drudis.2008.04.001
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Ministerio da Saude, 2011, DENG PREV DENG
   Ministerio da Saude, 2011, DEP VIG EP DENG DIAG
   Ministerio da Saude, 2010, COMB DENG HIST
   Ministerio da Saude, 2010, SECR VIG SAUD INF EP
   Ministerio da Saude, 2011, COMB DENG COM COMB
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Najioullah F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-164
   O Globo, 2010, PORT G1 GLOB CAS DEN
   Ouvidoria Anvisa: National Health Surveillance Agency, 2017, MAN ENV APL VAC DENG
   Pan American Health Organization, 2018, DISTR DENG VIR SER A
   Pan American Health Organization, 2018, NUMB REP CAS DENG DE
   Pan American Health Organization, 2018, DENG MORT RAT COUNTR
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Reuters, 2018, PHIL SAYS ANT VACC M
   Salles TS, 2017, ARCH CLIN MICROBIOL, V4, P55
   SBMT, 2016, AV VIR MAIS AGR DENG
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003
   Slonczewski JL, 2010, MICROBIOLOGY EVOLVIN
   SVS, 2013, DEP VIG EP GUIA VIG
   SVS, 2014, DEP VIG EP GUIA VIG
   SVS, 2017, DEP VIG EP GUIA VIG
   SVS, 2016, DEP VIG EP GUIA VIG
   SVS, 2015, DEP VIG EP GUIA VIG
   SVS, 2011, DEP VIG EP GUIA VIG
   SVS, 2012, DEP VIG EP GUIA VIG
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Thornton B, 2011, BIOCHEM MOL BIOL EDU, V39, P145, DOI 10.1002/bmb.20461
   Valle D, 2015, DENGUE TEORIAS PRATI
   Valle D, 2016, EPIDEMIOL SERV SAUDE, V25, P629, DOI 10.5123/S1679-49742016000300018
   Villar L, 2015, NEW ENGL J MED, V11, P164
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   World Health Organization, 2009, DENG GUID DIAGN TREA
   WorldHealth Organization, 1999, DENG HAEM FEV DIAGN
NR 56
TC 19
Z9 19
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 24
PY 2018
VL 11
AR 264
DI 10.1186/s13071-018-2830-8
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD9FY
UT WOS:000430819700004
PM 29690895
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Shahhosseini, N
   Luhken, R
   Jost, H
   Jansen, S
   Borstler, J
   Rieger, T
   Kruger, A
   Yadouleton, A
   Campos, RD
   Cirne-Santos, CC
   Ferreira, DF
   Garms, R
   Becker, N
   Tannich, E
   Cadar, D
   Schmidt-Chanasit, J
AF Shahhosseini, Nariman
   Luehken, Renke
   Joest, Hanna
   Jansen, Stephanie
   Boerstler, Jessica
   Rieger, Toni
   Krueger, Andreas
   Yadouleton, Anges
   Campos, Renata de Mendonca
   Cirne-Santos, Claudio Cesar
   Ferreira, Davis Fernandes
   Garms, Rolf
   Becker, Norbert
   Tannich, Egbert
   Cadar, Daniel
   Schmidt-Chanasit, Jonas
TI Detection and characterization of a novel rhabdovirus in Aedes cantans
   mosquitoes and evidence for a mosquito-associated new genus in the
   family Rhabdoviridae
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Rhabdovirus; Mosquitoes; Metagenomics; Evolution
ID STRAND RNA VIRUSES; VESICULAR STOMATITIS-VIRUS;
   PHYLOGENETIC-RELATIONSHIPS; PHLEBOTOMINE SANDFLIES; INDIANA SEROTYPE;
   P-GENE; SEQUENCE; IDENTIFICATION; POLYMERASE; PROTEIN
AB Thanks to recent advances in random amplification technologies, metagenomic surveillance expanded the number of novel, often unclassified viruses within the family Rhabdoviridae. Using a vector-enabled metagenomic (VEM) tool, we identified a novel rhabdovirus in Aedes cantans mosquitoes collected from Germany provisionally named Ohlsdorf virus (OHSDV). The OHSDV genome encodes the canonical rhabdovirus structural proteins (N, P, M, G and L) with alternative ORF in the P gene. Sequence analysis indicated that OHSDV exhibits a similar genome organization and characteristics compared to other mosquito-associated rhabdoviruses (Riverside virus, Tongilchon virus and North Creek virus). Complete L protein based phylogeny revealed that all four viruses share a common ancestor and form a deeply rooted and divergent monophyletic group within the dimarhabdovirus supergroup and define a new genus, tentatively named Ohlsdorfvirus. Although the Ohlsdorfvirus clade is basal within the dimarhabdovirus supergroup phylogeny that includes genera of arthropodborne rhabdoviruses, it remains unknown if viruses in the proposed new genus are vector-borne pathogens. The observed spatiotemporal distribution in mosquitoes suggests that members of the proposed genus Ohlsdorfvirus are geographically restricted/separated. These findings increase the current knowledge of the genetic diversity, classification and evolution of this virus family. Further studies are needed to determine the host range, transmission route and the evolutionary relationships of these mosquito-associated viruses with those infecting vertebrates.
C1 [Shahhosseini, Nariman; Luehken, Renke; Joest, Hanna; Jansen, Stephanie; Boerstler, Jessica; Rieger, Toni; Garms, Rolf; Tannich, Egbert; Cadar, Daniel; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Hemorrhag Fever, Hamburg, Germany.
   [Luehken, Renke; Joest, Hanna; Jansen, Stephanie; Tannich, Egbert; Cadar, Daniel; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Krueger, Andreas] Bundeswehr Hosp, Dept Trop Med, Hamburg, Germany.
   [Yadouleton, Anges] CREC, Cotonou, Benin.
   [Campos, Renata de Mendonca; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Cirne-Santos, Claudio Cesar] Fluminense Fed Univ, Inst Biol, Niteroi, RJ, Brazil.
   [Ferreira, Davis Fernandes] Dept Mol & Struct Biochem, Raleigh, NC USA.
   [Becker, Norbert] Inst Dipterol GFS, Speyer, Germany.
RP Cadar, D (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Hemorrhag Fever, Hamburg, Germany.
EM cadar@bnitm.de
RI Azevedo, Renata/V-3130-2019; Cirne-Santos, Claudio/T-4009-2019
OI Cirne-Santos, Claudio/0000-0001-8376-1830; Cadar,
   Daniel/0000-0002-8063-2766; Rieger, Toni/0000-0002-7863-1916; Luhken,
   Renke/0000-0002-1984-839X
FU German Federal Ministry of Food and Agriculture (BMEL) through Federal
   Office for Agriculture and Food (BLE) [2819104315]; Leibniz-Gesellschaft
   research Project IMPact-Vector [SAW-2014-SGN-3]
FX This research was partly supported by the German Federal Ministry of
   Food and Agriculture (BMEL) through the Federal Office for Agriculture
   and Food (BLE) with the grant number 2819104315. Nariman Shahhosseini's
   scholarship was supported by Leibniz-Gesellschaft research Project
   IMPact-Vector (SAW-2014-SGN-3).
CR Amarasinghe GK, 2017, ARCH VIROL
   ARTSOB H, 1991, CAN J MICROBIOL, V37, P329, DOI 10.1139/m91-053
   Blasdell KR, 2015, AM J TROP MED HYG, V92, P405, DOI 10.4269/ajtmh.14-0606
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0
   Charles J, 2016, J GEN VIROL, V97, P977, DOI 10.1099/jgv.0.000424
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   CRYSLER JG, 1990, J GEN VIROL, V71, P2191, DOI 10.1099/0022-1317-71-9-2191
   Curran J, 2008, VIROLOGY, V371, P227, DOI 10.1016/j.virol.2007.11.022
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dietzgen RG, 2012, VIRUS TAXONOMY, P686
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Ghedin E, 2013, J GEN VIROL, V94, P2609, DOI 10.1099/vir.0.055939-0
   Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hang J, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01644-15
   Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005
   Kuzmin IV, 2006, J GEN VIROL, V87, P2323, DOI 10.1099/vir.0.81879-0
   LABUDA M, 1974, ACTA VIROL, V18, P429
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Longdon B, 2010, P ROY SOC B-BIOL SCI, V277, P35, DOI 10.1098/rspb.2009.1472
   Mann KS, 2014, ARCH VIROL, V159, P1889, DOI 10.1007/s00705-014-2029-z
   Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277
   Nadin-Davis SA, 2002, VIROLOGY, V298, P286, DOI 10.1006/viro.2002.1492
   Nagai Y, 2004, CURR TOP MICROBIOL, V283, P197
   Norder H, 1996, VIROLOGY, V222, P440, DOI 10.1006/viro.1996.0441
   Peluso RW, 1996, VIROLOGY, V218, P335, DOI 10.1006/viro.1996.0202
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153
   POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x
   Quan PL, 2010, VIRUS RES, V147, P17, DOI 10.1016/j.virusres.2009.09.013
   Reuter G, 2016, INFECT GENET EVOL, V39, P336, DOI 10.1016/j.meegid.2016.02.016
   Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164
   TESH RB, 1972, SCIENCE, V175, P1477, DOI 10.1126/science.175.4029.1477
   Torok E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1484-7
   TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914
   Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97
   Vasilakis N, 2014, J GEN VIROL, V95, P787, DOI 10.1099/vir.0.058685-0
   Vasilakis N, 2013, VIROLOGY, V444, P80, DOI 10.1016/j.virol.2013.05.035
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Walker PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004664
   Walker PJ, 1999, J GEN VIROL, V80, P1211, DOI 10.1099/0022-1317-80-5-1211
NR 44
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2017
VL 55
BP 260
EP 268
DI 10.1016/j.meegid.2017.09.026
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FM2XO
UT WOS:000414866200036
PM 28943405
DA 2020-10-30
ER

PT J
AU Ayllon, T
   Campos, RD
   Brasil, P
   Morone, FC
   Camara, DCP
   Meira, GLS
   Tannich, E
   Yamamoto, KA
   Carvalho, MS
   Pedro, RS
   Schmidt-Chanasit, J
   Cadar, D
   Ferreira, DF
   Honorio, NA
AF Ayllon, Tania
   Campos, Renata de Mendonca
   Brasil, Patricia
   Morone, Fernanda Cristina
   Portela Camara, Daniel Cardoso
   Silva Meira, Guilherme Louzada
   Tannich, Egbert
   Yamamoto, Kristie Aimi
   Carvalho, Marilia Sa
   Pedro, Renata Saraiva
   Schmidt-Chanasit, Jonas
   Cadar, Daniel
   Ferreira, Davis Fernandes
   Honorio, Nildimar Alves
TI Early Evidence for Zika Virus Circulation among Aedes aegypti
   Mosquitoes, Rio de Janeiro, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
AB During 2014-2016, we conducted mosquito-based Zika virus surveillance in Rio de Janeiro, Brazil. Results suggest that Zika virus was probably introduced into the area during May-November 2013 via multiple in-country sources. Furthermore, our results strengthen the hypothesis that Zika virus in the Americas originated in Brazil during October 2012-May 2013.
C1 [Ayllon, Tania; Brasil, Patricia; Pedro, Renata Saraiva] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Ayllon, Tania; Morone, Fernanda Cristina; Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.
   [Campos, Renata de Mendonca; Silva Meira, Guilherme Louzada; Yamamoto, Kristie Aimi; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Tannich, Egbert; Schmidt-Chanasit, Jonas; Cadar, Daniel] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Carvalho, Marilia Sa] Fiocruz MS, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res Hamburg Luebeck Borstel, Hamburg, Germany.
RP Schmidt-Chanasit, J (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM jonassi@gmx.de
RI Azevedo, Renata/V-3130-2019; Camara, Daniel C. P./S-3504-2018; CARVALHO,
   MARILIA/AAD-8283-2020; Santiago, Tania Ayllon/B-2543-2019
OI Camara, Daniel C. P./0000-0002-5439-4477; CARVALHO,
   MARILIA/0000-0002-9566-0284; Santiago, Tania Ayllon/0000-0002-1195-5078;
   Cadar, Daniel/0000-0002-8063-2766
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroFAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [401542/2015-7, E-26/102.241/2013,
   E-26/010.001610/2016]; Fundacao Oswaldo Cruz
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico-CNPq, Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroFAPERJ (grant nos. 401542/2015-7,
   E-26/102.241/2013, and E-26/010.001610/2016) and Fundacao Oswaldo Cruz.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 25
Z9 25
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2017
VL 23
IS 8
BP 1411
EP 1412
DI 10.3201/eid2308.162007
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA FA8CG
UT WOS:000405673200030
PM 28628464
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Amorim, R
   de Meneses, MDF
   Borges, JC
   Pinheiro, LCD
   Caldas, LA
   Cirne-Santos, CC
   de Mello, MVP
   de Souza, AMT
   Castro, HC
   Paixao, ICND
   Campos, RD
   Bergmann, IE
   Malirat, V
   Bernardino, AMR
   Rebello, MA
   Ferreira, DF
AF Amorim, Raquel
   Ferreira de Meneses, Marcelo Damiao
   Borges, Julio Cesar
   da Silva Pinheiro, Luiz Carlos
   Caldas, Lucio Ayres
   Cirne-Santos, Claudio Cesar
   Palmeira de Mello, Marcos Vinicius
   Teles de Souza, Alessandra Mendonca
   Castro, Helena Carla
   Nunes de Palmer Paixao, Izabel Christina
   Campos, Renata de Mendonca
   Bergmann, Ingrid E.
   Malirat, Viviana
   Rolim Bernardino, Alice Maria
   Rebello, Moacyr Alcoforado
   Ferreira, Davis Fernandes
TI Thieno[2,3-b]pyridine derivatives: a new class of antiviral drugs
   against Mayaro virus
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID AEDES-ALBOPICTUS; VERO CELLS; REPLICATION; INHIBITION; AMERICA
AB Mayaro virus (MAYV) is an arthropod-borne virus and a member of the family Togaviridae, genus Alphavirus. Its infection leads to an acute illness accompanied by long-lasting arthralgia. To date, there are no antiviral drugs or vaccines against infection with MAYV and resources for the prevention or treatment of other alphaviruses are very limited. MAYV has served as a model to study the antiviral potential of several substances on alphavirus replication. In this work we evaluated the antiviral effect of seven new derivatives of thieno[2,3-b]pyridine against MAYV replication in a mammalian cell line. All derivatives were able to reduce viral production effectively at concentrations that were non-toxic for Vero cells. Molecular modeling assays predicted low toxicity risk and good oral bioavailability of the substances in humans. One of the molecules, selected for further study, demonstrated a strong anti-MAYV effect at early stages of replication, as it protected pre-treated cells and also during the late stages, affecting virus morphogenesis. This study is the first to demonstrate the antiviral effect of thienopyridine derivatives on MAYV replication in vitro, suggesting the potential application of these substances as antiviral molecules against alphaviruses. Additional in vivo research will be needed to expand the putative therapeutic applications.
C1 [Amorim, Raquel; Ferreira de Meneses, Marcelo Damiao; Cirne-Santos, Claudio Cesar; Campos, Renata de Mendonca; Rebello, Moacyr Alcoforado; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Ctr Ciencias Saude, Dept Virol, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
   [Borges, Julio Cesar] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Campus Nilopolis, BR-26530060 Nilopolis, Brazil.
   [da Silva Pinheiro, Luiz Carlos] Farmanguinhos FIOCRUZ, Inst Tecnol Farmacos, Dept Sintese Farmacos, BR-21041250 Rio De Janeiro, Brazil.
   [Caldas, Lucio Ayres] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrut Celular Hertha Meyer, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
   [Palmeira de Mello, Marcos Vinicius; Castro, Helena Carla] Univ Fed Fluminense, Lab Antibiot Bioquim Educ & Modelagem Mol, Campus Valonguinho,Outeiro Sao Joao Batista S-N, BR-24020150 Niteroi, RJ, Brazil.
   [Teles de Souza, Alessandra Mendonca] Univ Fed Rio de Janeiro, Lab Modelagem Mol, BR-21941590 Rio De Janeiro, Brazil.
   [Teles de Souza, Alessandra Mendonca] Univ Fed Rio de Janeiro, QSAR, Fac Farm, BR-21941590 Rio De Janeiro, Brazil.
   [Nunes de Palmer Paixao, Izabel Christina] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Lab Virol Mol Biotecnol Marinha,Programa, Niteroi, RJ, Brazil.
   [Bergmann, Ingrid E.; Malirat, Viviana] Consejo Nacl Invest Cient & Tecn, Inst Ciencia & Tecnol Dr Cesar Milstein, Ctr Virol Anim CEVAN, Consejo Nacl Invest Cient & Tecn, Saladillo 2468, RA-1440 Buenos Aires, DF, Argentina.
   [Rolim Bernardino, Alice Maria] Univ Fed Fluminense, Inst Quim, Dept Quim Organ, Outeiro Sao Joao Batista S-N, BR-24020141 Niteroi, RJ, Brazil.
RP Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol, Ctr Ciencias Saude, Dept Virol, Av Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI Castro, Helena/V-2137-2019; Azevedo, Renata/V-3130-2019; Paixao,
   Izabel/S-7490-2019; Palmeira-Mello, Marcos V./M-3659-2014; Ferreira,
   Davis/D-9356-2014; Souza, Alessandra M. T./R-5628-2016; Paixao,
   Izabel/AAM-1668-2020; Pinheiro, Luiz C. S./J-2937-2012; Cirne-Santos,
   Claudio/T-4009-2019; Amorim, Raquel/M-8161-2013
OI Palmeira-Mello, Marcos V./0000-0003-2550-5315; Souza, Alessandra M.
   T./0000-0001-9986-405X; Pinheiro, Luiz C. S./0000-0002-6398-7717;
   Cirne-Santos, Claudio/0000-0001-8376-1830; Amorim,
   Raquel/0000-0002-1605-0702; Rolim Bernardino, Alice
   Maria/0000-0003-0486-1468; Caldas, Lucio Ayres/0000-0002-1187-557X;
   Castro, Helena Carla/0000-0001-5283-1541
FU CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); INBEB/CNPq; National Institute of
   Structural Biology and Bioimages INBEB/CNPq [57.3767/2008-4]; Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [26/2013 110.034/2014, E26/110.370/2012]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; FAPERJ
   APQ1Carlos Chagas Filho Foundation for Research Support of the State of
   Rio de Janeiro (FAPERJ) [E26/110.370/2012]
FX We thank CAPES, FAPERJ and INBEB/CNPq for their financial support. This
   work was supported by The National Institute of Structural Biology and
   Bioimages INBEB/CNPq - Grant no. 57.3767/2008-4) and Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ Edital 26/2013
   110.034/2014 and FAPERJ APQ1 no.E26/110.370/2012); Raquel Amorim was
   supported with a Masters scholarship from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Bernardino AMR, 2004, HETEROCYCL COMMUN, V10, P407
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Brynes AP, 1998, J VIROL, V72, P7349, DOI 10.1128/JVI.72.9.7349-7356.1998
   Burlandy FM, 2001, INTERVIROLOGY, V44, P344, DOI 10.1159/000050069
   Da Costa LJ, 1999, ACTA VIROL, V43, P357
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   De Campos RM, 2003, ACTA VIROL, V47, P113
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   ELGIZOLI M, 1989, J VIROL, V63, P2921, DOI 10.1128/JVI.63.7.2921-2928.1989
   Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313
   Galal SA, 2009, BIOORG MED CHEM LETT, V19, P2420, DOI 10.1016/j.bmcl.2009.03.069
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Jakubowski A, 2005, PROSTAG LEUKOTR ESS, V72, P139, DOI 10.1016/j.plefa.2004.10.011
   Kanekiyo K, 2007, BIOL PHARM BULL, V30, P1573, DOI 10.1248/bpb.30.1573
   KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Patel RK, 2013, VIROLOGY, V441, P171, DOI 10.1016/j.virol.2013.03.022
   Pevet I, 2011, BIOORGAN MED CHEM, V19, P2517, DOI 10.1016/j.bmc.2011.03.021
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Bernardino AMR, 2007, MED CHEM RES, V16, P352, DOI 10.1007/s00044-007-9035-6
   Bernardino AMR, 2006, BIOORGAN MED CHEM, V14, P5765, DOI 10.1016/j.bmc.2006.03.013
   Spindola KCW, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0537-z
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Zhao LY, 2010, BIOORG MED CHEM LETT, V20, P7216, DOI 10.1016/j.bmcl.2010.10.105
NR 30
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUN
PY 2017
VL 162
IS 6
BP 1577
EP 1587
DI 10.1007/s00705-017-3261-0
PG 11
WC Virology
SC Virology
GA EU6BQ
UT WOS:000401119300012
PM 28213871
DA 2020-10-30
ER

PT J
AU de Souza, TLF
   de Lima, SMB
   Braga, VLDA
   Peabody, DS
   Ferreira, DF
   Bianconi, ML
   Gomes, AMDO
   Silva, JL
   de Oliveira, AC
AF de Souza, Theo Luiz Ferraz
   de Lima, Sheila Maria Barbosa
   Braga, Vanessa L. de Azevedo
   Peabody, David S.
   Ferreira, Davis Fernandes
   Bianconi, M. Lucia
   Gomes, Andre Marco de Oliveira
   Silva, Jerson Lima
   de Oliveira, Andrea Cheble
TI Charge neutralization as the major factor for the assembly of
   nucleocapsid-like particles from C-terminal truncated hepatitis C virus
   core protein
SO PEERJ
LA English
DT Article
DE HCV core protein; Capsid assembly; Circular dichroism; Fluorescence
   spectroscopy; Structural biology
ID NUCLEIC-ACID CHAPERONE; MOLTEN-GLOBULE; IN-VITRO; MOLECULAR-BIOLOGY;
   HOST RNAS; MICRORNA; IDENTIFICATION; BINDING; LIVER; STATE
AB Background Hepatitis C virus (HCV) core protein, in addition to its structural role to form the nucleocapsid assembly, plays a critical role in HCV pathogenesis by interfering in several cellular processes, including microRNA and mRNA homeostasis. The C-terminal truncated HCV core protein (C124) is intrinsically unstructured in solution and is able to interact with unspecific nucleic acids, in the micromolar range, and to assemble into nucleocapsid-like particles (NLPs) in vitro. The specificity and propensity of C124 to the assembly and its implications on HCV pathogenesis are not well understood.
   Methods Spectroscopic techniques, transmission electron microscopy and calorimetry were used to better understand the propensity of C124 to fold or to multimerize into NLPs when subjected to different conditions or in the presence of unspecific nucleic acids of equivalent size to cellular microRNAs.
   Results The structural analysis indicated that C124 has low propensity to self-folding. On the other hand, for the first time, we show that C124, in the absence of nucleic acids, multimerizes into empty NLPs when subjected to a pH close to its isoelectric point (pH ? 12), indicating that assembly is mainly driven by charge neutralization. Isothermal calorimetry data showed that the assembly of NLPs promoted by nucleic acids is enthalpy driven. Additionally, data obtained from fluorescence correlation spectroscopy show that C124, in nanomolar range, was able to interact and to sequester a large number of short unspecific nucleic acids into NLPs.
   Discussion Together, our data showed that the charge neutralization is the major factor for the nucleocapsid-like particles assembly from C-terminal truncated HCV core protein. This finding suggests that HCV core protein may physically interact with unspecific cellular polyanions, which may correspond to microRNAs and mRNAs in a host cell infected by HCV, triggering their confinement into infectious particles.
C1 [de Souza, Theo Luiz Ferraz] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
   [de Souza, Theo Luiz Ferraz; Braga, Vanessa L. de Azevedo; Ferreira, Davis Fernandes; Gomes, Andre Marco de Oliveira; Silva, Jerson Lima; de Oliveira, Andrea Cheble] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
   [de Lima, Sheila Maria Barbosa] Fundacao Oswaldo Cruz, Biomanguinhos, Rio De Janeiro, Brazil.
   [Braga, Vanessa L. de Azevedo; Bianconi, M. Lucia; Gomes, Andre Marco de Oliveira; Silva, Jerson Lima; de Oliveira, Andrea Cheble] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, Brazil.
   [Peabody, David S.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.
   [Peabody, David S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA.
   [Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
RP Silva, JL; de Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
RI Ferreira, Davis/D-9356-2014; de Souza, Theo LF/E-1705-2017; Silva,
   Jerson/J-8984-2014; Gomes, Andre/C-4009-2014
OI de Souza, Theo LF/0000-0002-0109-0357; Silva,
   Jerson/0000-0001-9523-9441; Barbosa de Lima, Sheila
   Maria/0000-0001-9234-1678; Gomes, Andre/0000-0003-1052-8004
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Fundacao
   Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia
   Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional
   de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB);
   Programa de Apoio a Nucleos de Excelencia (PRONEX)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   Fundacao Universitaria Jose Bonifacio (FUJB), Instituto Milenio de
   Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto
   Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem
   (INBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX) to JLS,
   AMOG, and ACO. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Acosta-Rivero N, 2005, BIOCHEM BIOPH RES CO, V334, P901, DOI 10.1016/j.bbrc.2005.06.185
   Ahmad E, 2010, BIOSCIENCE REP, V30, P125, DOI 10.1042/BSR20090035
   APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Blocquel D, 2012, MOL BIOSYST, V8, P392, DOI 10.1039/c1mb05401e
   Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144
   Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005
   Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645
   Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665
   Conrad KD, 2014, ARCH VIROL, V159, P849, DOI 10.1007/s00705-013-1883-4
   Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302
   Cristofari G, 2004, NUCLEIC ACIDS RES, V32, P2623, DOI 10.1093/nar/gkh579
   De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85
   Douam F, 2016, F1000RESEARCH, V5, DOI 10.12688/f1000research.7354.1
   Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157
   Duvignaud JB, 2010, BIOCHEM CELL BIOL, V88, P315, DOI [10.1139/O09-155, 10.1139/o09-155]
   Duvignaud JB, 2009, BIOCHEM BIOPH RES CO, V378, P27, DOI 10.1016/j.bbrc.2008.10.141
   DYSON HJ, 1993, CURR OPIN STRUC BIOL, V3, P60, DOI 10.1016/0959-440X(93)90203-W
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Fan ZY, 1999, J MED VIROL, V59, P131, DOI 10.1002/(SICI)1096-9071(199910)59:2<131::AID-JMV1>3.0.CO;2-C
   Foguel D, 1996, P NATL ACAD SCI USA, V93, P10642, DOI 10.1073/pnas.93.20.10642
   Fromentin R, 2007, ANAL BIOCHEM, V366, P37, DOI 10.1016/j.ab.2007.03.033
   Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017
   Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355
   GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993
   Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h
   Hamada D, 2000, NAT STRUCT BIOL, V7, P58
   Irshad M, 2006, MED PRIN PRACT, V15, P405, DOI 10.1159/000095485
   Ivanyi-Nagy R, 2006, NUCLEIC ACIDS RES, V34, P2618, DOI 10.1093/nar/gkl240
   Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kao CC, 2016, CURR OPIN VIROL, V17, P66, DOI 10.1016/j.coviro.2016.01.009
   Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x
   Konno T, 2000, PROTEIN SCI, V9, P564
   Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09
   Kunkel M, 2004, FEBS LETT, V557, P174, DOI 10.1016/S0014-5793(03)01486-8
   Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001
   Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107
   Lima SMB, 2006, FEBS J, V273, P1463, DOI 10.1111/j.1742-4658.2006.05167.x
   Lindenbach D, 2001, FIELDS VIROLOGY, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997
   Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036
   Lopez C, 2009, ARCH VIROL, V154, P695, DOI 10.1007/s00705-009-0350-8
   Lorenzo LJ, 2001, BIOCHEM BIOPH RES CO, V281, P962, DOI 10.1006/bbrc.2001.4449
   Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025
   Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774
   Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0
   McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202
   McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2
   Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Oehler V, 2012, J VIROL, V86, P7818, DOI 10.1128/JVI.00457-12
   Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373
   Pol S, 2012, CONTRIB NEPHROL, V176, P1, DOI 10.1159/000332374
   Polyak SJ, 2006, HEPATITIS C VIRUSES
   Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200
   Rodriguez-Casado A, 2006, BIOPOLYMERS, V82, P334, DOI 10.1002/bip.20474
   Rodriguez-Casado A, 2007, PROTEINS, V66, P110, DOI 10.1002/prot.21192
   ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006
   Routh A, 2012, CELL CYCLE, V11, P3713, DOI 10.4161/cc.22112
   Routh A, 2012, P NATL ACAD SCI USA, V109, P1907, DOI 10.1073/pnas.1116168109
   Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031
   Schneemann A, 1998, J VIROL, V72, P8738, DOI 10.1128/JVI.72.11.8738-8746.1998
   Sharma KK, 2010, NUCLEIC ACIDS RES, V38, P3632, DOI 10.1093/nar/gkq094
   SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006
   Siber A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061906
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Steuerwald NM, 2010, LIVER INT, V30, P1490, DOI 10.1111/j.1478-3231.2010.02321.x
   SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53
   Suzuki T, 2011, MICROBIOL IMMUNOL, V55, P12, DOI 10.1111/j.1348-0421.2010.00274.x
   Tanaka Y, 2000, VIROLOGY, V270, P229, DOI 10.1006/viro.2000.0252
   Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631
   Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072
   Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020
   Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Uversky VN, 1999, BIOCHEMISTRY-MOSCOW+, V64, P250
   Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x
   Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338
   Yan Xue-bing, 2005, J Zhejiang Univ Sci B, V6, P295, DOI 10.1007/BF02842467
   Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738
   Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998
NR 84
TC 2
Z9 2
U1 1
U2 7
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD NOV 9
PY 2016
VL 4
AR e2670
DI 10.7717/peerj.2670
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC4EE
UT WOS:000388078200004
PM 27867765
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Meira, GLS
   Campos, FS
   Albuquerque, JP
   Cabral, MC
   Fracalanzza, SEL
   Campos, RM
   Vermelho, AB
   Ferreira, DF
AF Meira, Guilherme L. S.
   Campos, Fabricio S.
   Albuquerque, Julia P.
   Cabral, Maulori C.
   Fracalanzza, Sergio E. L.
   Campos, Renata M.
   Vermelho, Alane B.
   Ferreira, Davis F.
TI Genome Sequence of KP-Rio/2015, a Novel Klebsiella pneumoniae
   (Podoviridae) Phage
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB Klebsiella pneumoniae is a pathogen frequently associated with antibiotic-resistant nosocomial infections. Here, we describe the genome of KP-Rio/2015, a novel phage of K. pneumoniae belonging to the family Podoviridae.
C1 [Meira, Guilherme L. S.; Cabral, Maulori C.; Fracalanzza, Sergio E. L.; Campos, Renata M.; Vermelho, Alane B.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Campos, Fabricio S.] Univ Brasilia, Vet Med & Agron, Brasilia, DF, Brazil.
   [Albuquerque, Julia P.] Fluminense Fed Univ, Inst Biomed, Rio De Janeiro, Brazil.
RP Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI VERMELHO/J-8803-2013; Campos, Fabricio Souza/ABA-6693-2020; Azevedo,
   Renata/V-3130-2019
OI VERMELHO/0000-0001-5926-4172; Campos, Fabricio
   Souza/0000-0002-5948-472X; 
FU MCTI \ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work, including the efforts of Alane B. Vermelho, was funded by
   MCTI vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq). This work, including the efforts of Guilherme L.S.
   Meira and Alane B. Vermelho, was funded by Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Drulis-Kawa Z, 2011, APPL MICROBIOL BIOT, V90, P1333, DOI 10.1007/s00253-011-3149-y
   Eriksson H, 2015, VIRUSES-BASEL, V7, P1804, DOI 10.3390/v7041804
   Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589
   Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129
   Verbeken G., 2016, J MICROB BIOCH TECHN, V8, P021, DOI [DOI 10.4172/1948-5948.1000257, 10.4172/1948-5948.1000257]
NR 5
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD NOV-DEC
PY 2016
VL 4
IS 6
AR e01298-16
DI 10.1128/genomeA.01298-16
PG 1
WC Microbiology
SC Microbiology
GA VI1DT
UT WOS:000460673800108
PM 28007847
OA Green Published, Other Gold
DA 2020-10-30
ER

PT J
AU Tappe, D
   Perez-Giron, JV
   Zammarchi, L
   Rissland, J
   Ferreira, DF
   Jaenisch, T
   Gomez-Medina, S
   Gunther, S
   Bartoloni, A
   Munoz-Fontela, C
   Schmidt-Chanasit, J
AF Tappe, Dennis
   Perez-Giron, Jose Vicente
   Zammarchi, Lorenzo
   Rissland, Juergen
   Ferreira, Davis F.
   Jaenisch, Thomas
   Gomez-Medina, Sergio
   Guenther, Stephan
   Bartoloni, Alessandro
   Munoz-Fontela, Cesar
   Schmidt-Chanasit, Jonas
TI Cytokine kinetics of Zika virus-infected patients from acute to
   reconvalescent phase
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Arbovirus; Flavivirus; Zika fever; Outbreak; Cytokine
ID SERUM-LEVELS; DENGUE
AB Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome and laboratory diagnostic procedures have been described, little attention was paid to the immunology of the disease and its possible use for clinical follow-up of patients. Here, we investigate the role of cytokines in the pathogenesis of Zika fever in travelers returning from Asia, the Pacific, and Brazil. Polyfunctional T cell activation (Th1, Th2, Th9, and Th17 response) was seen during the acute phase characterized by respective cytokine level increases, followed by a decrease in the reconvalescent phase.
C1 [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Perez-Giron, Jose Vicente; Gomez-Medina, Sergio; Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Rissland, Juergen] Univ Saarland, Med Ctr, Inst Virol, Homburg, Germany.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
RP Tappe, D (corresponding author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Tappe, D (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
EM tappe@bnitm.de
RI BARTOLONI, ALESSANDRO/K-3403-2018; Jaenisch, Thomas/H-3473-2017
OI BARTOLONI, ALESSANDRO/0000-0001-9758-1523; Gunther,
   Stephan/0000-0002-6562-0230; ZAMMARCHI, Lorenzo/0000-0003-0892-8404
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Martina Byron E. E., 2014, Science Progress, V97, P197, DOI 10.3184/003685014X14049173153889
   McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 76
Z9 78
U1 0
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD JUN
PY 2016
VL 205
IS 3
BP 269
EP 273
DI 10.1007/s00430-015-0445-7
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DM3QR
UT WOS:000376261700009
PM 26702627
OA Other Gold, Green Published
DA 2020-10-30
ER

PT J
AU Campos, RD
   Cirne-Santos, C
   Meira, GLS
   Santos, LLR
   de Meneses, MD
   Friedrich, J
   Jansen, S
   Ribeiro, MS
   Cruz, IC
   Schmidt-Chanasit, J
   Ferreira, DF
AF Campos, Renata de M.
   Cirne-Santos, Claudio
   Meira, Guilherme L. S.
   Santos, Luana L. R.
   de Meneses, Marcelo D.
   Friedrich, Johannes
   Jansen, Stephanie
   Ribeiro, Mario S.
   da Cruz, Igor C.
   Schmidt-Chanasit, Jonas
   Ferreira, Davis F.
TI Prolonged detection of Zika virus RNA in urine samples during the
   ongoing Zika virus epidemic in Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
ID INFECTION; TRAVEL
C1 [Campos, Renata de M.; Cirne-Santos, Claudio; Meira, Guilherme L. S.; Santos, Luana L. R.; de Meneses, Marcelo D.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [de Meneses, Marcelo D.; Ribeiro, Mario S.; da Cruz, Igor C.] Noel Nutels Cent Lab LACEN, Rio De Janeiro, Brazil.
   [Friedrich, Johannes; Jansen, Stephanie] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Ribeiro, Mario S.] Univ Fed Rio de Janeiro, Inst Publ Hlth, BR-21941 Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Bochum, Germany.
RP Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Bloco 1,Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI Azevedo, Renata/V-3130-2019; Ferreira, Davis/D-9356-2014; Cirne-Santos,
   Claudio/T-4009-2019
OI Cirne-Santos, Claudio/0000-0001-8376-1830
CR Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 8
TC 74
Z9 75
U1 0
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2016
VL 77
BP 69
EP 70
DI 10.1016/j.jcv.2016.02.009
PG 2
WC Virology
SC Virology
GA DG0WR
UT WOS:000371787100014
PM 26921737
OA Bronze
DA 2020-10-30
ER

PT J
AU Dalmaso, GZL
   Lage, CAS
   Mazotto, AM
   Dias, EPD
   Caldas, LA
   Ferreira, D
   Vermelho, AB
AF Dalmaso, Gabriel Z. L.
   Lage, Claudia A. S.
   Mazotto, Ana Maria
   de Souza Dias, Edilma Paraguai
   Caldas, Lucio Ayres
   Ferreira, Davis
   Vermelho, Alane B.
TI Extracellular peptidases from Deinococcus radiodurans
SO EXTREMOPHILES
LA English
DT Article
DE Extremophiles in biotechnology; Enzymes; Keratinase; Peptidases;
   Deinococcus radiodurans
ID KERATINOLYTIC ACTIVITY; PROTEOLYTIC-ENZYMES; FEATHER WASTE; KERATINASES;
   BACTERIUM; PROTEASES; MICROORGANISMS; DEGRADATION; BACILLUS;
   BIODEGRADATION
AB The extremophile Deinococcus radiodurans wild type R1 produces peptidases (metallo- and serine-) in TGY medium and in the media supplemented with human hair (HMY) and chicken feathers (FMY). Enzymatic screening on agar plates revealed peptidase activity. In TGY medium metallopeptidases were detected corresponding to a molecular mass range of 300-85 kDa (gelatinases); 280-130 (caseinases) and a 300 and a 170 kDa (keratinases); and a gelatinolytic serine peptidase (75 kDa). In HMY medium after 144 h, D. radiodurans produced keratinase (290 U/ml), gelatinase (619 U/ml) and sulfite (26 A mu g/ml). TGY medium produced higher proteolytic activity: 950 U/ml of gelatinolytic (24 h); 470 U/ml of keratinolytic (24 h) and 110 U/ml of caseinolytic (72 h). In the FMY medium, we found gelatinolytic (317 U/ml), keratinolytic (43 U/ml) and caseinolytic (85 U/ml) activities. The sulfite had a maximum release at 48 h (8.1 A mu g/ml). Enzymography analysis revealed that the keratinases degraded keratin after 24 h of reaction. The addition of sodium sulfite (1.0 %) improved the keratin degradation. Environmental Scanning Electron microscopy revealed alterations such as damage and holes in the hair fiber cuticle after D. radiodurans growth. This work presents for the first time D. radiodurans as a new keratinolytic microorganism.
C1 [Dalmaso, Gabriel Z. L.; Mazotto, Ana Maria; de Souza Dias, Edilma Paraguai; Vermelho, Alane B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, BIOINOVAR Unidade Biocatalise Bioprod & Bioenergi, BR-21941902 Rio De Janeiro, Brazil.
   [Dalmaso, Gabriel Z. L.; Lage, Claudia A. S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Dept Biol Mol, Lab Radiacoes Biol, BR-21941902 Rio De Janeiro, Brazil.
   [Caldas, Lucio Ayres] Inst Nacl Metrol Qualidade & Tecnol, INMETRO, Lab Microscopia Aplicada Ciencias Vida, BR-25250020 Rio De Janeiro, Brazil.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Lab Interacao Virus Celula, BR-21941902 Rio De Janeiro, Brazil.
RP Vermelho, AB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Microbiol Geral, BIOINOVAR Unidade Biocatalise Bioprod & Bioenergi, BR-21941902 Rio De Janeiro, Brazil.
EM abvermelho@micro.ufrj.br
RI Dalmaso, Gabriel/P-3966-2014; VERMELHO/J-8803-2013; Lage, Claudia A
   S/K-6563-2012
OI VERMELHO/0000-0001-5926-4172; Lage, Claudia A S/0000-0001-9870-9955;
   Caldas, Lucio Ayres/0000-0002-1187-557X
FU Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)CAPES;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (MCTi/CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We would like to thank Dr. Veronica Cardoso, Samyra Tiburcio, Joao
   Barreto and Luiz Eduardo Ferreira for their assistance and give our
   thanks to Instituto Nacional de Ciencia e Tecnologia de Biologia
   Estrutural e Bioimagem (INBEB). This study was supported by grants from
   Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (MCTi/CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ).
CR Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117
   Are VN, 2014, ACTA CRYSTALLOGR F, V70, P1292, DOI 10.1107/S2053230X14017944
   Arikawa Y, 1967, ACAD J, V41, P1454
   Basu B, 2008, BBA-PROTEINS PROTEOM, V1784, P1256, DOI 10.1016/j.bbapap.2008.05.009
   Bergquist P. L., 2014, CURRENT BIOTECHNOLOG, V3, P45, DOI DOI 10.2174/2211550102999131230150918
   Bernal C, 2006, ENZYME MICROB TECH, V38, P49, DOI 10.1016/j.enzmictec.2005.02.021
   Binod P, 2013, J SCI IND RES INDIA, V72, P271
   Brandelli A, 2008, FOOD BIOPROCESS TECH, V1, P105, DOI 10.1007/s11947-007-0025-y
   Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5
   Chan WF, 1999, APPL ENVIRON MICROB, V65, P846
   Chaturvedi R, 2012, J MICROBIOL METH, V90, P197, DOI 10.1016/j.mimet.2012.05.005
   Chojnacka K, 2011, WASTE BIOMASS VALORI, V2, P317, DOI 10.1007/s12649-011-9074-6
   Claverie-Martin F, 2007, IND ENZYMES, P207
   Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073
   Elleuche S, 2014, CURR OPIN BIOTECH, V29, P116, DOI 10.1016/j.copbio.2014.04.003
   Farci D, 2014, BBA-BIOMEMBRANES, V1838, P1978, DOI 10.1016/j.bbamem.2014.02.014
   Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875, DOI 10.1128/AEM.62.8.2875-2882.1996
   Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7
   Gopinath SCB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/140726
   Grumbt M, 2013, J INVEST DERMATOL, V133, P1550, DOI 10.1038/jid.2013.41
   GRZYWNOWICZ G, 1989, J MED VET MYCOL, V27, P319
   Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8
   Gupta R, 2013, CRIT REV BIOTECHNOL, V33, P216, DOI 10.3109/07388551.2012.685051
   Hassan MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/175012
   HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3
   Jensen K, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-47
   Jones BL, 1998, ANAL BIOCHEM, V263, P214, DOI 10.1006/abio.1998.2819
   Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4
   Karlyshev AV, 2014, FEBS OPEN BIO, V4, P468, DOI 10.1016/j.fob.2014.04.012
   Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003
   Kornillowicz-Kowalska Teresa, 2011, Acta Mycologica, V46, P83, DOI 10.5586/am.2011.005
   Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024
   Kornillowicz-Kowalska Teresa, 1997, Acta Mycologica, V32, P51
   Krisko A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012765
   KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649
   Kunert J., 2000, REV IBEROAMERICANA M, V15, P77
   Laba W, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.8896
   Laba W, 2013, POL J ENVIRON STUD, V22, P1101
   Cedrola SML, 2012, WORLD J MICROB BIOT, V28, P1259, DOI 10.1007/s11274-011-0930-0
   Lage CAS, 2012, INT J ASTROBIOL, V11, P251, DOI 10.1017/S1473550412000316
   Dalmaso GZL, 2015, MAR DRUGS, V13, P1925, DOI 10.3390/md13041925
   Liedert C, 2012, J BACTERIOL, V194, P1552, DOI 10.1128/JB.06429-11
   Torres EJL, 2013, VET PARASITOL, V196, P409, DOI 10.1016/j.vetpar.2013.02.026
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marchisio F.V., 2000, BIOL DERMATOPHYTES O, V17, P86
   Mazotto AM, 2010, LETT APPL MICROBIOL, V50, P89, DOI 10.1111/j.1472-765X.2009.02760.x
   Mazotto AM, 2011, WORLD J MICROB BIOT, V27, P1355, DOI 10.1007/s11274-010-0586-1
   Morozkina EV, 2010, APPL BIOCHEM MICRO+, V46, P1, DOI 10.1134/S0003683810010011
   Urista CM, 2011, FOOD SCI TECHNOL INT, V17, P293, DOI 10.1177/1082013211398801
   Murray R. G. E., 1992, PROKARYOTES, P3732
   Nam GW, 2002, ARCH MICROBIOL, V178, P538, DOI 10.1007/s00203-002-0489-0
   Nigam PS, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030597
   Paulino-Lima IG, 2011, ASTROBIOLOGY, V11, P875, DOI 10.1089/ast.2011.0649
   Paulino-Lima IG, 2010, PLANET SPACE SCI, V58, P1180, DOI 10.1016/j.pss.2010.04.010
   Pietrow O., 2013, AFR J BIOTECHNOL, V12, P4020, DOI DOI 10.5897/AJB12.2926
   Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]
   Riessen S, 2001, EXTREMOPHILES, V5, P399, DOI 10.1007/s007920100209
   Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06
   Sarrouh B., 2012, J BIOPROCESS BIOTE S, DOI [10.4172/2155-9821.S4-002., DOI 10.4172/2155-9821.S4-002]
   Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10
   Suzuki Y, 2006, J BIOSCI BIOENG, V102, P73, DOI 10.1263/jbb.102.73
   TOMARELLI RM, 1949, J LAB CLIN MED, V34, P428
   Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092
   Vermelho A. B., 2013, PROKARYOTES, V1, P213
   Vermelho AB, 1996, MEM I OSWALDO CRUZ, V91, P755, DOI 10.1590/S0074-02761996000600020
   Vermelho AB, 2010, US Patent Application, Patent No. [12/666, 409, 12666409]
   Vermelho AB, 2010, MYCOPATHOLOGIA, V169, P57, DOI 10.1007/s11046-009-9231-7
   Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0
   White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571
   Yamamura S, 2002, BIOCHEM BIOPH RES CO, V294, P1138, DOI 10.1016/S0006-291X(02)00580-6
   Zeng YH, 2011, MICROBIOL RES, V167, P40, DOI 10.1016/j.micres.2011.02.008
   Zhou Xu-bin, 2005, Weishengwu Xuebao, V45, P264
NR 72
TC 4
Z9 5
U1 0
U2 19
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1431-0651
EI 1433-4909
J9 EXTREMOPHILES
JI Extremophiles
PD SEP
PY 2015
VL 19
IS 5
BP 989
EP 999
DI 10.1007/s00792-015-0773-y
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA CP9CZ
UT WOS:000360192600009
PM 26216108
DA 2020-10-30
ER

PT J
AU Barroso, SPC
   Nico, D
   Nascimento, D
   Santos, ACV
   Couceiro, JNSS
   Bozza, FA
   Ferreira, AMA
   Ferreira, DF
   Palatnik-de-Sousa, CB
   Souza, TML
   Gomes, AMO
   Silva, JL
   Oliveira, AC
AF Barroso, Shana P. C.
   Nico, Dirlei
   Nascimento, Danielle
   Santos, Ana Clara V.
   Couceiro, Jose Nelson S. S.
   Bozza, Fernando A.
   Ferreira, Ana M. A.
   Ferreira, Davis F.
   Palatnik-de-Sousa, Clarisa B.
   Souza, Thiago Moreno L.
   Gomes, Andre M. O.
   Silva, Jerson L.
   Oliveira, Andrea C.
TI Intranasal Immunization with Pressure Inactivated Avian Influenza
   Elicits Cellular and Humoral Responses in Mice
SO PLOS ONE
LA English
DT Article
ID FC-ALPHA-RI; HYDROSTATIC-PRESSURE; A-VIRUS; HIGH IMMUNOGENICITY;
   IMMUNE-RESPONSES; VACCINE; PROTECTION; CHALLENGE; INFECTION; H5N1
AB Influenza viruses pose a serious global health threat, particularly in light of newly emerging strains, such as the avian influenza H5N1 and H7N9 viruses. Vaccination remains the primary method for preventing acquiring influenza or for avoiding developing serious complications related to the disease. Vaccinations based on inactivated split virus vaccines or on chemically inactivated whole virus have some important drawbacks, including changes in the immunogenic properties of the virus. To induce a greater mucosal immune response, intranasally administered vaccines are highly desired as they not only prevent disease but can also block the infection at its primary site. To avoid these drawbacks, hydrostatic pressure has been used as a potential method for viral inactivation and vaccine production. In this study, we show that hydrostatic pressure inactivates the avian influenza A H3N8 virus, while still maintaining hemagglutinin and neuraminidase functionalities. Challenged vaccinated animals showed no disease signs (ruffled fur, lethargy, weight loss, and huddling). Similarly, these animals showed less Evans Blue dye leakage and lower cell counts in their bronchoalveolar lavage fluid compared with the challenged non-vaccinated group. We found that the whole inactivated particles were capable of generating a neutralizing antibody response in serum, and IgA was also found in nasal mucosa and feces. After the vaccination and challenge we observed Th1/Th2 cytokine secretion with a prevalence of IFN-gamma Our data indicate that the animals present a satisfactory immune response after vaccination and are protected against infection. Our results may pave the way for the development of a novel pressure-based vaccine against influenza virus.
C1 [Barroso, Shana P. C.; Santos, Ana Clara V.; Gomes, Andre M. O.; Silva, Jerson L.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Barroso, Shana P. C.; Santos, Ana Clara V.; Bozza, Fernando A.; Gomes, Andre M. O.; Silva, Jerson L.; Oliveira, Andrea C.] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
   [Nico, Dirlei; Couceiro, Jose Nelson S. S.; Ferreira, Ana M. A.; Ferreira, Davis F.; Palatnik-de-Sousa, Clarisa B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Nascimento, Danielle; Bozza, Fernando A.] Fundacao Oswaldo Cruz FIOCRUZ, Fundacao Pesquisa Clin Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Barroso, Shana P. C.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Oswaldo Cruz, WHO NIC, Lab Virus Resp, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM cheble@bioqmed.ufrj.br
RI Souza, Thiago Moreno L./G-2900-2012; Ferreira, Davis/D-9356-2014; Bozza,
   Fernando A/A-2618-2013; Couceiro, Jose Nelson SS/J-3933-2016; Silva,
   Jerson/J-8984-2014; Gomes, Andre/C-4009-2014
OI Souza, Thiago Moreno L./0000-0003-2212-3899; Bozza, Fernando
   A/0000-0003-4878-0256; Couceiro, Jose Nelson SS/0000-0001-8712-4847;
   Silva, Jerson/0000-0001-9523-9441; Gomes, Andre/0000-0003-1052-8004; de
   Amorim Ferreira, Ana Maria/0000-0003-2507-0171; Palatnik-de-Sousa,
   Clarisa B./0000-0002-6231-0608
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Instituto
   Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB);
   Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e
   Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia
   (IMBEBB), Instituto Nacional de Ciencia e Tecnologia de Biologia
   Estrutural e Bioimagem (INBEB), and Programa de Apoio a Nucleos de
   Excelencia (PRONEX) to J.L.S., A.M.O.G., and A.C.O. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adams S, 2010, MED PRIN PRACT, V19, P421, DOI 10.1159/000320299
   Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6
   [Anonymous], 2003, INFL OV
   Asanuma H, 2007, VACCINE, V25, P6975, DOI 10.1016/j.vaccine.2007.06.060
   Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9
   Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09
   Boonyaratanakornkit BB, 2002, BBA-PROTEIN STRUCT M, V1595, P235, DOI 10.1016/S0167-4838(01)00347-8
   Calci KR, 2005, APPL ENVIRON MICROB, V71, P339, DOI 10.1128/AEM.71.1.339-343.2005
   Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085
   Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027
   Castleman WL, 2010, VET PATHOL, V47, P507, DOI 10.1177/0300985810363718
   Ceylan C, 2012, VET MICROBIOL, V154, P266, DOI 10.1016/j.vetmic.2011.07.026
   Chawla R, 2011, J FOOD SCI TECH MYS, V48, P260, DOI 10.1007/s13197-010-0180-4
   Committee for Proprietary Medicinal Products (CPMP), 1997, NOT GUID HARM REQ IN
   Cox RJ, 2009, INFLUENZA OTHER RESP, V3, P107, DOI 10.1111/j.1750-2659.2009.00082.x
   Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x
   Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950
   Dumard CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080785
   Epstein SL, 2002, EMERG INFECT DIS, V8, P796
   Freitas TRP, 2003, J VIROL METHODS, V108, P205, DOI 10.1016/S0166-0934(02)00289-6
   Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207
   Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x
   Gehlen Marcelo Luiz, 2004, Arq. Bras. Oftalmol., V67, P219, DOI 10.1590/S0004-27492004000200007
   Gomes AMO, 2003, BIOCHEMISTRY-US, V42, P5540, DOI 10.1021/bi027207k
   Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025
   Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9
   Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2
   Hierholzer JC, 1995, VIROLOGY METHODS MAN, P25
   Hoffman AM, 1997, VET CLIN N AM-EQUINE, V13, P463, DOI 10.1016/S0749-0739(17)30224-9
   INGRAM DK, 1982, MECH AGEING DEV, V20, P253, DOI 10.1016/0047-6374(82)90092-6
   JAKAB GJ, 1983, AM REV RESPIR DIS, V128, P730
   JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935
   KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9
   Kingsley DH, 2007, APPL ENVIRON MICROB, V73, P581, DOI 10.1128/AEM.02117-06
   Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711
   Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07
   LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11
   Lamm ME, 2002, J EXP MED, V195, pF5, DOI 10.1084/jem.20011910
   Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368
   Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2
   Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069649
   Longhi MP, 2008, PLOS PATHOG, V4, DOI [10.1371/ journal. ppat. 1000006, DOI 10.1371/J0URNAL.PPAT.1000006]
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU BL, 1982, INFECT IMMUN, V38, P530, DOI 10.1128/IAI.38.2.530-535.1982
   Marchal S, 2005, BRAZ J MED BIOL RES, V38, P1175, DOI 10.1590/S0100-879X2005000800004
   Masson Patrick, 2001, Journal of Biomedicine and Biotechnology, V1, P85, DOI 10.1155/S1110724301000158
   Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07
   Mei L, 2013, BIOSCI TRENDS, V7, P64, DOI 10.5582/bst.2013.v7.2.64
   Mesquita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101056
   Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952
   Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999
   Rovozzo GC, 1973, MANUAL VIROLOGICAL B
   Schwarcz WD, 2004, CELL MOL BIOL, V50, P419
   Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z
   SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10
   Sundararajan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034377
   Szretter Kristy J, 2006, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/0471729256.mc15g01s3
   Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237
   Tian SM, 2000, EUR J BIOCHEM, V267, P4486, DOI 10.1046/j.1432-1327.2000.01496.x
   Tian SM, 1999, ACTA BIOCH BIOPH SIN, V31, P334
   van Egmond M, 2000, NAT MED, V6, P680
   Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1
   van Schaik SM, 2000, J MED VIROL, V62, P257, DOI 10.1002/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M
   Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x
   Wilschut JC, 2006, INFLUENZA, P150
   WOOD JM, 1998, TXB INFLUENZA, P333
   World Health Organization, MAN AN INFL DIAGN SU
   Yondon M, 2014, EMERG INFECT DIS, V20, P2144, DOI 10.3201/eid2012.140435
   Zosky GR, 2009, J APPL PHYSIOL, V107, P1472, DOI 10.1152/japplphysiol.00393.2009
NR 79
TC 5
Z9 5
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 9
PY 2015
VL 10
IS 6
AR e0128785
DI 10.1371/journal.pone.0128785
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CK6PC
UT WOS:000356349000030
PM 26056825
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Dalmaso, GZL
   Ferreira, D
   Vermelho, AB
AF Leal Dalmaso, Gabriel Zamith
   Ferreira, Davis
   Vermelho, Alane Beatriz
TI Marine Extremophiles: A Source of Hydrolases for Biotechnological
   Applications
SO MARINE DRUGS
LA English
DT Review
ID COLD-ADAPTED LIPASE; ALPHA-AMYLASE; SP-NOV.; THERMOSTABLE ESTERASE;
   BIODIESEL PRODUCTION; PYROCOCCUS-FURIOSUS; THERMOTOGA-MARITIMA;
   HIGH-PRESSURE; FERVIDOBACTERIUM-PENNAVORANS; PHOTOBACTERIUM-LIPOLYTICUM
AB The marine environment covers almost three quarters of the planet and is where evolution took its first steps. Extremophile microorganisms are found in several extreme marine environments, such as hydrothermal vents, hot springs, salty lakes and deep-sea floors. The ability of these microorganisms to support extremes of temperature, salinity and pressure demonstrates their great potential for biotechnological processes. Hydrolases including amylases, cellulases, peptidases and lipases from hyperthermophiles, psychrophiles, halophiles and piezophiles have been investigated for these reasons. Extremozymes are adapted to work in harsh physical-chemical conditions and their use in various industrial applications such as the biofuel, pharmaceutical, fine chemicals and food industries has increased. The understanding of the specific factors that confer the ability to withstand extreme habitats on such enzymes has become a priority for their biotechnological use. The most studied marine extremophiles are prokaryotes and in this review, we present the most studied archaea and bacteria extremophiles and their hydrolases, and discuss their use for industrial applications.
C1 [Leal Dalmaso, Gabriel Zamith; Vermelho, Alane Beatriz] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BIOINOVAR Biotechnol Lab Biocatalysis Bioprod & B, BR-21941902 Rio De Janeiro, Brazil.
   [Leal Dalmaso, Gabriel Zamith] Univ Fed Rio de Janeiro, Hlth & Sci Ctr, Grad Program Plant Biotechnol, BR-21941902 Rio De Janeiro, Brazil.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BIOINOVAR Biotechnol Labs Virus Cell Interact, BR-21941902 Rio De Janeiro, Brazil.
RP Vermelho, AB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BIOINOVAR Biotechnol Lab Biocatalysis Bioprod & B, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM gdalmaso@gmail.com; davisf@micro.ufrj.br; abvermelho@micro.ufrj.br
RI VERMELHO/J-8803-2013; Ferreira, Davis/D-9356-2014; Dalmaso,
   Gabriel/P-3966-2014
OI VERMELHO/0000-0001-5926-4172; 
FU Brazilian National Council for Scientific and Technological Development
   (MCT-CNPq)National Council for Scientific and Technological Development
   (CNPq); Carlos Chagas Filho Foundation for Research Support in the State
   of Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES
FX The authors wish to acknowledge the Brazilian National Council for
   Scientific and Technological Development (MCT-CNPq), Carlos Chagas Filho
   Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)
   and Coordination for the Improvement of Higher Education Personnel
   (CAPES) for the financial support. This manuscript was reviewed by a
   professional science editor and by a native English-speaking copy editor
   to improve readability.
CR Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X
   Abe F, 2001, TRENDS BIOTECHNOL, V19, P102, DOI 10.1016/S0167-7799(00)01539-0
   Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117
   Al Khudary R, 2010, EXTREMOPHILES, V14, P273, DOI 10.1007/s00792-010-0306-7
   Amoozegar MA, 2008, J BASIC MICROB, V48, P160, DOI 10.1002/jobm.200700361
   Andualema B., 2012, Biotechnology, V11, P100
   Anto H, 2006, BIORESOURCE TECHNOL, V97, P1161, DOI 10.1016/j.biortech.2005.05.007
   Cristobal HA, 2011, J BASIC MICROB, V51, P590, DOI 10.1002/jobm.201000413
   Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x
   Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731
   Arora R, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P498, DOI 10.1079/9781845938147.0498
   Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177
   Arpigny JL, 1998, FEMS MICROBIOL LETT, V167, P69, DOI 10.1016/S0378-1097(98)00375-9
   Asker D, 2009, INT J SYST EVOL MICR, V59, P144, DOI 10.1099/ijs.0.65762-0
   Asker D, 2008, SYST APPL MICROBIOL, V31, P43, DOI 10.1016/j.syapm.2007.10.002
   Asker D, 2011, INT J SYST EVOL MICR, V61, P1448, DOI 10.1099/ijs.0.013482-0
   Atomi H, 2005, CURR OPIN CHEM BIOL, V9, P166, DOI 10.1016/j.cbpa.2005.02.013
   Aung HL, 2015, PROTEIN EXPRES PURIF, V107, P62, DOI 10.1016/j.pep.2014.11.009
   Bajaj A, 2010, J MOL CATAL B-ENZYM, V62, P9, DOI 10.1016/j.molcatb.2009.09.018
   Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005
   Bakermans C., 2011, POLAR MICROBIOLOGY L, P126
   Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0
   BARTLETT DH, 1999, ENIGMATIC MICROORGAN, P503
   BCC Research, 2014, GLOB MARK ENZ IND AP, P146
   Bertoldo C, 1999, APPL ENVIRON MICROB, V65, P2084
   Bhattacharya A, 2014, ENZYME MICROB TECH, V55, P159, DOI 10.1016/j.enzmictec.2013.10.011
   Binod P, 2013, J SCI IND RES INDIA, V72, P271
   Blaser HU, 2003, CHEM COMMUN, P293, DOI 10.1039/b209968n
   Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673
   Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Bosley J.A., 1993, Preparation of Immobilized Lipase by Adsorption of Lipase and a Non-Lipase Protein on a Support, Patent No. [US 5232843, 5232843]
   Brown I, 2013, BBA-PROTEINS PROTEOM, V1834, P2600, DOI 10.1016/j.bbapap.2013.09.008
   BROWN SH, 1993, APPL ENVIRON MICROB, V59, P2614, DOI 10.1128/AEM.59.8.2614-2621.1993
   Bull AT, 2000, MICROBIOL MOL BIOL R, V64, P573, DOI 10.1128/MMBR.64.3.573-606.2000
   BURLINI N, 1992, BIOCHIM BIOPHYS ACTA, V1122, P283, DOI 10.1016/0167-4838(92)90406-4
   Callen W., 2012, U.S. Patent, Patent No. [8,338,131, 8338131]
   Canganella Francesco, 2014, Life-Basel, V4, P77, DOI 10.3390/life4010077
   Capece MC, 2013, POLYEXTREMOPHILES LI, P3, DOI DOI 10.1007/978-94-007-6488-0_1
   Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002
   Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390
   Cavicchioli R, 2002, CURR OPIN BIOTECH, V13, P253, DOI 10.1016/S0958-1669(02)00317-8
   Cerletti M, 2014, ENVIRON MICROBIOL, V16, P1779, DOI 10.1111/1462-2920.12385
   Chandrasekaran M., 2010, BIOTECHNOLOGY, V9, P47
   Charpe TW, 2011, WASTE MANAGE, V31, P85, DOI 10.1016/j.wasman.2010.09.003
   Chen SL, 2010, WORLD J MICROB BIOT, V26, P1427, DOI 10.1007/s11274-010-0317-7
   Chen Z, 2010, TRENDS BIOTECHNOL, V28, P534, DOI 10.1016/j.tibtech.2010.07.004
   Colletier JP, 2012, MOL BIOL EVOL, V29, P1683, DOI 10.1093/molbev/mss015
   Collins T, 2006, J CEREAL SCI, V43, P79, DOI 10.1016/j.jcs.2005.08.002
   Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005
   Cordova-Lopez J., 2014, IJERT, V3, P1257
   Corral P, 2013, INT J SYST EVOL MICR, V63, P104, DOI 10.1099/ijs.0.036558-0
   DasSarma S., 2012, ELS, P1
   de Castro AM, 2013, METHODS TO DETERMINE ENZYMATIC ACTIVITY, P100
   De Castro RE, 2006, FEMS MICROBIOL REV, V30, P17, DOI 10.1111/j.1574-6976.2005.00003.x
   de Lourdes Moreno Maria, 2013, Life-Basel, V3, P38, DOI 10.3390/life3010038
   De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170
   de Pascale D, 2008, EXTREMOPHILES, V12, P311, DOI 10.1007/s00792-008-0163-9
   Delgado-Garcia M, 2012, J SCI FOOD AGR, V92, P2575, DOI 10.1002/jsfa.5860
   Deming J.W., 2009, ENCY MICROBIOLOGY, P147
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Diaz-Tena E, 2013, PROCEDIA ENGINEER, V63, P67, DOI 10.1016/j.proeng.2013.08.197
   Do H, 2013, ACTA CRYSTALLOGR F, V69, P920, DOI 10.1107/S1744309113019428
   Dornez E, 2011, J AGR FOOD CHEM, V59, P9553, DOI 10.1021/jf201752g
   Duffaud GD, 1997, APPL ENVIRON MICROB, V63, P169, DOI 10.1128/AEM.63.1.169-177.1997
   Duffner F, 2000, J BACTERIOL, V182, P6331, DOI 10.1128/JB.182.22.6331-6338.2000
   Eichler J, 2003, MICROBIOL-SGM, V149, P3347, DOI 10.1099/mic.0.26591-0
   Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026
   Enache M, 2012, ADAPTION OF MICROBIAL LIFE TO ENVIRONMENTAL EXTREMES: NOVEL RESEARCH RESULTS AND APPLICATION, P173
   Feller G, 1998, APPL ENVIRON MICROB, V64, P1163
   Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773
   Feller G, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/512840
   Fendrihan S, 2012, ADAPTION OF MICROBIAL LIFE TO ENVIRONMENTAL EXTREMES: NOVEL RESEARCH RESULTS AND APPLICATION, P133
   Fernandes P, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00046
   Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001
   Ferrer M, 2005, CHEM BIOL, V12, P895, DOI 10.1016/j.chembiol.2005.05.020
   Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266
   Friedrich AB, 1996, APPL ENVIRON MICROB, V62, P2875, DOI 10.1128/AEM.62.8.2875-2882.1996
   Fuchida S, 2014, ORG GEOCHEM, V66, P98, DOI 10.1016/j.orggeochem.2013.11.008
   Fucinos P, 2012, METHODS MOL BIOL, V861, P239, DOI 10.1007/978-1-61779-600-5_15
   Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5
   Fukushima T, 2005, EXTREMOPHILES, V9, P85, DOI 10.1007/s00792-004-0423-2
   Fulzele R, 2011, BRAZ J MICROBIOL, V42, P1364, DOI [10.1590/S1517-83822011000400018, 10.1590/S1517-838220110004000018]
   Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7
   Garsoux G, 2004, BIOCHEM J, V384, P247, DOI 10.1042/BJ20040325
   GELFAND DH, 1989, Patent No. 4889818
   Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4
   Gimenez MI, 2000, EXTREMOPHILES, V4, P181, DOI 10.1007/s007920070033
   GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187
   Gomes I, 2003, BIORESOURCE TECHNOL, V90, P207, DOI 10.1016/S0960-8524(03)00110-X
   Gonzalez JM, 1999, ARCH MICROBIOL, V172, P95, DOI 10.1007/s002030050745
   Gotor-Fernandez V, 2006, ADV SYNTH CATAL, V348, P797, DOI 10.1002/adsc.200606057
   Goyal K, 2001, J MOL CATAL B-ENZYM, V15, P45, DOI 10.1016/S1381-1177(01)00003-0
   Gunbin KV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-639
   Gupta P., 2011, Research Journal of Microbiology, V6, P281, DOI 10.3923/jm.2011.281.288
   Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8
   Gurumurthy DM, 2012, J PURE APPL MICROBIO, V6, P1759
   Halio SB, 1997, APPL ENVIRON MICROB, V63, P289, DOI 10.1128/AEM.63.1.289-295.1997
   Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x
   Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004
   Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016
   Hicks PM, 1998, FEBS LETT, V440, P393, DOI 10.1016/S0014-5793(98)01451-3
   Hidalgo A., 2013, CURR BIOTECHNOL, V2, P304
   Hii SL, 2012, ENZYME RES, DOI DOI 10.1155/2012/921362
   Hildebrandt P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-151
   Horikoshi K., 2011, EXTREMOPHILES HDB, P4
   Horikoshi K., 2011, EXTREMOPHILES HDB, P1247
   Hotta Y, 2002, APPL ENVIRON MICROB, V68, P3925, DOI 10.1128/AEM.68.8.3925-3931.2002
   Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8
   HUDDLESTON S, 1995, BIOCHEM BIOPH RES CO, V216, P495, DOI 10.1006/bbrc.1995.2650
   Hurst LD, 2001, P ROY SOC B-BIOL SCI, V268, P493, DOI 10.1098/rspb.2000.1397
   Huston Adrienne L., 2008, P347, DOI 10.1007/978-3-540-74335-4_20
   Huston AL, 2004, APPL ENVIRON MICROB, V70, P3321, DOI 10.1128/AEM.70.6.3321-3328.2004
   Ikeda M, 1998, BIOTECHNOL BIOENG, V57, P624, DOI 10.1002/(SICI)1097-0290(19980305)57:5<624::AID-BIT15>3.0.CO;2-B
   Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2
   Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5
   Jang HJ, 2002, EXTREMOPHILES, V6, P233, DOI 10.1007/s00792-001-0248-1
   Javor B, 1989, HYPERSALINE ENV, P176
   Jiang ZQ, 2004, J MOL CATAL B-ENZYM, V27, P207, DOI 10.1016/j.molcatb.2003.11.012
   JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x
   Joseph B, 2008, BIOTECHNOL ADV, V26, P457, DOI 10.1016/j.biotechadv.2008.05.003
   Joshi Swati, 2013, Biology (Basel), V2, P755, DOI 10.3390/biology2020755
   Junge K., 2011, EXTREMOPHILES HDB, P794
   Kampfer P, 2008, INT J SYST EVOL MICR, V58, P2803, DOI 10.1099/ijs.0.2008/001206-0
   Kamekura M, 1996, BBA-PROTEIN STRUCT M, V1294, P159, DOI 10.1016/0167-4838(96)00016-7
   Kang HJ, 2007, EXTREMOPHILES, V11, P251, DOI 10.1007/s00792-006-0033-2
   Karan R, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-3
   Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4
   Kasana RC, 2010, CRIT REV MICROBIOL, V36, P134, DOI 10.3109/10408410903485525
   Kato C, 1998, APPL ENVIRON MICROB, V64, P1510
   Kato C, 2011, EXTREMOPHILES HDB, P658
   Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608
   Kim J, 1997, BIOTECHNOL BIOENG, V55, P471, DOI 10.1002/(SICI)1097-0290(19970805)55:3<471::AID-BIT2>3.0.CO;2-9
   Kim SB, 2008, J MICROBIOL, V46, P100, DOI 10.1007/s12275-007-0185-5
   Kimura H, 2003, APPL ENVIRON MICROB, V69, P644, DOI 10.1128/AEM.69.1.644-648.2003
   KLINGEBERG M, 1991, APPL MICROBIOL BIOT, V34, P715
   Klippel B., 2011, EXTREMOPHILES HDB, P444
   Koga Y, 2012, ARCHAEA, V2012, DOI 10.1155/2012/789652
   Kotera M., 2014, ENCY METAGENOMICS, P1
   Kourist R, 2011, GREEN CHEM, V13, P2607, DOI 10.1039/c1gc15162b
   Kourist R, 2011, APPL MICROBIOL BIOT, V91, P505, DOI 10.1007/s00253-011-3418-9
   Kuddus M., 2011, Biotechnology, V10, P246
   Kulakova L, 1999, APPL ENVIRON MICROB, V65, P611
   Kumar A, 2013, CRIT REV BIOTECHNOL, V33, P365, DOI 10.3109/07388551.2012.716810
   Kumar L., 2011, BIOTECHNOL APPL BIOC, V10, P1
   Kumar V., 2013, POLYEXTREMOPHILES LI, V27, P271
   Kumar V, 2015, BIORESOURCE TECHNOL, V179, P382, DOI 10.1016/j.biortech.2014.12.049
   Kumar V, 2012, INT BIODETER BIODEGR, V75, P138, DOI 10.1016/j.ibiod.2012.09.007
   Kurosawa N, 2010, POLAR SCI, V4, P421, DOI 10.1016/j.polar.2010.04.002
   Kyaw N, 2010, APPL BIOCHEM BIOTECH, V161, P171, DOI 10.1007/s12010-009-8773-y
   LADERMAN KA, 1993, J BIOL CHEM, V268, P24402
   Lang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062510
   LANYI JK, 1972, CAN J MICROBIOL, V18, P993, DOI 10.1139/m72-154
   Lauro FM, 2008, EXTREMOPHILES, V12, P15, DOI 10.1007/s00792-006-0059-5
   Lauro FM, 2007, APPL ENVIRON MICROB, V73, P838, DOI 10.1128/AEM.01726-06
   Le Borgne S, 2008, J MOL MICROB BIOTECH, V15, P74, DOI 10.1159/000121323
   Leveque E, 2000, ENZYME MICROB TECH, V26, P3, DOI 10.1016/S0141-0229(99)00142-8
   Li XL, 2013, APPL MICROBIOL BIOT, V97, P5359, DOI 10.1007/s00253-012-4397-1
   Liedert C, 2012, J BACTERIOL, V194, P1552, DOI 10.1128/JB.06429-11
   Lim J, 2000, J MOL BIOL, V297, P553, DOI 10.1006/jmbi.2000.3585
   Liszka MJ, 2012, ANNU REV CHEM BIOMOL, V3, P77, DOI 10.1146/annurev-chembioeng-061010-114239
   Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033
   Lo Giudice A, 2006, J APPL MICROBIOL, V101, P1039, DOI 10.1111/j.1365-2672.2006.03006.x
   Lopez-Lopez O, 2014, CURR PROTEIN PEPT SC, V15, P445, DOI 10.2174/1389203715666140228153801
   Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228
   Lorv JSH, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/976895
   Madigan M.T., 2014, BROCK BIOL MICROORGA, P1136
   Maki M, 2009, INT J BIOL SCI, V5, P500
   Mao XX, 2010, APPL BIOCHEM BIOTECH, V162, P2136, DOI 10.1007/s12010-010-8988-y
   Mapelli F, 2012, ADAPTION OF MICROBIAL LIFE TO ENVIRONMENTAL EXTREMES: NOVEL RESEARCH RESULTS AND APPLICATION, P21
   Mardanov AV, 2009, APPL ENVIRON MICROB, V75, P4580, DOI 10.1128/AEM.00718-09
   Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004
   Matsui I, 2000, FEBS LETT, V467, P195, DOI 10.1016/S0014-5793(00)01156-X
   McGenity TJ, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P402, DOI 10.1079/9781845938147.0402
   Mesbah NM, 2007, INT J SYST EVOL MICR, V57, P2507, DOI 10.1099/ijs.0.65068-0
   Mesbah NM, 2011, HALOPHILES AND HYPERSALINE ENVIRONMENTS: CURRENT RESEARCH AND FUTURE TRENDS, P249, DOI 10.1007/978-3-642-20198-1_14
   Miyake R, 2007, APPL ENVIRON MICROB, V73, P4849, DOI 10.1128/AEM.00824-07
   Morozkina EV, 2010, APPL BIOCHEM MICRO+, V46, P1, DOI 10.1134/S0003683810010011
   Mota MJ, 2013, BIOTECHNOL ADV, V31, P1426, DOI 10.1016/j.biotechadv.2013.06.007
   Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006
   Mykytczuk NCS, 2013, ISME J, V7, P1211, DOI 10.1038/ismej.2013.8
   Naik SN, 2010, RENEW SUST ENERG REV, V14, P578, DOI 10.1016/j.rser.2009.10.003
   Nath IVA, 2011, EXTREMOPHILES, V15, P129, DOI 10.1007/s00792-010-0348-x
   NC-IUBMB, ENC LIST CLASS 3 HYD
   Nedwin G.E., 2013, U.S. Patent, Patent No. [8,545,907, 8545907]
   Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456
   Nielsen TB, 1999, BIOTECHNOLOGICAL APPLICATIONS OF COLD-ADAPTED ORGANISMS, P49
   Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003
   Oger Philippe, 2014, Biologie Aujourd hui, V208, P193, DOI 10.1051/jbio/2014023
   Ooteghem V.S., 2005, Process for Generation of Hydrogen Gas from Various Feedstocks Using Thermophilic Bacteria, Patent No. [US 6,942,998, 6942998]
   Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2
   Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592
   Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010
   Pancha I, 2010, INT J BIOL MACROMOL, V47, P288, DOI 10.1016/j.ijbiomac.2010.04.006
   Park YJ, 2008, J BACTERIOL, V190, P8086, DOI 10.1128/JB.00803-08
   Perez-Pomares F, 2003, EXTREMOPHILES, V7, P299, DOI 10.1007/s00792-003-0327-6
   Pietrow O., 2013, AFR J BIOTECHNOL, V12, P4020, DOI DOI 10.5897/AJB12.2926
   Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948
   Prakash O, 2010, APPL BIOCHEM BIOTECH, V160, P2401, DOI 10.1007/s12010-009-8735-4
   Qin B, 2013, CATAL COMMUN, V38, P1, DOI 10.1016/j.catcom.2013.03.040
   Qin YJ, 2014, EXTREMOPHILES, V18, P271, DOI 10.1007/s00792-013-0614-9
   Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x
   Rampelotto P.H., 2013, CURR BIOTECHNOL, V2, P273
   Ratanakhanokchai K, 2013, BIOMASS NOW CULTIVAT, P369, DOI DOI 10.5772/51820
   Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]
   Rawlings ND, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-437
   Reed CJ, 2013, ARCHAEA, V2013, DOI 10.1155/2013/373275
   Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826
   Reetz MT, 1998, CHEM PHYS LIPIDS, V93, P3, DOI 10.1016/S0009-3084(98)00033-4
   Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5
   Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215
   Russo R, 2010, MAR GENOM, V3, P125, DOI 10.1016/j.margen.2010.09.001
   Ryu HS, 2006, APPL MICROBIOL BIOT, V70, P321, DOI 10.1007/s00253-005-0058-y
   Sakaff MKLM, 2012, J BACTERIOL, V194, P1239, DOI 10.1128/JB.06580-11
   Samuel P., 2012, INT J OCEAN MAR ECOL, V1, P1, DOI DOI 10.3923/ijomes.2012.1.10
   Sangeetha R., 2011, Research Journal of Microbiology, V6, P1, DOI 10.3923/jm.2011.1.24
   Sastre DE, 2011, MICROBIOL RES, V166, P304, DOI 10.1016/j.micres.2010.07.002
   Schafer T., 2011, Lipases from Thermophilic Anaerobes, Patent No. [US 7,972,831, 79728315]
   Seckbach J., 2013, POLYEXTREMOPHILES LI, P634
   Seth-Pasricha M, 2013, ENV MICROBIOL REP, V5, P263, DOI 10.1111/1758-2229.12010
   Sharma A, 2013, PROCESS BIOCHEM, V48, P201, DOI 10.1016/j.procbio.2012.12.018
   Shu ZY, 2010, J MOL CATAL B-ENZYM, V62, P1, DOI 10.1016/j.molcatb.2009.09.003
   Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514
   Siddiqui KS, 2006, PROTEINS, V64, P486, DOI 10.1002/prot.20989
   Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723
   Siddiqui KS, 2005, EXTREMOPHILES, V9, P471, DOI 10.1007/s00792-005-0464-1
   Siglioccolo A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-50
   Simonato F, 2006, J BIOTECHNOL, V126, P11, DOI 10.1016/j.jbiotec.2006.03.038
   Singh N., 2014, RECENT ADV BIOENERGY, V3, P298
   Singh O.V., 2012, EXTREMOPHILES SUSTAI, P456
   Sivaramakrishnan S, 2006, FOOD TECHNOL BIOTECH, V44, P173
   Srimathi S, 2007, EXTREMOPHILES, V11, P505, DOI 10.1007/s00792-007-0062-5
   Stan-Lotter H, 2012, ADAPTION OF MICROBIAL LIFE TO ENVIRONMENTAL EXTREMES: NOVEL RESEARCH RESULTS AND APPLICATION, P1
   Stetter K.O., 2011, EXTREMOPHILES HDB, P404
   Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7
   Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450
   Sun HY, 2010, APPL BIOCHEM BIOTECH, V160, P988, DOI 10.1007/s12010-009-8579-y
   Suresh K, 2004, INT J SYST EVOL MICR, V54, P457, DOI 10.1099/ijs.0.02758-0
   Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257
   Tajima T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-69
   Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105
   Tehei M, 2005, J BIOL CHEM, V280, P40974, DOI 10.1074/jbc.M508417200
   Tokunaga H, 2008, PROTEIN SCI, V17, P1603, DOI 10.1110/ps.035725.108
   Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5
   Trincone A, 2011, MAR DRUGS, V9, P478, DOI 10.3390/md9040478
   Trincone A, 2010, J MOL CATAL B-ENZYM, V66, P241, DOI 10.1016/j.molcatb.2010.06.004
   Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9
   Uzyol KS, 2012, TURK J BIOL, V36, P327, DOI 10.3906/biy-1106-7
   ValdesStauber N, 1996, APPL ENVIRON MICROB, V62, P1283, DOI 10.1128/AEM.62.4.1283-1286.1996
   van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569
   Vanlint D., 2011, EXTREMOPHILES HDB, P669
   Varbanets L D, 2011, Mikrobiol Z, V73, P9
   Venkatesh R, 1998, ANN NY ACAD SCI, V864, P512, DOI 10.1111/j.1749-6632.1998.tb10370.x
   Venkatesh R, 1998, PROTEIN ENG, V11, P691, DOI 10.1093/protein/11.8.691
   Vermelho A. B., 2013, PROKARYOTES, V1, P213
   Vidyasagar M, 2009, BRAZ J MICROBIOL, V40, P12, DOI 10.1590/S1517-83822009000100002
   Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001
   Vijayalaxmi S, 2013, APPL BIOCHEM BIOTECH, V171, P382, DOI 10.1007/s12010-013-0333-9
   Vind J., 2012, Lipase Variants, Patent No. [US 8,187,854, 8187854]
   Ward Donald E., 2002, Archaea, V1, P63, DOI 10.1155/2002/503191
   WHITE RH, 1984, NATURE, V310, P430, DOI 10.1038/310430a0
   Widersten M, 2014, CURR OPIN CHEM BIOL, V21, P42, DOI 10.1016/j.cbpa.2014.03.015
   Wiegel J., 2011, EXTREMOPHILES HDB, P81
   Wilson DB, 2008, BIOMASS RECALCITRANC, P374
   WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576
   Yakimov M, 2014, ENCY METAGENOMICS, P1
   Yang KS, 2009, J BIOSCI BIOENG, V107, P599, DOI 10.1016/j.jbiosc.2009.01.009
   Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0
   Yumoto I, 2004, INT J SYST EVOL MICR, V54, P2379, DOI 10.1099/ijs.0.63130-0
   Zaccai G., 2011, ORIGINS EVOLUTION LI, P375
   Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301
   Zeng X, 2004, J MICROBIOL BIOTECHN, V14, P952
   Zhan DL, 2014, MOLECULES, V19, P1828, DOI 10.3390/molecules19021828
NR 273
TC 94
Z9 102
U1 0
U2 182
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD APR
PY 2015
VL 13
IS 4
BP 1925
EP 1965
DI 10.3390/md13041925
PG 41
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA CH0NA
UT WOS:000353715900018
PM 25854643
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Spindola, KCW
   Simas, NK
   Salles, TS
   de Meneses, MDF
   Sato, A
   Ferreira, D
   Romao, W
   Kuster, RM
AF Spindola, Kassia C. W.
   Simas, Naomi K.
   Salles, Tiago S.
   de Meneses, Marcelo D. F.
   Sato, Alice
   Ferreira, Davis
   Romao, Wanderson
   Kuster, Ricardo M.
TI Anti-Mayaro virus activity of Cassia australis extracts (Fabaceae,
   Leguminosae)
SO PARASITES & VECTORS
LA English
DT Article
DE Cassia australis; Flavonoids; Tannins; Antiviral; MAYV; Larvicidal
   activity; Aedes aegypti
ID IN-VITRO; FLAVONOIDS; DIMERS; STATE
AB Background: The arthropod-borne Mayaro virus (MAYV) causes 'Mayaro fever', a disease of medical significance, primarily affecting individuals in permanent contact with forested areas in tropical South America. Studies showed that the virus could also be transmitted by the mosquito Aedes aegypti. Recently, MAYV has attracted attention due to its likely urbanization. To date, there are no drugs that can treat this illness.
   Methods: Fractions and compounds were obtained by chromatography from leaf extracts of C. australis and chemically identified as flavonoids and condensed tannins using spectroscopic and spectrometric techniques (UV, NMR, and ESI-FT-ICR MS). Cytotoxicity of EtOAc, n-BuOH and EtOAc-Pp fractions were measured by the dye-uptake assay while their antiviral activity was evaluated by a virus yield inhibition assay. Larvicidal activity was measured by the procedures recommended by the WHO expert committee for determining acute toxicity.
   Results: The following group of substances was identified from EtOAc, n-BuOH and EtOAc-Pp fractions: flavones, flavonols, and their glycosides and condensed tannins. EtOAc and n-BuOH fractions inhibited MAYV production, respectively, by more than 70% and 85% at 25 mu g/mL. EtOAc-Pp fraction inhibited MAYV production by more than 90% at 10 mu g/mL, displaying a stronger antiviral effect than the licensed antiviral ribavirin. This fraction had an excellent antiviral effect (IC90 = 4.7 +/- 0.3 mu g/mL), while EtOAc and n-BuOH fractions were less active (IC90 = 89.1 +/- 4.4 mu g/mL and IC90 = 40.9 +/- 5.7 mu g/mL, respectively).
   Conclusions: C. australis can be used as a source of compounds with anti-Mayaro virus activity. This is the first report on the biological activity of C. australis.
C1 [Spindola, Kassia C. W.; Kuster, Ricardo M.] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Inst Nat Prod Res, Rio De Janeiro, Brazil.
   [Simas, Naomi K.] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Nat Product & Food Dept, Rio De Janeiro, Brazil.
   [de Meneses, Marcelo D. F.; Ferreira, Davis] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol, Rio De Janeiro, Brazil.
   [Salles, Tiago S.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, Brazil.
   [Sato, Alice] Fed Univ State Rio de Janeiro, Ctr Biol & Hlth Sci, Dept Bot, Rio De Janeiro, Brazil.
   [Romao, Wanderson] Univ Fed Espirito Santo, Dept Chem, Petrole & Forens Lab, BR-29075910 Vitoria, ES, Brazil.
RP Spindola, KCW (corresponding author), Univ Fed Rio de Janeiro, Ctr Hlth Sci, Inst Nat Prod Res, Rio De Janeiro, Brazil.
EM kawaldhelm@gmail.com
RI Kuster, Ricardo/AAG-3975-2019; Sato, Alice/L-6476-2013
OI Romao, Wanderson/0000-0002-2254-6683; Salles, Tiago/0000-0002-5822-1426;
   Kuster, Ricardo Machado/0000-0002-8961-5348
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); INBEB
FX The authors would like to thank CNPq and INBEB for financial support.
CR Barbosa FG, 2004, BIOCHEM SYST ECOL, V32, P363, DOI 10.1016/j.bse.2003.07.005
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Brasil Ministerio da Saude, SAUD AT SIT VIR CHIK
   Coetzee J, 2000, PHYTOCHEMISTRY, V53, P795, DOI 10.1016/S0031-9422(00)00017-0
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   De Bruyne T, 1999, BIOCHEM SYST ECOL, V27, P445, DOI 10.1016/S0305-1978(98)00101-X
   Dehmlow EV, 1998, PHYTOCHEMISTRY, V49, P1805, DOI 10.1016/S0031-9422(98)00218-0
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   dos Santos RN, 2008, QUIM NOVA, V31, P1979, DOI 10.1590/S0100-40422008000800011
   Franco E. A. P., 2006, Revista Brasileira de Plantas Medicinais, V8, P78
   Frazier RA, 2010, J PHARMACEUT BIOMED, V51, P490, DOI 10.1016/j.jpba.2009.05.035
   George DR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-28
   Gescher K, 2011, J ETHNOPHARMACOL, V134, P468, DOI 10.1016/j.jep.2010.12.038
   Guzman E, 2008, PHYTOMEDICINE, V15, P892, DOI 10.1016/j.phymed.2008.02.013
   Hatano T, 1997, PHYTOCHEMISTRY, V46, P893, DOI 10.1016/S0031-9422(97)00367-1
   Hatano T, 1999, PHYTOCHEMISTRY, V52, P1379, DOI 10.1016/S0031-9422(99)00437-9
   Hennebelle T, 2009, FITOTERAPIA, V80, P385, DOI 10.1016/j.fitote.2009.05.008
   Irwin HS, 1982, MEM NEW YORK BOT GAR, V35, P1, DOI DOI 10.2307/4108613
   Jones L., 2000, Fitoterapia, V71, P580
   Kanno M, 1999, CHEM PHARM BULL, V47, P915, DOI 10.1248/cpb.47.915
   Lombardo M, 2009, REV CIENC FARM BASIC, V30, P1
   Longuefosse JL, 1996, J ETHNOPHARMACOL, V53, P117, DOI 10.1016/0378-8741(96)01425-0
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Ntandou GFN, 2010, J ETHNOPHARMACOL, V127, P108, DOI 10.1016/j.jep.2009.09.040
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Silva ALG, 2002, BOL MUSEU NAC BOT, V121, P1
   TAKECHI M, 1985, PHYTOCHEMISTRY, V24, P2245, DOI 10.1016/S0031-9422(00)83018-6
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Viegas C, 2006, QUIM NOVA, V29, P326, DOI [10.1590/S0100-40422006000200025, 10.1590/S0100-40422006000600025]
   Viegas C, 2004, J NAT PROD, V67, P908, DOI 10.1021/np0303963
   WIERSEMA JH, 1989, TAXON, V38, P652, DOI 10.2307/1222658
   Xie C, 2003, CHEM PHARM BULL, V51, P1204, DOI 10.1248/cpb.51.1204
   Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011
   Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009
   Yuping T, 2009, J CHIN PHARM SCI, V9, P119
NR 38
TC 6
Z9 7
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 27
PY 2014
VL 7
AR 537
DI 10.1186/s13071-014-0537-z
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AY0AN
UT WOS:000347260100001
PM 25428163
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Allonso, D
   Meneses, MDF
   Fernandes, CA
   Ferreira, DF
   Mohana-Borges, R
AF Allonso, Diego
   Meneses, Marcelo D. F.
   Fernandes, Carlos A.
   Ferreira, Davis F.
   Mohana-Borges, Ronaldo
TI Assessing Positivity and Circulating Levels of NS1 in Samples from a
   2012 Dengue Outbreak in Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; PROTEIN NS1; PLASMA-LEVELS; SOLUBLE ST2;
   VIRUS; ANTIGEN; DIAGNOSIS; CORRELATE; DISEASE
AB Dengue virus (DENV) represents a major threat to public health worldwide. Early DENV diagnosis should not only detect the infection but also identify patients with a higher likelihood to develop severe cases. Previous studies have suggested the potential for NS1 to serve as a viral marker for dengue severity. However, further studies using different sera panels are required to confirm this hypothesis. In this context, we developed a lab-based ELISA to detect and quantitate NS1 protein from the four DENV serotypes and from primary and secondary cases. This approach was used to calculate the circulating NS1 concentration in positive samples. We also tested the NS1 positivity of DENV-positive samples according to the Platelia Dengue NS1 Ag assay. A total of 128 samples were positive for DENV infection and were classified according to the WHO guidelines. The overall NS1 positivity was 68% according to the Platelia assay, whereas all samples were NS1-positive when analyzed with our lab-based ELISA. Fifty-four samples were positive by PCR, revealing a co-circulation of DENV1 and DENV4, and the NS1 positivity for DENV4 samples was lower than that for DENV1. The circulating NS1 concentration ranged from 7 to 284 ng/mL. Our results support previous data indicating the low efficiency of the Platelia assay to detect DENV4 infection. Moreover, this work is the first to analyze NS1 antigenemia using retrospective samples from a Brazilian outbreak.
C1 [Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Meneses, Marcelo D. F.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Fernandes, Carlos A.] Lab Cent Noel Nutels LACEN, Rio De Janeiro, RJ, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Allonso, Diego/Y-3446-2018; Borges, Ronaldo S Mohana/C-5575-2013;
   Ferreira, Davis/D-9356-2014
OI Allonso, Diego/0000-0002-1410-480X; 
FU Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em
   Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency:
   Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES);
   Brazilian Funding Agency: Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Brazilian Funding Agency: Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Brazilian Funding
   Agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia
   Estrutural e Bioimagem (INCT-INBEB), Coordenacao de Aperfeicoamento de
   Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ).
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   [Anonymous], 2008, EVALUATION 2 NEW COM, V2, pe280
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Guerrero CD, 2013, CYTOKINE, V61, P766, DOI 10.1016/j.cyto.2012.12.024
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Lima MDQ, 2011, CLIN VACCINE IMMUNOL, V18, P1031, DOI 10.1128/CVI.00024-11
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   WHO, 2009, WHO TECH REP SER, V958, P1
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 27
TC 25
Z9 25
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 20
PY 2014
VL 9
IS 11
AR e113634
DI 10.1371/journal.pone.0113634
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT9ND
UT WOS:000345253000067
PM 25412084
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU dos Santos, AE
   Kuster, RM
   Yamamoto, KA
   Salles, TS
   Campos, R
   de Meneses, MDF
   Soares, MR
   Ferreira, D
AF dos Santos, Alda E.
   Kuster, Ricardo M.
   Yamamoto, Kristie A.
   Salles, Tiago S.
   Campos, Renata
   de Meneses, Marcelo D. F.
   Soares, Marcia R.
   Ferreira, Davis
TI Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.)
   Steud. show anti-Mayaro virus activity
SO PARASITES & VECTORS
LA English
DT Article
DE Bauhinia longifolia; Flavonoids; Quercetin derivatives; Antiviral; MAYV
ID HUMAN-DISEASE AGENT; ANTIVIRAL ACTIVITY; IN-VITRO; GLYCOSIDES; BRAZIL;
   FEVER; FLAVONOIDS; INFECTION; EPIDEMIC; LEAVES
AB Background: The arthropod-borne Mayaro virus (MAYV) causes 'Mayaro fever', a disease of medical significance, primarily affecting individuals in permanent contact with forested areas in tropical South America. Recently, MAYV has attracted attention due to its likely urbanization. Currently, there are no licensed drugs against most mosquito-transmitted viruses. Here, we investigated the in vitro anti-MAYV activity of the flavonoids quercetin and its derivatives from the Brazilian shrub Bauhinia longifolia (Bong.) Steud.
   Methods: Flavonoids were purified by chromatographic fractionation from leaf extracts of B. longifolia and chemically identified as quercetin and quercetin glycosides using spectroscopic techniques. Cytotoxicity of purified flavonoids and of EtOAc- and n-BuOH-containing flavonoid mixtures was measured by the dye-uptake assay while their antiviral activity was evaluated by a virus yield inhibition assay.
   Results: The following flavonoids were purified from B. longifolia leaves: non-glycosylated quercetin and its glycosides guaijaverin, quercitrin, isoquercitrin, and hyperin. EtOAc and n-BuOH fractions containing these flavonoids demonstrated the highest antiviral activity of all tested substances, while quercetin had the highest antiviral activity amongst purified flavonoids. Quercetin, EtOAc, or n-BuOH fractions inhibited MAYV production by more than 90% at 25 mu g/mL, displaying a stronger antiviral effect than the licensed antiviral ribavirin. A mixture of the isomers isoquercitrin and hyperin had a modest antiviral effect (IC90 = 104.9), while guaijaverin and quercitrin did not show significant antiviral activity.
   Conclusions: B. longifolia is a good source of flavonoids with anti-Mayaro virus activity. This is the first report of the activity of quercetin and its derivatives against an alphavirus.
C1 [dos Santos, Alda E.; Kuster, Ricardo M.] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Nat Prod Res Inst, Rio De Janeiro, Brazil.
   [Campos, Renata; de Meneses, Marcelo D. F.; Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, BR-21941 Rio De Janeiro, Brazil.
   [Yamamoto, Kristie A.; Salles, Tiago S.; Soares, Marcia R.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, Rio De Janeiro, Brazil.
   [Ferreira, Davis] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
RP Ferreira, D (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, BR-21941 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI Azevedo, Renata/V-3130-2019; Ferreira, Davis/D-9356-2014; Kuster,
   Ricardo/AAG-3975-2019
OI Salles, Tiago/0000-0002-5822-1426; dos Santos, Alda
   Ernestina/0000-0001-8086-7170; Kuster, Ricardo
   Machado/0000-0002-8961-5348
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); INBEB
FX The authors would like to thank CAPES, CNPq, FAPERJ, and INBEB for
   financial support. We thank Cleber Barreto for the NMR analysis and Ana
   Claudia Amaral for ESI-MS analysis.
CR Almeida ER, 2006, FITOTERAPIA, V77, P276, DOI 10.1016/j.fitote.2006.03.001
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Cechinel V, 2009, PHYTOTHER RES, V23, P1347, DOI 10.1002/ptr.2756
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Cortez LP, 2003, REV CIENCIAS MED BIO, V1, P5
   Davies KM, 2006, FLAVONOIDS CHEM BIOC, P168
   Elia G, 2008, ANTIVIR RES, V77, P108, DOI 10.1016/j.antiviral.2007.09.004
   Fan DS, 2011, FITOTERAPIA, V82, P805, DOI 10.1016/j.fitote.2011.04.007
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Fossen T., 2006, Flavonoids: chemistry, biochemistry and applications, P37
   George DR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-28
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Gould KS., 2006, FLAVONOIDS CHEM BIOC, P416
   GROOT H, 1959, AM J TROP MED HYG, V8, P175, DOI 10.4269/ajtmh.1959.8.175
   Kalegari M, 2011, BRAZ J PHARM SCI, V47, P635, DOI 10.1590/S1984-82502011000300023
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Leduc JW, 1981, AM J TROP MED HYG, V30, P683
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418
   Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002
   Piccinelli AL, 2007, FOOD CHEM, V100, P344, DOI 10.1016/j.foodchem.2005.09.053
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pinheiro FP, 1998, ARBOVIRUSES EPIDEMIO, P138
   Pizzolatti MG, 2003, QUIM NOVA, V26, P466, DOI 10.1590/S0100-40422003000400003
   Receveur MC, 2010, EUROSURVEILLANCE, V15, P6
   Rodrigues ED, 2009, MAGN RESON CHEM, V47, P1095, DOI 10.1002/mrc.2516
   Rosa APAT, 1998, OVERVIEW ARBOVIROLOG
   Politi FAS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-295
   SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Thapa M, 2012, BIOORG MED CHEM LETT, V22, P353, DOI 10.1016/j.bmcl.2011.10.119
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Vasconcelos P., 1998, OVERVIEW ARBOVIROLOG, P72
   Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587
   Yarmolinsky L, 2012, FITOTERAPIA, V83, P362, DOI 10.1016/j.fitote.2011.11.014
   Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259
NR 45
TC 33
Z9 34
U1 0
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 28
PY 2014
VL 7
AR 130
DI 10.1186/1756-3305-7-130
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AG3TL
UT WOS:000335342500003
PM 24678592
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Dumard, CH
   Barroso, SPC
   de Oliveira, GAP
   Carvalho, CAM
   Gomes, AMO
   Couceiro, JNSS
   Ferreira, DF
   Nico, D
   Oliveira, AC
   Silva, JL
   Santos, PS
AF Dumard, Carlos H.
   Barroso, Shana P. C.
   de Oliveira, Guilherme A. P.
   Carvalho, Carlos A. M.
   Gomes, Andre M. O.
   Couceiro, Jose Nelson S. S.
   Ferreira, Davis F.
   Nico, Dirlei
   Oliveira, Andrea C.
   Silva, Jerson L.
   Santos, Patricia S.
TI Full Inactivation of Human Influenza Virus by High Hydrostatic Pressure
   Preserves Virus Structure and Membrane Fusion While Conferring
   Protection to Mice against Infection
SO PLOS ONE
LA English
DT Article
ID A VIRUS; HETEROSUBTYPIC IMMUNITY; VACCINE; PROTEIN; HEMAGGLUTININ;
   STABILITY; RESPONSES; IMMUNOGENICITY; ANTIBODIES; INDUCTION
AB Whole inactivated vaccines (WIVs) possess greater immunogenicity than split or subunit vaccines, and recent studies have demonstrated that WIVs with preserved fusogenic activity are more protective than non-fusogenic WIVs. In this work, we describe the inactivation of human influenza virus X-31 by high hydrostatic pressure (HHP) and analyze the effects on the structure by spectroscopic measurements, light scattering, and electron microscopy. We also investigated the effects of HHP on the glycoprotein activity and fusogenic activity of the viral particles. The electron microscopy data showed pore formation on the viral envelope, but the general morphology was preserved, and small variations were seen in the particle structure. The activity of hemagglutinin (HA) during the process of binding and fusion was affected in a time-dependent manner, but neuraminidase (NA) activity was not affected. Infectious activity ceased after 3 hours of pressurization, and mice were protected from infection after being vaccinated. Our results revealed full viral inactivation with overall preservation of viral structure and maintenance of fusogenic activity, thereby conferring protection against infection. A strong response consisting of serum immunoglobulin IgG1, IgG2a, and serum and mucosal IgA was also detected after vaccination. Thus, our data strongly suggest that applying hydrostatic pressure may be an effective method for developing new vaccines against influenza A as well as other viruses.
C1 [Dumard, Carlos H.; Barroso, Shana P. C.; de Oliveira, Guilherme A. P.; Carvalho, Carlos A. M.; Gomes, Andre M. O.; Oliveira, Andrea C.; Silva, Jerson L.; Santos, Patricia S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.
   [Dumard, Carlos H.; Barroso, Shana P. C.; de Oliveira, Guilherme A. P.; Carvalho, Carlos A. M.; Gomes, Andre M. O.; Oliveira, Andrea C.; Silva, Jerson L.; Santos, Patricia S.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrut & Bioimage, Rio De Janeiro, RJ, Brazil.
   [Couceiro, Jose Nelson S. S.; Ferreira, Davis F.; Nico, Dirlei] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.
EM jerson@bioqmed.ufrj.br; pssantos@bioqmed.ufrj.br
RI Ferreira, Davis/D-9356-2014; Couceiro, Jose Nelson SS/J-3933-2016;
   Gomes, Andre/C-4009-2014; Silva, Jerson/J-8984-2014; de Oliveira,
   Guilherme A. P./O-1192-2013
OI Couceiro, Jose Nelson SS/0000-0001-8712-4847; Gomes,
   Andre/0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; de
   Oliveira, Guilherme A. P./0000-0002-0063-5888; Carvalho,
   Carlos/0000-0001-6615-1387; Dumard, Carlos/0000-0002-9276-6518
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa Carlos Chagas Filho do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do
   Estado do Rio de Janeiro (FAPERJ). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alsharifi M, 2009, PLOS ONE, V4, pe5536, DOI [10.1371/journal.pone.0005536, DOI 10.1371/J0URNAL.P0NE.0005536.PUBMED:19436754]
   Barroso SPC, 2012, PROCEDIA VACCINOL, V6, P98, DOI 10.1016/j.provac.2012.04.014
   Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0
   Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538
   BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211
   Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898
   Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007
   Calci KR, 2005, APPL ENVIRON MICROB, V71, P339, DOI 10.1128/AEM.71.1.339-343.2005
   Chawla R, 2011, J FOOD SCI TECH MYS, V48, P260, DOI 10.1007/s13197-010-0180-4
   Daum LT, 2002, J CLIN VIROL, V25, P345, DOI 10.1016/S1386-6532(02)00043-4
   Demazeau G, 2011, APPL MICROBIOL BIOT, V89, P1305, DOI 10.1007/s00253-010-3070-9
   Freitas MS, 2006, CELL BIOCHEM BIOPHYS, V44, P325, DOI 10.1385/CBB:44:3:325
   Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809
   Gaspar LP, 2002, J BIOL CHEM, V277, P8433, DOI 10.1074/jbc.M106096200
   Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x
   Gomes AMO, 2003, BIOCHEMISTRY-US, V42, P5540, DOI 10.1021/bi027207k
   Goncalves LDR, 2008, J PERIODONTAL RES, V43, P570, DOI 10.1111/j.1600-0765.2008.01101.x
   Goncalves RB, 2007, J MOL BIOL, V366, P295, DOI 10.1016/j.jmb.2006.11.033
   Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002
   Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025
   Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9
   Hierholzer JC, 1996, VIROLOGY METHODS MAN, P41
   Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213
   Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x
   Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06
   Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026
   Isbarn S, 2007, J FOOD PROTECT, V70, P667, DOI 10.4315/0362-028X-70.3.667
   Ishimaru D, 2004, VACCINE, V22, P2334, DOI 10.1016/j.vaccine.2003.10.034
   Janulikova J, 2012, ACTA VIROL, V56, P169, DOI 10.4149/av_2012_03_169
   JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935
   Kovac K, 2012, INT J FOOD MICROBIOL, V152, P35, DOI 10.1016/j.ijfoodmicro.2011.10.005
   Leimkuhler M, 2000, J MOL BIOL, V296, P1295, DOI 10.1006/jmbi.2000.3538
   Neuzil KM, 2008, NEW ENGL J MED, V342, P225
   Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5
   PALADINI AA, 1981, REV SCI INSTRUM, V52, P419, DOI 10.1063/1.1136596
   PALATNIKDESOUSA CB, 1995, T ROY SOC TROP MED H, V89, P390, DOI 10.1016/0035-9203(95)90022-5
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Pontes L, 2001, J MOL BIOL, V307, P1171, DOI 10.1006/jmbi.2001.4512
   POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   RENEGAR KB, 1991, J IMMUNOL, V146, P1972
   Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x
   Schwarcz WD, 2004, CELL MOL BIOL, V50, P419
   SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61
   Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179
   Tian SM, 2000, EUR J BIOCHEM, V267, P4486, DOI 10.1046/j.1432-1327.2000.01496.x
   URQUHART GE, 1974, J CLIN PATHOL, V27, P198, DOI 10.1136/jcp.27.3.198
   van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109
   Winter R, 2009, SOFT MATTER, V5, P3157, DOI 10.1039/b901690b
NR 55
TC 7
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2013
VL 8
IS 11
AR e80785
DI 10.1371/journal.pone.0080785
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 259RH
UT WOS:000327543500055
PM 24282553
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Vancini, R
   Wang, GB
   Ferreira, D
   Hernandez, R
   Brown, DT
AF Vancini, Ricardo
   Wang, Gongbo
   Ferreira, Davis
   Hernandez, Raquel
   Brown, Dennis T.
TI Alphavirus Genome Delivery Occurs Directly at the Plasma Membrane in a
   Time- and Temperature-Dependent Process
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID LYSOSOMOTROPIC WEAK BASES; SINDBIS-VIRUS; MOSQUITO CELLS; LOW-PH; ENTRY;
   INFECTION; FUSION; PROTEIN; PENETRATION; CHOLESTEROL
AB It is widely held that arboviruses such as the alphavirus Sindbis virus gain entry into cells by a process of receptor-mediated endocytosis followed by membrane fusion in the acid environment of the endosome. We have used an approach of direct observation of Sindbis virus entry into cells by electron microscopy and immunolabeling of virus proteins with antibodies conjugated to gold beads. We found that upon attaching to the cell surface, intact RNA-containing viruses became empty shells that could be identified only by antibody labeling. We found that the rate at which full particles were converted to empty particles increased with time and temperature. We found that this entry event takes place at temperatures that inhibit both endosome formation and membrane fusion. We conclude that entry of alphaviruses is by direct penetration of cell plasma membranes through a pore structure formed by virus and, possibly, host proteins.
C1 [Vancini, Ricardo; Wang, Gongbo; Hernandez, Raquel; Brown, Dennis T.] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, INCTBEB, Rio De Janeiro, Brazil.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
RI Ferreira, Davis/D-9356-2014
FU Foundation for Research (Carson City, NV); North Carolina Agricultural
   Research Service
FX This research was supported by a grant from The Foundation for Research
   (Carson City, NV) and by the North Carolina Agricultural Research
   Service.
CR Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000
   Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479
   Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183
   Brown DT, 2012, ADV EXP MED BIOL, V726, P181, DOI 10.1007/978-1-4614-0980-9_8
   Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   CASSELL S, 1984, J VIROL, V52, P857, DOI 10.1128/JVI.52.3.857-864.1984
   CONDIT RC, 2001, FIELDS VIROLOGY, V1, P19
   COOMBS K, 1981, J VIROL, V37, P1060, DOI 10.1128/JVI.37.3.1060-1065.1981
   Daneshtalab N, 2010, J PHARMACOL TOXICOL, V61, P127, DOI 10.1016/j.vascn.2009.12.002
   De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585
   Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817
   EDWARDS J, 1986, J GEN VIROL, V67, P377, DOI 10.1099/0022-1317-67-2-377
   Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09
   Haywood AM, 2010, J VIROL, V84, P10946, DOI 10.1128/JVI.00229-10
   HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47
   HELENIUS A, 1982, CIBA F SYMP, V92, P59
   Hernandez R, 2003, J VIROL, V77, P12710, DOI 10.1128/JVI.77.23.12710-12719.2003
   Hernandez R, 2001, J VIROL, V75, P2010, DOI 10.1128/JVI.75.4.2010-2013.2001
   Hernandez R, 2005, CURRENT PROTOCOLS MI, V1
   Hernandez Raquel, 2010, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15b01s16
   Hunt SR, 2011, J VIROL, V85, P1257, DOI 10.1128/JVI.01864-10
   KIELIAN M, 1990, MOL BIOL MED, V7, P17
   KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7
   Kononchik JP, 2011, VIROLOGY, V415, P132, DOI 10.1016/j.virol.2011.04.011
   Kononchik JP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-304
   Koschinski A, 2003, J GEN VIROL, V84, P1711, DOI 10.1099/vir.0.19062-0
   Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   Madan V, 2005, VIROLOGY, V332, P307, DOI 10.1016/j.virol.2004.11.001
   MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679
   Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996
   Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   RENZ D, 1976, J VIROL, V19, P775, DOI 10.1128/JVI.19.3.775-781.1976
   Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999
   Smit JM, 2002, FEBS LETT, V521, P62, DOI 10.1016/S0014-5793(02)02823-5
   Vancini R, 2013, VIROLOGY, V435, P406, DOI 10.1016/j.virol.2012.10.013
   WANG G, 2008, SINDBIS VIRUS INTERA
   Wang GB, 2007, VIROLOGY, V362, P461, DOI 10.1016/j.virol.2006.12.036
   WENGLER G, 1982, VIROLOGY, V118, P401, DOI 10.1016/0042-6822(82)90359-2
   Wengler G, 2003, J GEN VIROL, V84, P173, DOI 10.1099/vir.0.18696-0
NR 41
TC 26
Z9 26
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD APR
PY 2013
VL 87
IS 8
BP 4352
EP 4359
DI 10.1128/JVI.03412-12
PG 8
WC Virology
SC Virology
GA 113MC
UT WOS:000316671000021
PM 23388718
OA Green Published, Bronze
DA 2020-10-30
ER

PT J
AU Stevens, RH
   dos Santos, CDML
   Zuanazzi, D
   Mattos, MBD
   Ferreira, DF
   Kachlany, SC
   Tinoco, EMB
AF Stevens, Roy H.
   Martins Lobo dos Santos, Caroline de Moura
   Zuanazzi, David
   de Accioly Mattos, Marcelo Barbosas
   Ferreira, Davis Fernandes
   Kachlany, Scott C.
   Tinoco, Eduardo M. B.
TI Prophage induction in lysogenic Aggregatibacter actinomycetemcomitans
   cells co-cultured with human gingival fibroblasts, and its effect on
   leukotoxin release
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Bacteriophage; Aggregatibacter actinomycetemcomitans; Lysogeny;
   Induction; Leukotoxin
ID GRAM-NEGATIVE MICROORGANISM; ENCODED VIRULENCE FACTORS; HUMAN PHARYNGEAL
   CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; IN-VIVO; GROUP-A; BACTERIAL
   VIRULENCE; PERIODONTAL-DISEASE; HOST TISSUES; TEMPERATE BACTERIOPHAGES
AB Lysogeny is common among strains of the periodontal pathogen Aggregatibacter actinomycetemcomitans. Since lysogenic induction is known to result in the increased synthesis and release of bacterial toxins from lysogens, it would be important to elucidate the conditions under which induction of these bacteria may occur. Co-cultures of A. actinomycetemcomitans strains (either lysogenic or non-lysogenic) and human cells (either gingival fibroblasts or pharyngeal epithelial cells) were prepared. Following incubation, bacteriophage titers of up to 6.2 x 10(7) pfu/ml were detected in the cell-free, spent culture media from the co-cultures of the lysogenic A. actinomycetemcomitans strains and the fibroblasts. Little (maximum of 2 x 10(0) pfu/ml) or no titers of phage could be detected in the mono-cultures of the lysogenic A. actinomycetemcomitans strains alone. In contrast, no phage were detectable in the cell-free spent culture media of the lysogens cocultured with the epithelial cells. Futhermore, co-culture of the A. actinomycetemcomitans lysogens with the fibroblasts resulted in enhanced release of the A. actinomycetemcomitans leukotoxin into the culture medium, in comparison with the spent culture media from mono-cultures of the lysogens alone. These results are consistent with the concept that interaction with fibroblasts may mediate prophage induction in lysogenic strains of A. actinomycetemcomitans, and that leukotoxin release is greatly augmented following induction of the lysogens. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Stevens, Roy H.; de Accioly Mattos, Marcelo Barbosas] Temple Univ, Sch Dent, Lab Oral Infect Dis, Philadelphia, PA 19140 USA.
   [Stevens, Roy H.; de Accioly Mattos, Marcelo Barbosas] Temple Univ, Sch Dent, Dept Endodontol, Philadelphia, PA 19140 USA.
   [Martins Lobo dos Santos, Caroline de Moura; Tinoco, Eduardo M. B.] UERJ Unigranrio, Dept Periodontol, Rio De Janeiro, Brazil.
   [Zuanazzi, David; de Accioly Mattos, Marcelo Barbosas; Ferreira, Davis Fernandes] Fed Univ Rio de Janeiro UFRJ, Inst Microbiol, Rio De Janeiro, Brazil.
   [Kachlany, Scott C.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA.
RP Stevens, RH (corresponding author), Temple Univ, Sch Dent, Lab Oral Infect Dis, 3223 N Broad St, Philadelphia, PA 19140 USA.
EM rstevens@dental.temple.edu; carolinedemouramartins@yahoo.com.br;
   davidzuanazzi@gmail.com; acciolymarcelo@gmail.com; davisf@micro.ufrj.br;
   kachlasc@umdnj.edu; tinoco@wb.com.br
RI Tinoco, Eduardo/B-5571-2014; Ferreira, Davis/D-9356-2014; Santos,
   Caroline/A-8938-2019
OI Santos, Caroline/0000-0002-5816-5436; Tinoco,
   Eduardo/0000-0003-4798-7175; Stevens, Roy/0000-0002-4363-341X
CR BAEHNI P, 1979, INFECT IMMUN, V24, P233, DOI 10.1128/IAI.24.1.233-243.1979
   BAEHNI PC, 1981, ARCH ORAL BIOL, V26, P671, DOI 10.1016/0003-9969(81)90164-3
   Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003
   BENCHETRIT LC, 1978, J BACTERIOL, V134, P221, DOI 10.1128/JB.134.1.221-228.1978
   Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001
   BERTHOLD P, 1992, ORAL MICROBIOL IMMUN, V7, P24, DOI 10.1111/j.1399-302X.1992.tb00015.x
   Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9
   Broudy TB, 2002, INFECT IMMUN, V70, P2805, DOI 10.1128/IAI.70.6.2805-2811.2002
   Broudy TB, 2001, INFECT IMMUN, V69, P1440, DOI 10.1128/IAI.69.3.1440-1443.2001
   Cao SL, 2004, FEMS MICROBIOL LETT, V237, P97, DOI 10.1016/j.femsle.2004.06.021
   CHEN C, 1995, J DENT RES, V74, P197
   CHRISTERSSON LA, 1987, J PERIODONTOL, V58, P529, DOI 10.1902/jop.1987.58.8.529
   Cotter PA, 1998, CURR OPIN MICROBIOL, V1, P17, DOI 10.1016/S1369-5274(98)80138-0
   DIRIENZO JM, 1985, INFECT IMMUN, V47, P31, DOI 10.1128/IAI.47.1.31-36.1985
   Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x
   Gemski P, 1978, INFECT IMMUN, V9, P1076
   HALPERIN SA, 1987, J INFECT DIS, V155, P253, DOI 10.1093/infdis/155.2.253
   Handfield M, 2005, PERIODONTOL 2000, V38, P123, DOI 10.1111/j.1600-0757.2005.00110.x
   HOUSTON CW, 1981, INFECT IMMUN, V32, P916, DOI 10.1128/IAI.32.2.916-926.1981
   Johansson A, 2003, EUR J ORAL SCI, V111, P209, DOI 10.1034/j.1600-0722.2003.00030.x
   Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682
   Kachlany SC, 2000, INFECT IMMUN, V68, P6094, DOI 10.1128/IAI.68.11.6094-6100.2000
   KILEY P, 1980, INFECT IMMUN, V30, P862
   LALLY ET, 1991, MICROB PATHOGENESIS, V11, P111, DOI 10.1016/0882-4010(91)90004-T
   Livny J, 2004, MOL MICROBIOL, V51, P1691, DOI 10.1111/j.1365-2958.2003.03934.x
   LOFTUS A, 1995, CURR MICROBIOL, V30, P317, DOI 10.1007/BF00295508
   Los JM, 2009, MICROB PATHOGENESIS, V47, P289, DOI 10.1016/j.micpath.2009.09.006
   MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319
   MAHAN MJ, 1993, INFECT AGENT DIS, V2, P263
   MEKALANOS JJ, 1992, J BACTERIOL, V174, P1
   Meyer DH, 1996, INFECT IMMUN, V64, P2988, DOI 10.1128/IAI.64.8.2988-2997.1996
   MEYER DH, 1991, INFECT IMMUN, V59, P2719, DOI 10.1128/IAI.59.8.2719-2726.1991
   OHTA H, 1987, MICROBIOL IMMUNOL, V31, P313, DOI 10.1111/j.1348-0421.1987.tb03092.x
   OHTA H, 1991, INFECT IMMUN, V59, P4599, DOI 10.1128/IAI.59.12.4599-4605.1991
   PETERSON JW, 1981, INFECT IMMUN, V32, P232, DOI 10.1128/IAI.32.1.232-242.1981
   Rudney JD, 2001, INFECT IMMUN, V69, P2700, DOI 10.1128/IAI.69.4.2700-2707.2001
   SAGLIE FR, 1982, J PERIODONTAL RES, V17, P452, DOI 10.1111/j.1600-0765.1982.tb02024.x
   SANDMEIER H, 1995, J PERIODONTAL RES, V30, P418, DOI 10.1111/j.1600-0765.1995.tb01296.x
   SLAUCH JM, 1994, METHOD ENZYMOL, V235, P481
   Song Yo-Han, 2002, Ann Periodontol, V7, P38, DOI 10.1902/annals.2002.7.1.38
   Stevens R, 2012, J DENT RES, V91
   STEVENS RH, 1994, FEMS MICROBIOL LETT, V119, P329
   STEVENS RH, 1993, ORAL MICROBIOL IMMUN, V8, P100, DOI 10.1111/j.1399-302X.1993.tb00553.x
   STEVENS RH, 1982, INFECT IMMUN, V35, P343, DOI 10.1128/IAI.35.1.343-349.1982
   Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998
   Tinoco EMB, 1997, EUR J ORAL SCI, V105, P310, DOI 10.1111/j.1600-0722.1997.tb00246.x
   TSAI CC, 1979, INFECT IMMUN, V25, P427, DOI 10.1128/IAI.25.1.427-439.1979
   TSAI CC, 1984, INFECT IMMUN, V43, P700, DOI 10.1128/IAI.43.2.700-705.1984
   Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x
   Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002
   Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001
   Waldor MK, 2005, PHAGES THEIR ROLE BA
   Willi K, 1997, ORAL MICROBIOL IMMUN, V12, P40, DOI 10.1111/j.1399-302X.1997.tb00365.x
   ZABRISKIE JB, 1964, J EXP MED, V119, P761, DOI 10.1084/jem.119.5.761
   ZAMBON JJ, 1983, INFECT IMMUN, V40, P205, DOI 10.1128/IAI.40.1.205-212.1983
NR 55
TC 7
Z9 8
U1 1
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JAN
PY 2013
VL 54
BP 54
EP 59
DI 10.1016/j.micpath.2012.09.005
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA 078XP
UT WOS:000314134700007
PM 23022667
DA 2020-10-30
ER

PT J
AU Campos, RD
   Veiga, CSB
   Meneses, MDF
   de Souza, LM
   Fernandes, CAS
   Malirat, V
   Albuquerque, JP
   Tanuri, A
   Schmidt-Chanasit, J
   Ferreira, DF
AF Campos, Renata de M.
   Veiga, Camila S. B.
   Meneses, Marcelo D. F.
   de Souza, Leandro M.
   Fernandes, Carlos A. S.
   Malirat, Viviana
   Albuquerque, Julia P.
   Tanuri, Amilcar
   Schmidt-Chanasit, Jonas
   Ferreira, Davis F.
TI Emergence of Dengue virus 4 genotypes II b and I in the city of Rio de
   Janeiro
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
DE Dengue; Brazil; Emergence; Genotype; Serotype; Surveillance; Phylogeny
C1 [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, BR-21941902 Rio De Janeiro, Brazil.
   [Veiga, Camila S. B.; Meneses, Marcelo D. F.; de Souza, Leandro M.; Fernandes, Carlos A. S.] Noel Nutels Cent Lab LACEN, Rio De Janeiro, Brazil.
   [Malirat, Viviana] Consejo Nacl Invest Cient & Tecn, Inst Ciencia & Tecnol Dr Cesar Milstein, RA-1033 Buenos Aires, DF, Argentina.
   [Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
RP Ferreira, DF (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Bloco 1,Av Carlos Chagas Filho,373 Cidade Univ, BR-21941902 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
RI Ferreira, Davis/D-9356-2014; Azevedo, Renata/V-3130-2019
OI Fernandes, Carlos/0000-0003-2941-4744; Schmidt-Chanasit,
   Jonas/0000-0003-4433-0231
CR Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
NR 11
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2013
VL 56
IS 1
BP 86
EP 88
DI 10.1016/j.jcv.2012.10.006
PG 3
WC Virology
SC Virology
GA 061YG
UT WOS:000312885600020
PM 23127562
DA 2020-10-30
ER

PT J
AU Marinho, PR
   Simas, NK
   Kuster, RM
   Duarte, RS
   Fracalanzza, SEL
   Ferreira, DF
   Romanos, MTV
   Muricy, G
   Giambiagi-DeMarval, M
   Laport, MS
AF Marinho, Palloma R.
   Simas, Naomi Kato
   Kuster, Ricardo Machado
   Duarte, Rafael Silva
   Longo Fracalanzza, Sergio Eduardo
   Ferreira, Davis Fernandes
   Villela Romanos, Maria Teresa
   Muricy, Guilherme
   Giambiagi-DeMarval, Marcia
   Laport, Marinella Silva
TI Antibacterial activity and cytotoxicity analysis of halistanol
   trisulphate from marine sponge Petromica citrina
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE antibiotic-resistant bacteria; bioactive substance; Staphylococcus;
   sulphated sterol; Porifera
ID METABOLITES; INFECTION; OUTBREAK
AB An aqueous extract and fraction from the marine sponge Petromica citrina have antibacterial activity. We performed a chemical and biological characterization of the antibiotic substance from P. citrina and investigated its mode of action on Staphylococcus aureus cells.
   The inhibitory activity of the aqueous extract of P. citrina was determined against 14 bacteria belonging to type strains and clinical antibiotic-resistant strains. The aqueous extract was fractionated under bioassay guidance and the bioactive substance was identified by its H-1-NMR, C-13-NMR and mass spectra. The MIC and the MBC of this substance were determined. This substance was also subjected to cytotoxic bioassays. The mode of action on S. aureus cells was investigated by light and transmission electron microscopy analysis.
   P. citrina showed a large spectrum of activity against type strains and resistant-bacteria such as S. aureus, Staphylococcus epidermidis, Enterococcus faecalis, Mycobacterium fortuitum and Neisseria gonorrhoeae. The aqueous extract was fractionated and halistanol trisulphate (24?,25-dimethylcholestane-2,3,6-triol trisodium sulphate) was isolated for the first time from P. citrina. Halistanol trisulphate had a bactericidal effect on exponentially growing S. aureus cells at the MIC (512 mg/L). Cytotoxicity biossays showed moderate toxicity against cancer cell line L929 (fibrosarcoma). This substance apparently acts by damaging the cell membrane, with subsequent cell lysis.
   Halistanol trisulphate is a broad-spectrum antibiotic isolated from P. citrina with a mode of action involving disruption of the cytoplasmic membrane. It is a new candidate for research on antibacterial substances.
C1 [Marinho, Palloma R.; Duarte, Rafael Silva; Longo Fracalanzza, Sergio Eduardo; Ferreira, Davis Fernandes; Villela Romanos, Maria Teresa; Giambiagi-DeMarval, Marcia; Laport, Marinella Silva] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941590 Rio De Janeiro, Brazil.
   [Simas, Naomi Kato] Univ Fed Rio de Janeiro, Curso Farm, BR-27930560 Macae, RJ, Brazil.
   [Kuster, Ricardo Machado] Univ Fed Rio de Janeiro, Nucleo Pesquisas Prod Nat, BR-21941590 Rio De Janeiro, Brazil.
   [Muricy, Guilherme] Univ Fed Rio de Janeiro, Museu Nacl, BR-20940040 Rio De Janeiro, Brazil.
RP Laport, MS (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Av Carlos Chagas Filho 373,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM marinella@micro.ufrj.br
RI Duarte, Rafael/AAK-7946-2020; Laport, Marinella Silva/AAW-9301-2020;
   Muricy, Guilherme/O-2012-2015; Laport, Marinella S/L-3596-2016;
   Giambiagi-deMarval, Marcia/V-3105-2019; Kuster, Ricardo/AAG-3975-2019
OI Laport, Marinella Silva/0000-0001-5252-0671; Muricy,
   Guilherme/0000-0002-1705-3673; Laport, Marinella S/0000-0001-5252-0671;
   Kuster, Ricardo Machado/0000-0002-8961-5348
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by grants from CAPES, CNPq and FAPERJ to M. S.
   L. and G. M., and P. R. M. received a CAPES fellowship.
CR CDC, 2002, MMWR-MORBID MORTAL W, V51, P36
   Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
   Das P, 2010, ADV EXP MED BIOL, V672, P88
   Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10
   Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226
   Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09
   Freitas D, 2003, OPHTHALMOLOGY, V110, P276, DOI 10.1016/S0161-6420(02)01643-3
   FUSETANI N, 1981, TETRAHEDRON LETT, V22, P1985, DOI 10.1016/S0040-4039(01)92885-0
   Isenberg HD, 1992, CLIN MICROBIOLOGY PR
   KANAZAWA S, 1992, TETRAHEDRON, V48, P5467, DOI 10.1016/S0040-4020(01)88300-9
   Kossuga MH, 2007, QUIM NOVA, V30, P1194, DOI 10.1590/S0100-40422007000500027
   Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625
   Laport MS, 2012, VET MICROBIOL, V155, P362, DOI 10.1016/j.vetmic.2011.09.004
   Marinho PR, 2010, REV BRAS FARMACOGN, V20, P267, DOI 10.1590/S0102-695X2010000200022
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nunes APF, 2002, CURR MICROBIOL, V44, P385, DOI 10.1007/s00284-001-0027-3
   Padoveze MC, 2007, J HOSP INFECT, V67, P161, DOI 10.1016/j.jhin.2007.07.007
   RAHALISON L, 1994, PLANTA MED, V60, P41, DOI 10.1055/s-2006-959405
   Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220
   SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588
   Sperry S, 1997, J NAT PROD, V60, P29, DOI 10.1021/np960592s
   Uehara AA, 2011, J CLIN MICROBIOL, V49, P4208, DOI 10.1128/JCM.01175-11
   White AR, 2011, J ANTIMICROB CHEMOTH, V66, P1948, DOI 10.1093/jac/dkr260
   Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996
   Yang JH, 2011, IMMUNOPHARM IMMUNOT, V33, P373, DOI 10.3109/08923973.2010.520716
NR 25
TC 13
Z9 13
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD OCT
PY 2012
VL 67
IS 10
BP 2396
EP 2400
DI 10.1093/jac/dks229
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 011CL
UT WOS:000309140900016
PM 22729926
OA Bronze
DA 2020-10-30
ER

PT J
AU Vancini, R
   Paredes, A
   Ribeiro, M
   Blackburn, K
   Ferreira, D
   Kononchik, JP
   Hernandez, R
   Brown, D
AF Vancini, Ricardo
   Paredes, Angel
   Ribeiro, Mariana
   Blackburn, Kevin
   Ferreira, Davis
   Kononchik, Joseph P., Jr.
   Hernandez, Raquel
   Brown, Dennis
TI Espirito Santo Virus: a New Birnavirus That Replicates in Insect Cells
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID BURSAL DISEASE VIRUS; PANCREATIC NECROSIS VIRUS; DEPENDENT
   RNA-POLYMERASES; DENGUE-VIRUS; AEDES-ALBOPICTUS; ELECTRON-MICROSCOPY;
   CRYSTAL-STRUCTURE; GENOME SEGMENT; MOSQUITO CELLS; DENSOVIRUS
AB Espirito Santo virus (ESV) is a newly discovered virus recovered as contamination in a sample of a virulent strain of dengue-2 virus (strain 44/2), which was recovered from a patient in the state of Espirito Santo, Brazil, and amplified in insect cells. ESV was found to be dependent upon coinfection with a virulent strain of dengue-2 virus and to replicate in C6/36 insect cells but not in mammalian Vero cells. A sequence of the genome has been produced by de novo assembly and was not found to match to any known viral sequence. An incomplete match to the nucleotide sequence of the RNA-dependent RNA polymerase from Drosophila X virus (DXV), another birnavirus, could be detected. Mass spectrometry analysis of ESV proteins found no matches in the protein data banks. However, peptides recovered by mass spectrometry corresponded to the de novo-assembled sequence by BLAST analysis. The composition and three-dimensional structure of ESV are presented, and its sequence is compared to those of other members of the birnavirus family. Although the virus was found to belong to the family Birnaviridae, biochemical and sequence information for ESV differed from that of DXV, the representative species of the genus Entomobirnavirus. Thus, significant differences underscore the uniqueness of this infectious agent, and its relationship to the coinfecting virus is discussed.
C1 [Vancini, Ricardo; Ribeiro, Mariana; Blackburn, Kevin; Kononchik, Joseph P., Jr.; Hernandez, Raquel; Brown, Dennis] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
   [Paredes, Angel] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [Ferreira, Davis] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil.
RP Brown, D (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
RI Ferreira, Davis/D-9356-2014
OI Kononchik, Joseph/0000-0002-6707-5213
FU Foundation for Research, Carson City, NV; North Carolina Agricultural
   Research Service at North Carolina State University; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [P41 RR001081]
FX This research was supported by a grant from the Foundation for Research,
   Carson City, NV, and by the North Carolina Agricultural Research Service
   at North Carolina State University. Molecular graphics images were
   produced by using the UCSF Chimera package from the Resource for
   Bio-computing, Visualization, and Informatics at the University of
   California, San Francisco (supported by NIH grant P41 RR001081).
CR Abdel-Alim GA, 2003, AVIAN DIS, V47, P1452, DOI 10.1637/7032
   Angelastro JM, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e62
   AZAD AA, 1985, VIROLOGY, V143, P35, DOI 10.1016/0042-6822(85)90094-7
   Barreau C, 1996, J INVERTEBR PATHOL, V68, P299, DOI 10.1006/jipa.1996.0100
   Bottcher B, 1997, J VIROL, V71, P325
   Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277
   BRUENN JA, 1991, NUCLEIC ACIDS RES, V19, P217, DOI 10.1093/nar/19.2.217
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Chen SX, 2004, VIROLOGY, V318, P123, DOI 10.1016/j.virol.2003.09.013
   CHRISTIE KE, 1988, ARCH VIROL, V103, P167, DOI 10.1007/BF01311090
   Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610
   COHEN J, 1973, J GEN VIROL, V21, P485, DOI 10.1099/0022-1317-21-3-485
   COMPS M, 1991, J GEN VIROL, V72, P1229, DOI 10.1099/0022-1317-72-6-1229
   Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009
   Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09
   DAVEY MW, 1973, J GEN VIROL, V20, P225, DOI 10.1099/0022-1317-20-2-225
   DOBOS P, 1979, J VIROL, V32, P1046, DOI 10.1128/JVI.32.3.1047-1050.1979
   DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979
   DOBOS P, 1983, CAN J MICROBIOL, V29, P377, DOI 10.1139/m83-062
   DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011
   Fukami A, 1965, J Electron Microsc (Tokyo), V14, P112
   HARKNESS JW, 1975, ARCH VIROL, V48, P63, DOI 10.1007/BF01320566
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   HIRUMI H, 1976, IN VITRO CELL DEV B, V12, P83
   Kanthong N, 2008, DEV COMP IMMUNOL, V32, P1063, DOI 10.1016/j.dci.2008.02.008
   Kanthong N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-14
   KELLY DC, 1982, J GEN VIROL, V62, P313, DOI 10.1099/0022-1317-62-2-313
   Lombardo E, 1999, J VIROL, V73, P6973, DOI 10.1128/JVI.73.8.6973-6983.1999
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Luque D, 2007, J VIROL, V81, P6869, DOI 10.1128/JVI.00077-07
   Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029
   MACDONALD RD, 1981, VIROLOGY, V114, P414, DOI 10.1016/0042-6822(81)90222-1
   Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003
   Mariante RM, 2006, HISTOCHEM CELL BIOL, V125, P545, DOI 10.1007/s00418-005-0098-5
   Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004
   Mitchell C. J., 1995, Parassitologia (Rome), V37, P109
   NAGY E, 1984, VIROLOGY, V137, P58, DOI 10.1016/0042-6822(84)90008-4
   NAGY E, 1984, VIROLOGY, V134, P358, DOI 10.1016/0042-6822(84)90303-9
   OZEL M, 1985, ARCH VIROL, V84, P149, DOI 10.1007/BF01378968
   Pous J, 2005, J GEN VIROL, V86, P2339, DOI 10.1099/vir.0.80942-0
   RHODE SL, 1978, J VIROL, V27, P347, DOI 10.1128/JVI.27.2.347-356.1978
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200
   SUITOR EC, 1969, VIROLOGY, V38, P482, DOI 10.1016/0042-6822(69)90162-7
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Villanueva RA, 2004, J VIROL, V78, P13829, DOI 10.1128/JVI.78.24.13829-13838.2004
   Wei W, 2006, AM J TROP MED HYG, V75, P1118, DOI 10.4269/ajtmh.2006.75.1118
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhang CX, 2003, ARCH VIROL, V148, P745, DOI 10.1007/s00705-002-0951-y
NR 50
TC 12
Z9 12
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2012
VL 86
IS 5
BP 2390
EP 2399
DI 10.1128/JVI.06614-11
PG 10
WC Virology
SC Virology
GA 896AC
UT WOS:000300536800001
PM 22171264
OA Green Published, Bronze
DA 2020-10-30
ER

PT J
AU Sousa, IP
   Carvalho, CAM
   Ferreira, DF
   Weissmuller, G
   Rocha, GM
   Silva, JL
   Gomes, AMO
AF Sousa, Ivanildo P., Jr.
   Carvalho, Carlos A. M.
   Ferreira, Davis F.
   Weissmueller, Gilberto
   Rocha, Gustavo M.
   Silva, Jerson L.
   Gomes, Andre M. O.
TI Envelope Lipid-packing as a Critical Factor for the Biological Activity
   and Stability of Alphavirus Particles Isolated from Mammalian and
   Mosquito Cells
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SEMLIKI-FOREST-VIRUS; SINDBIS VIRUS; IMMUNODEFICIENCY-VIRUS; MEMBRANE
   CHOLESTEROL; INFLUENZA-VIRUS; LAURDAN FLUORESCENCE; PLASMA-MEMBRANE;
   LOW-PH; ENTRY; PROTEINS
AB Alphaviruses are enveloped arboviruses. The viral envelope is derived from the host cell and is positioned between two icosahedral protein shells (T = 4). Because the viral envelope contains glycoproteins involved in cell recognition and entry, the integrity of the envelope is critical for the success of the early events of infection. Differing levels of cholesterol in different hosts leads to the production of alphaviruses with distinct levels of this sterol loaded in the envelope. Using Mayaro virus, a New World alphavirus, we investigated the role of cholesterol on the envelope of alphavirus particles assembled in either mammalian or mosquito cells. Our results show that although quite different in their cholesterol content, Mayaro virus particles obtained from both cells share a similar high level of lateral organization in their envelopes. This organization, as well as viral stability and infectivity, is severely compromised when cholesterol is depleted from the envelope of virus particles isolated from mammalian cells, but virus particles isolated from mosquito cells are relatively unaffected by cholesterol depletion. We suggest that it is not cholesterol itself, but rather the organization of the viral envelope, that is critical for the biological activity of alphaviruses.
C1 [Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21341902 Rio De Janeiro, Brazil.
   [Sousa, Ivanildo P., Jr.; Carvalho, Carlos A. M.; Silva, Jerson L.; Gomes, Andre M. O.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21341902 Rio De Janeiro, Brazil.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, BR-21341902 Rio De Janeiro, Brazil.
   [Weissmueller, Gilberto; Rocha, Gustavo M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21341902 Rio De Janeiro, Brazil.
RP Gomes, AMO (corresponding author), Ave Carlos Chagas Filho,373 CCS Rm E1-008,Cidade, BR-21941902 Rio De Janeiro, Brazil.
EM amog@bioqmed.ufrj.br
RI Silva, Jerson/J-8984-2014; Ferreira, Davis/D-9356-2014; Sousa,
   ivanildo/ABC-1067-2020; Gomes, Andre/C-4009-2014
OI Silva, Jerson/0000-0001-9523-9441; Gomes, Andre/0000-0003-1052-8004;
   Carvalho, Carlos/0000-0001-6615-1387
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Fundacao
   Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia
   Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional
   de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB);
   Programa de Apoio a Nucleos de Excelencia (PRONEX)
FX The work was supported by grants from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria
   Jose Bonifacio (FUJB), Instituto Milenio de Biologia Estrutural em
   Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e
   Tecnologia em Biologia Estrutural e Bioimagem (INCTBEB), and Programa de
   Apoio a Nucleos de Excelencia (PRONEX).
CR Bagatolli LA, 2003, METHOD ENZYMOL, V360, P481
   Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07
   Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004
   Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7
   Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005
   Clayton R. B., 1964, J LIPID RES, V15, P3
   Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180
   Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0
   Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857
   Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003
   Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002
   Hafer A, 2009, J VIROL, V83, P9113, DOI 10.1128/JVI.00755-09
   Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07
   Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10
   Huang HL, 2006, J GEN VIROL, V87, P277, DOI 10.1099/vir.0.81551-0
   Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g
   IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993
   Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914
   Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256
   Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   LUUKKONEN A, 1976, BIOCHIM BIOPHYS ACTA, V450, P109, DOI 10.1016/0005-2760(76)90082-5
   LUUKKONEN A, 1977, VIROLOGY, V78, P331, DOI 10.1016/0042-6822(77)90105-2
   MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57
   MEZENCIO JMS, 1993, MEM I OSWALDO CRUZ, V88, P299, DOI 10.1590/S0074-02761993000200020
   MOORE NF, 1976, J VIROL, V19, P126, DOI 10.1128/JVI.19.1.126-135.1976
   Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X
   PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0
   Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046
   PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615
   Polozov IV, 2004, BIOPHYS J, V87, P1741, DOI 10.1529/biophysj.104.040725
   Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77
   RECEVEUR MC, 2010, EUROSURVEILLANCE, V15, pP11
   Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038
   SEFTON BM, 1974, J MOL BIOL, V90, P343, DOI 10.1016/0022-2836(74)90378-7
   Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6
   Smit JM, 1999, J VIROL, V73, P8476, DOI 10.1128/JVI.73.10.8476-8484.1999
   Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003
   Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002
   Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026
NR 49
TC 8
Z9 8
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 21
PY 2011
VL 286
IS 3
BP 1730
EP 1736
DI 10.1074/jbc.M110.198002
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 706BV
UT WOS:000286191500012
PM 21075845
OA Green Published, Bronze
DA 2020-10-30
ER

PT J
AU Oliveira, MF
   Araujo, JMG
   Ferreira, OC
   Ferreira, DF
   Lima, DB
   Santos, FB
   Schatzmayr, HG
   Tanuri, A
   Nogueira, RMR
AF Oliveira, Michelli Faria
   Galvao Araujo, Joselio Maria
   Ferreira, Orlando Costa, Jr.
   Ferreira, Davis Fernandes
   Lima, Dirce Bonfim
   Santos, Flavia Barreto
   Schatzmayr, Hermann Goncalves
   Tanuri, Amilcar
   Ribeiro Nogueira, Rita Maria
TI Two Lineages of Dengue Virus Type 2, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID SEROTYPES; SELECTION
C1 [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Lab Virol Mol Anim,CCS,Ilha Fundao, BR-21944970 Rio De Janeiro, Brazil.
   [Galvao Araujo, Joselio Maria; Santos, Flavia Barreto; Schatzmayr, Hermann Goncalves; Ribeiro Nogueira, Rita Maria] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
   [Lima, Dirce Bonfim] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Lab Virol Mol Anim,CCS,Ilha Fundao, Bloco A,Sala 121,Av Brigadeiro Trompowski S-N, BR-21944970 Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Ferreira, Davis/D-9356-2014; de Oliveira, Michelli Faria/J-4189-2019;
   Araujo, Joselio M G/B-5502-2013
OI de Oliveira, Michelli Faria/0000-0001-5045-7939; Araujo, Joselio M
   G/0000-0003-3548-2786
CR Aquino JDJD, 2008, VIRUS RES, V137, P266, DOI 10.1016/j.virusres.2008.07.011
   Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   *SVS, 2009, REL CAS DENG 2008
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   WHO Global Alert and Response (GAR), IMP DENG
NR 10
TC 34
Z9 36
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2010
VL 16
IS 3
BP 576
EP 578
DI 10.3201/eid1603.090996
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 566WR
UT WOS:000275404700047
PM 20202456
OA DOAJ Gold, Green Published
DA 2020-10-30
ER

PT J
AU Bernardino, AMR
   de Azevedo, AR
   Pinheiro, LCD
   Borges, JC
   Carvalho, VL
   Miranda, MD
   de Meneses, MDF
   Nascimento, M
   Ferreira, D
   Rebello, MA
   da Silva, VAGG
   de Frugulhetti, ICPP
AF Rolim Bernardino, Alice Maria
   Reis de Azevedo, Alexandre
   da Silva Pinheiro, Luiz Carlos
   Cesar Borges, Julio
   Lucio Carvalho, Vinicius
   Dias Miranda, Milene
   Ferreira de Meneses, Marcelo Damiao
   Nascimento, Marcelo
   Ferreira, Davis
   Alcoforado Rebello, Moacyr
   Giongo Galvao da Silva, Viveca Antonia
   de Frugulhetti, Izabel Christina Palmer Paixao
TI Synthesis and antiviral activity of new
   4-(phenylamino)/4-[(methylpyridin-2-yl)amino]-1-phenyl-1H-pyrazolo[3,4-b
   ]pyridine-4-carboxylic acids derivatives
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE 1H-pyrazolo[3,4-b]pyridine; antiviral; HSV-1; MAY; VSV
ID HUMAN-DISEASE AGENT; MAYARO VIRUS
AB The synthesis of new 4-( phenylamino)-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (3a-l) derivatives and the new 4-[(methylpyridin-2-yl) amino]-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (5a-c) derivatives was achieved with an efficient synthetic route. Ethyl 4-chloro-1-phenyl-1H-pyrazolo[ 3,4-b]pyridine-5-carboxylate ( 1) on fusion with appropriate substituted anilines or aminopicolines gave the required new ethyl-4-(phenylamino)-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carboxylates (2a-l) ( 52-82%) or new ethyl 4[(methylpyridin-2-yl) amino]-1-phenyl-1H- pyrazolo[3,4-b]pyridine-5-carboxylates (4a-c) ( 50-60%), respectively. Subsequent hydrolysis of the esters afforded the corresponding carboxylic acids (3a-l) ( 86-93%) and (5a-c) in high yield (80-93%). Inhibitory effects of 4-( phenylamino)/4-[(methylpyridin-2-yl) amino]-1-phenyl-1Hpyrazolo[3,4-b]pyridine-4-carboxylic acids. Derivatives on Herpes simplex virus type 1 (HSV-1), Mayaro virus ( MAY) and vesicular stomatitis virus (VSV) were investigated. Compounds 2d, 3f, 3a, and 3c exhibited antiviral activity against HSV-1, MAY, and VSV virus with EC50 values of 6.8, 2.2, 4.8, 0.52, 2.5, and 1.0. None of these compounds showed toxicity for Vero cells.
C1 [Rolim Bernardino, Alice Maria; Reis de Azevedo, Alexandre; da Silva Pinheiro, Luiz Carlos; Cesar Borges, Julio; Lucio Carvalho, Vinicius] Univ Fed Fluminense, Inst Quim, Dept Quim Organ, Program Posgrad Quim Organ, BR-24020141 Niteroi, RJ, Brazil.
   [Dias Miranda, Milene; Nascimento, Marcelo; de Frugulhetti, Izabel Christina Palmer Paixao] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, BR-24020141 Niteroi, RJ, Brazil.
   [Ferreira de Meneses, Marcelo Damiao; Ferreira, Davis; Alcoforado Rebello, Moacyr; Giongo Galvao da Silva, Viveca Antonia] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941902 Rio De Janeiro, Brazil.
RP Bernardino, AMR (corresponding author), Univ Fed Fluminense, Inst Quim, Dept Quim Organ, Program Posgrad Quim Organ, Outerio Sao Jjoao Batista,S-N, BR-24020141 Niteroi, RJ, Brazil.
EM alicerolim@globo.com
RI Pinheiro, Luiz C. S./J-2937-2012; Paixao, Izabel/AAM-1668-2020; Paixao,
   Izabel/S-7490-2019; Ferreira, Davis/D-9356-2014
OI Pinheiro, Luiz C. S./0000-0002-6398-7717; Rolim Bernardino, Alice
   Maria/0000-0003-0486-1468
CR Ahluwalia VK, 1996, SYNTHETIC COMMUN, V26, P1341, DOI 10.1080/00397919608003494
   Azevedo AR, 2002, HETEROCYCL COMMUN, V8, P427
   Bernardino AMR, 1996, HETEROCYCL COMMUN, V2, P415
   Bernardino AMR, 1996, J BRAZIL CHEM SOC, V7, P273, DOI 10.5935/0103-5053.19960055
   BERNARDINO AMR, 2007, IN PRESS BIOORG MED
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   De Clercq E, 2005, CURR OPIN MICROBIOL, V8, P552, DOI 10.1016/j.mib.2005.08.010
   de Mello H, 2004, J MED CHEM, V47, P5427, DOI 10.1021/jm0401006
   de Mello H, 1999, QUIM NOVA, V22, P26, DOI 10.1590/S0100-40421999000100006
   Eizuru Yoshito, 2003, Antiviral Chemistry & Chemotherapy, V14, P299
   HOHN H, 1972, J HETEROCYCLIC CHEM, V9, P235
   Lucero BD, 2006, BIOORG MED CHEM LETT, V16, P1010, DOI 10.1016/j.bmcl.2005.10.111
   LYNCH BM, 1988, CAN J CHEM, V66, P420, DOI 10.1139/v88-074
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PINHEIRO LCS, 2004, HETEROCYCL COMMUN, V10, P5
   Quiroga J, 1998, J HETEROCYCLIC CHEM, V35, P409, DOI 10.1002/jhet.5570350225
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   ROSE JK, 2007, FIELDS VIROLOGY KNIP
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9
NR 21
TC 61
Z9 62
U1 0
U2 6
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD DEC
PY 2007
VL 16
IS 7-9
BP 352
EP 369
DI 10.1007/s00044-007-9035-6
PG 18
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 280DJ
UT WOS:000254404800004
DA 2020-10-30
ER

PT J
AU Mudiganti, U
   Hernandez, R
   Ferreira, D
   Brown, DT
AF Mudiganti, Usharani
   Hernandez, Raquel
   Ferreira, Davis
   Brown, Dennis T.
TI Sindbis virus infection of two model insect cell systems - A comparative
   study
SO VIRUS RESEARCH
LA English
DT Article
DE arbovirus; insect cells; virus replication; Drosophila
ID ALBOPICTUS MOSQUITO CELLS; TEMPERATURE-SENSITIVE MUTANTS;
   AEDES-ALBOPICTUS; DROSOPHILA-MELANOGASTER; PROSTATE-CANCER; RNA
   REPLICATION; CULTURES; ALPHAVIRUSES; CULICIDAE; DIPTERA
AB Sindbis, the prototype of the Alphaviruses causes mosquito-borne diseases in mammals and replicates in a wide variety of vertebrate and invertebrate cell cultures. This characteristic can be exploited to use the vast array of Drosophila genetic information available for investigations of the interaction of Sindbis virus with an alternate invertebrate host. For this purpose, a comparative study of Sindbis virus infection of Schnieder-2 Drosophila (S2) cells to cells of the mosquito Aedes albopictus (clone U4.4) was undertaken. After infection, vertebrate cells die within 24-48 h, while invertebrate cell cultures survive an acute phase of infection and become persistently infected. In this study, infection of a model Drosophila system, S2 cells, was compared to U4.4 cells. Virus production, the time course of the establishment of persistence and changes in growth properties of the S2 cells upon infection, were studied in comparison to those of the U4.4 cells. S2 cells survived acute Sindbis infection without any significant cytopathology and continued to produce low levels of virus characteristic of persistently infected cells. S2 cells produced 10 PFU/cell on day 1 post-infection, which falls to 2 PFU/cell on day 2. This result is in contrast to U4.4 cells, which produce peak virus titer on day 2 post-infection and establish persistence by day 5. Onset of the persistent phase of infection of either U4.4 or S2 cells did not result in any change in morphology or growth characteristics. This study establishes S2 cells as an additional invertebrate model system to study the interactions of an invertebrate host with Sindbis virus. (c) 2006 Elsevier B.V. All rights reserved.
C1 N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Campus Box 7622, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
CR BOWERS DF, 1995, VIROLOGY, V212, P1, DOI 10.1006/viro.1995.1447
   Bowers DF, 2003, J MED ENTOMOL, V40, P698, DOI 10.1603/0022-2585-40.5.698
   BRASHERRENG F, 1973, ANN INST PASTEUR MIC, VA124, P507
   BRASHERRENG F, 1975, ARCH VIROL, V48, P121, DOI 10.1007/BF01318145
   BRASHERRENG F, 1976, ANN INST PASTEUR MIC, VB127, P541
   Brown D. T., 1980, TOGAVIRUSES, P473
   Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   Chen JX, 2003, COMPUT SCI ENG, V5, P12, DOI 10.1109/MCISE.2003.1182957
   Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597
   CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986
   CONDREAY LD, 1988, J VIROL, V62, P346, DOI 10.1128/JVI.62.1.346-348.1988
   CZARNIECKI CW, 1980, J GEN VIROL, V48, P75, DOI 10.1099/0022-1317-48-1-75
   DOHERTY RL, 1979, AUST J EXP BIOL MED, V57, P509, DOI 10.1038/icb.1979.52
   DOHM DJ, 1995, J MED ENTOMOL, V32, P818, DOI 10.1093/jmedent/32.6.818
   Elwell C, 2005, CELL MICROBIOL, V7, P725, DOI 10.1111/j.1462-5822.2005.00508.x
   Foy BD, 2004, INSECT MOL BIOL, V13, P89, DOI 10.1111/j.1365-2583.2004.00464.x
   FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075
   GLIEDMAN JB, 1975, J VIROL, V16, P913, DOI 10.1128/JVI.16.4.913-926.1975
   Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005
   Hernandez R, 2003, J VIROL, V77, P12710, DOI 10.1128/JVI.77.23.12710-12719.2003
   Hernandez R, 2001, J VIROL, V75, P2010, DOI 10.1128/JVI.75.4.2010-2013.2001
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   IGARASHI A, 1976, VIROLOGY, V74, P174, DOI 10.1016/0042-6822(76)90139-2
   Kallioniemi O, 2005, BJU INT, V96, P10, DOI 10.1111/j.1464-410X.2005.05941.x
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Karpf AR, 1997, VIRUS RES, V50, P1, DOI 10.1016/S0168-1702(97)01461-5
   Karpf AR, 1998, VIROLOGY, V240, P193, DOI 10.1006/viro.1997.8914
   Kim KH, 2004, VIROLOGY, V323, P153, DOI 10.1016/j.virol.2004.03.009
   Klein EA, 2005, NAT CLIN PRACT UROL, V2, P24, DOI 10.1038/ncpuro0072
   Laine M, 2004, J INTERN MED, V256, P457, DOI 10.1111/j.1365-2796.2004.01413.x
   LUO T, 1994, VIROLOGY, V200, P200, DOI 10.1006/viro.1994.1178
   MILLER ML, 1992, J VIROL, V66, P4180, DOI 10.1128/JVI.66.7.4180-4190.1992
   MILLER ML, 1993, J GEN VIROL, V74, P293, DOI 10.1099/0022-1317-74-2-293
   MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985
   MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435
   OHANESSIAN A, 1967, CR ACAD SCI D NAT, V264, P1356
   Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7
   RENZ D, 1976, J VIROL, V19, P775, DOI 10.1128/JVI.19.3.775-781.1976
   RIEDEL B, 1979, J VIROL, V29, P51, DOI 10.1128/JVI.29.1.51-60.1979
   SCHEELE CM, 1970, J VIROL, V5, P329, DOI 10.1128/JVI.5.3.329-337.1970
   SCOTTER AJ, 2005, PROTEIN EXP PURIF
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   STOLLAR V, 1973, J VIROL, V11, P592, DOI 10.1128/JVI.11.4.592-595.1973
   STOLLAR V, 1975, VIROLOGY, V66, P620, DOI 10.1016/0042-6822(75)90235-4
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   TAYLOR RM, 1955, AM J TROP MED HYG, V4, P844, DOI 10.4269/ajtmh.1955.4.844
   Van Den Hurk AF, 2002, J MED ENTOMOL, V39, P786, DOI 10.1603/0022-2585-39.5.786
NR 47
TC 15
Z9 17
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
J9 VIRUS RES
JI Virus Res.
PD DEC
PY 2006
VL 122
IS 1-2
BP 28
EP 34
DI 10.1016/j.virusres.2006.06.007
PG 7
WC Virology
SC Virology
GA 108GC
UT WOS:000242227300004
PM 16854488
DA 2020-10-30
ER

PT J
AU West, J
   Hernandez, R
   Ferreira, D
   Brown, DT
AF West, J
   Hernandez, R
   Ferreira, D
   Brown, DT
TI Mutations in the endodomain of Sindbis virus glycoprotein E2 define
   sequences critical for virus assembly
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID SITE-DIRECTED MUTATIONS; ALBOPICTUS MOSQUITO CELLS; CAPSID PROTEIN;
   CYTOPLASMIC DOMAIN; ALPHAVIRUS GLYCOPROTEINS; MORPHOLOGICAL VARIANTS;
   TRANSMEMBRANE DOMAIN; NUCLEOCAPSID PROTEIN; BINDING-SITE; ENDO DOMAIN
AB Envelopment of Sindbis virus at the plasma membrane is a multistep process in which an initial step is the association of the E2 protein via a cytoplasmic endodomain with the preassernbled nucleocapsid. Sindbis virus is vectored in nature by blood-sucking insects and grows efficiently in a number of avian and mammalian vertebrate hosts. The assembly of Sindbis virus, therefore, must occur in two very different host cell environments. Mammalian cells contain cholesterol which insect membranes lack. This difference in membrane composition may be critical in determining what requirements are placed on the E2 tail for virus assembly. To examine the interaction between the E2 tail and the nucleocapsid in Sindbis virus, we have produced substitutions and deletions in a region of the E2 tail (E2 amino acids 408 to 415) that is initially integrated into the endoplasmic reticulum. This sequence was identified as being critical for nucleocapsid binding in an in vitro peptide protection assay. The effects of these mutations on virus assembly and function were determined in both vertebrate and invertebrate cells. Amino acid substitutions (at positions E2: 408, 410, 411, and 413) reduced infectious virus production in a position-dependent fashion but were not efficient in disrupting assembly in mammalian cells. Deletions in the E2 endodomain (Delta 406-407, Delta 409-411, and Delta 414-417) resulted in the failure to assemble virions in mammalian cells. Electron microscopy of BHK cells transfected with these mutants revealed assembly of nucleocapsids that failed to attach to membranes. However, introduction of these deletion mutants into insect cells resulted in the assembly of virus-like particles but no assayable infectivity. These data help define protein interactions critical for virus assembly and suggest a fundamental difference between Sindbis virus assembly in mammalian and insect cells.
C1 N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Campus Box 7622, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
RI Ferreira, Davis/D-9356-2014
CR ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991
   BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242
   BROWN DT, 1972, J VIROL, V10, P534
   Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   Carleton M, 1997, J VIROL, V71, P1558, DOI 10.1128/JVI.71.2.1558-1566.1997
   CHENG RH, 1995, CELL, V80, P621
   CLAYTON RB, 1964, J LIPID RES, V5, P3
   Cleverley DZ, 1997, EXP CELL RES, V233, P288, DOI 10.1006/excr.1997.3573
   COOMBS K, 1987, VIRUS RES, V7, P131, DOI 10.1016/0168-1702(87)90075-X
   Ferreira D, 2003, VIROLOGY, V307, P54, DOI 10.1016/S0042-6822(02)00034-X
   GAEDIGKNITSCHKO K, 1991, VIROLOGY, V183, P206, DOI 10.1016/0042-6822(91)90133-V
   GLIEDMAN JB, 1975, J VIROL, V16, P913, DOI 10.1128/JVI.16.4.913-926.1975
   Hernandez R, 2005, J VIROL, V79, P7682, DOI 10.1128/JVI.79.12.7682-7697.2005
   Hernandez R, 2000, J VIROL, V74, P4220, DOI 10.1128/JVI.74.9.4220-4228.2000
   Hernandez R, 2003, J VIROL, V77, P12710, DOI 10.1128/JVI.77.23.12710-12719.2003
   IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993
   LEE H, 1994, VIROLOGY, V204, P471, DOI 10.1006/viro.1994.1557
   LEE HR, 1994, VIROLOGY, V202, P390, DOI 10.1006/viro.1994.1355
   Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7
   LILJESTROM P, 1991, J VIROL, V65, P147
   Liu LN, 1996, VIROLOGY, V222, P236, DOI 10.1006/viro.1996.0414
   LIU N, 1993, J CELL BIOL, V120, P877, DOI 10.1083/jcb.120.4.877
   LIU N, 1993, VIROLOGY, V196, P703, DOI 10.1006/viro.1993.1527
   LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994
   LUO T, 1993, VIROLOGY, V194, P44, DOI 10.1006/viro.1993.1233
   LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8
   MANN E, 1983, J VIROL, V45, P1083, DOI 10.1128/JVI.45.3.1083-1089.1983
   MILLER ML, 1992, J VIROL, V66, P4180, DOI 10.1128/JVI.66.7.4180-4190.1992
   MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435
   MITSUHASHI J, 1983, CELL BIOL INT REP, V7, P1057, DOI 10.1016/0309-1651(83)90011-5
   Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229
   MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   Nelson S, 2005, VIROLOGY, V332, P629, DOI 10.1016/j.virol.2004.12.013
   Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996
   Owen KE, 1997, VIROLOGY, V230, P187, DOI 10.1006/viro.1997.8480
   Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6
   RENZ D, 1976, J VIROL, V19, P775, DOI 10.1128/JVI.19.3.775-781.1976
   RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987
   Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049
   Ryan C, 1998, VIROLOGY, V249, P62, DOI 10.1006/viro.1998.9281
   Ryan C, 1998, VIROLOGY, V243, P380, DOI 10.1006/viro.1998.9074
   SARKAR G, 1990, BIOTECHNIQUES, V8, P404
   Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5
   STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   WEISS B, 1994, NUCLEIC ACIDS RES, V22, P780, DOI 10.1093/nar/22.5.780
   West J, 2006, J GEN VIROL, V87, P657, DOI 10.1099/vir.0.81304-0
   Wilkinson TA, 2005, BIOCHEMISTRY-US, V44, P2800, DOI 10.1021/bi0479961
NR 51
TC 21
Z9 22
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2006
VL 80
IS 9
BP 4458
EP 4468
DI 10.1128/JVI.80.9.4458-4468.2006
PG 11
WC Virology
SC Virology
GA 035DI
UT WOS:000236980000027
PM 16611906
OA Green Published, Bronze
DA 2020-10-30
ER

PT J
AU Nelson, S
   Hernandez, R
   Ferreira, D
   Brown, DT
AF Nelson, S
   Hernandez, R
   Ferreira, D
   Brown, DT
TI In vivo processing and isolation of furin protease-sensitive alphavirus
   glycoproteins: a new technique for producing mutations in virus assembly
SO VIROLOGY
LA English
DT Article
DE alphavirus; Sindbis; membrane glycoproteins; form protease; virus
   assembly
ID BORNE ENCEPHALITIS-VIRUS; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; LOW-PH;
   ENVELOPE GLYCOPROTEIN; DISULFIDE BONDS; E1; MATURATION; CRYSTALLIZATION;
   CONFORMATION
AB Sindbis virus particles are composed of three structural proteins (Capsid/E2/E1). In the mature virion the El glycoprotein is organized in a highly constrained, energy-rich conformation. It is hypothesized that this energy is utilized to drive events that deliver the viral genome to the cytoplasm of a host cell. The extraction of the E1 glycoprotein from virus membranes with detergent results in disulfide-bridge rearrangement and the collapse of the protein to a number of low-energy, non-native configurations. In a new approach to the production of membrane-free membrane glycoproteins, furin protease recognition motifs were installed at various positions in the El glycoprotein ectodomain. Proteins containing the farm-sensitive sites undergo normal folding and assembly in the endoplasmic reticulum and only experience the consequence of the mutation during transport to the cell surface. Processing by furin in the Golgi results in the release of the protein from the membrane. Processing of the proteins also impacts the envelopment of the nucleocapsid in the modified plasma membrane. This technique provides a unique method for studying the mechanism of virus assembly and protein structure without altering crucial early events in protein assembly, folding, and maturation. (C) 2004 Elsevier Inc. All rights reserved.
C1 N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Campus Box 7622, Raleigh, NC 27695 USA.
EM dennis_brown@ncsu.edu
RI Ferreira, Davis/D-9356-2014
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-42775] Funding Source: Medline
CR Allen SJ, 2004, J MOL BIOL, V342, P1293, DOI 10.1016/j.jmb.2004.07.041
   ANTHONY RP, 1992, VIROLOGY, V190, P330, DOI 10.1016/0042-6822(92)91219-K
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brown D. T., 1980, TOGAVIRUSES, P473
   Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   Carleton M, 1997, J VIROL, V71, P1558, DOI 10.1128/JVI.71.2.1558-1566.1997
   Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239
   HEINZ FX, 1991, J VIROL, V65, P5579, DOI 10.1128/JVI.65.10.5579-5583.1991
   Hernandez R, 2000, J VIROL, V74, P4220, DOI 10.1128/JVI.74.9.4220-4228.2000
   Hernandez R, 2003, J VIROL, V77, P12710, DOI 10.1128/JVI.77.23.12710-12719.2003
   KELLENBERGER E, 1976, MICROSC ACTA, V78, P131
   KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7
   Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   LILIJESTROM P, 1991, J VIROL, V65, P147
   LIU N, 1993, J CELL BIOL, V120, P877, DOI 10.1083/jcb.120.4.877
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   MOEHRING JM, 1993, J BIOL CHEM, V268, P2590
   Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229
   MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046
   Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   Phinney BS, 2000, J VIROL, V74, P9313, DOI 10.1128/JVI.74.19.9313-9316.2000
   Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000
   RENZ D, 1976, J VIROL, V19, P775, DOI 10.1128/JVI.19.3.775-781.1976
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03
   Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661
NR 31
TC 7
Z9 8
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD FEB 20
PY 2005
VL 332
IS 2
BP 629
EP 639
DI 10.1016/j.virol.2004.12.013
PG 11
WC Virology
SC Virology
GA 896EU
UT WOS:000226918200017
PM 15680428
DA 2020-10-30
ER

PT J
AU Burlandy, FM
   Ferreira, DF
   Rebello, MA
AF Burlandy, FM
   Ferreira, DF
   Rebello, MA
TI Inhibition of vesicular stomatitis virus replication by prostaglandin
   A(1) in Aedes albopictus cells
SO ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES
LA English
DT Article
DE prostaglandin; Aedes albopictus cells; vesicular stomatitis virus
ID HEAT-SHOCK PROTEINS; CYCLOPENTENONE PROSTAGLANDINS; EICOSANOID
   BIOSYNTHESIS
AB Cyclopentenone prostaglandins (PGs) exhibit antiviral activity against RNA and DNA viruses in mammalian cell lines, and this effect has been associated with the induction of a heat shock protein (hsp70). We investigated the effect of prostaglandin A(1) (PGA(1)) on the replication of vesicular stomatitis virus (VSV) in Aedes albopictus (mosquito) cells. PGA, was found to inhibit VSV replication dose dependently. Virus yield was reduced to 50% (3,mug PGA(1)/ml) and to 95% with 8,mug PGA(1)/ml. Even with the dramatic reduction of virus production observed in cells treated with PGA(1), VSV-specific protein synthesis was unaltered. Treatment of cells with PGA(1) (5,mug/ml) stimulated the synthesis of a polypeptide identified as a heat-shock protein (lisp) by immunoblot analysis. PGA(1) induced hsp70 synthesis in uninfected cells. However, in VSV-infected cells the induction of hsp70 by PGA(1) was reduced. This is the first report of antiviral effects of PGs affecting the replication of VSV in a mosquito cell line.
C1 Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, CCS, BR-21941590 Rio De Janeiro, Brazil.
RP Rebello, MA (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, CCS, BR-21941590 Rio De Janeiro, Brazil.
EM rebello@micro.ufrj.br
RI Ferreira, Davis/D-9356-2014
CR BARBOSA JA, 1995, BRAZ J MED BIOL RES, V28, P27
   Conti C, 1996, ANTIMICROB AGENTS CH, V40, P367, DOI 10.1128/AAC.40.2.367
   Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871
   GILLIES S, 1980, VIROLOGY, V107, P509, DOI 10.1016/0042-6822(80)90317-7
   GILLIES S, 1982, MOL CELL BIOL, V2, P66, DOI 10.1128/MCB.2.1.66
   Johnson DE, 1996, CURR MICROBIOL, V32, P1, DOI 10.1007/s002849900001
   MASTROMARINO P, 1993, ANTIVIR RES, V20, P209, DOI 10.1016/0166-3542(93)90021-A
   MENESES MDF, 2001, Z NATURFORSCH C, V56, P298
   PARKER J, 1995, ANTIVIR RES, V26, P83, DOI 10.1016/0166-3542(94)00067-I
   PETZEL DH, 1992, J INSECT PHYSIOL, V38, P1, DOI 10.1016/0022-1910(92)90016-7
   PICA F, 1993, ANTIVIR RES, V20, P193, DOI 10.1016/0166-3542(93)90020-J
   Rose J. K., 2001, FIELDS VIROLOGY, P1221
   Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520
   SANTORO MG, 1983, J GEN VIROL, V64, P2797, DOI 10.1099/0022-1317-64-12-2797
   SANTORO MG, 1994, EXPERIENTIA, V50, P1039, DOI 10.1007/BF01923459
   Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4
   SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111
   STANLEYSAMUELSON DW, 1991, P NATL ACAD SCI USA, V88, P1064, DOI 10.1073/pnas.88.3.1064
   STANLEYSAMUELSON DW, 1994, AM ZOOL, V34, P589
NR 19
TC 5
Z9 6
U1 0
U2 0
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0939-5075
EI 1865-7125
J9 Z NATURFORSCH C
JI Z.Naturforsch.(C)
PD JAN-FEB
PY 2004
VL 59
IS 1-2
BP 127
EP 131
PG 5
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 811SA
UT WOS:000220790400024
PM 15018065
DA 2020-10-30
ER

PT J
AU Hernandez, R
   Sinodis, C
   Horton, M
   Ferreira, D
   Yang, CN
   Brown, DT
AF Hernandez, R
   Sinodis, C
   Horton, M
   Ferreira, D
   Yang, CN
   Brown, DT
TI Deletions in the transmembrane domain of a Sindbis virus glycoprotein
   alter virus infectivity, stability, and host range
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ALBOPICTUS MOSQUITO CELLS; MORPHOLOGICAL VARIANTS; ENVELOPE
   GLYCOPROTEIN; NUCLEOCAPSID PROTEIN; DISULFIDE BONDS; CAPSID PROTEIN; LOW
   PH; MEMBRANE; E1; E2
AB The alphaviruses are composed of two icosahedral protein shells, one nested within the other. A membrane bilayer derived from the host cell is sandwiched between the protein shells. The protein shells are attached to one another by protein domains which extend one of the proteins of the outer shell through the membrane bilayer to attach to the inner shell. We have examined the interaction of the membrane-spanning domain of one of the membrane glycoproteins with the membrane bilayer and with other virus proteins in an attempt to understand the role this domain plays in virus assembly and function. Through incremental deletions, we have reduced the length of a virus membrane protein transmembrane domain from its normal 26 amino acids to 8 amino acids. We examined the effect of these deletions on the assembly and function of virus particles. We found that progressive truncations in the transmembrane domain profoundly affected production of infectious virus in a cyclic fashion. We also found that membrane composition effects protein-protein and protein-membrane interactions during virus assembly.
C1 N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Campus Box 7622, Raleigh, NC 27695 USA.
RI Ferreira, Davis/D-9356-2014
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI042775, AI-42775] Funding Source:
   Medline
CR ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7
   ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991
   ANTHONY RP, 1992, VIROLOGY, V190, P330, DOI 10.1016/0042-6822(92)91219-K
   BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242
   Brown DT, 1986, TOGAVIRIDAE FLAVIVIR, P171
   BURGE BOYCE W., 1967, J VIROL, V1, P956
   BURGE BW, 1966, VIROLOGY, V30, P204, DOI 10.1016/0042-6822(66)90096-1
   Carleton M, 1997, J VIROL, V71, P1558, DOI 10.1128/JVI.71.2.1558-1566.1997
   Carleton M, 1996, J VIROL, V70, P5541, DOI 10.1128/JVI.70.8.5541-5547.1996
   CLAYTON RB, 1964, J LIPID RES, V5, P3
   Cleverley DZ, 1997, EXP CELL RES, V233, P288, DOI 10.1006/excr.1997.3573
   EDWARDS J, 1983, J VIROL, V45, P1090, DOI 10.1128/JVI.45.3.1090-1097.1983
   Ferreira D, 2003, VIROLOGY, V307, P54, DOI 10.1016/S0042-6822(02)00034-X
   Hernandez R, 2000, J VIROL, V74, P4220, DOI 10.1128/JVI.74.9.4220-4228.2000
   Karpf AR, 1997, VIRUS RES, V50, P1, DOI 10.1016/S0168-1702(97)01461-5
   KELLENBERGER E, 1976, MICROSC ACTA, V78, P131
   LEE HR, 1994, VIROLOGY, V202, P390, DOI 10.1006/viro.1994.1355
   Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7
   LILIJESTROM P, 1991, J VIROL, V65, P147
   LIU N, 1993, J CELL BIOL, V120, P877, DOI 10.1083/jcb.120.4.877
   LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988
   LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   MILLER ML, 1992, J VIROL, V66, P4180, DOI 10.1128/JVI.66.7.4180-4190.1992
   MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435
   MOEHRING JM, 1993, J BIOL CHEM, V268, P2590
   Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   OMAR A, 1988, VIROLOGY, V166, P17, DOI 10.1016/0042-6822(88)90141-9
   Owen KE, 1996, J VIROL, V70, P2757, DOI 10.1128/JVI.70.5.2757-2763.1996
   Owen KE, 1997, VIROLOGY, V230, P187, DOI 10.1006/viro.1997.8480
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000
   Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6
   RENZ D, 1976, J VIROL, V19, P775, DOI 10.1128/JVI.19.3.775-781.1976
   RICE CM, 1982, J MOL BIOL, V154, P355, DOI 10.1016/0022-2836(82)90069-9
   RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987
   ROST B, 1995, PROTEIN SCI, V4, P521
   SARKAR G, 1990, BIOTECHNIQUES, V8, P404
   Schlesinger R W, 1971, Curr Top Microbiol Immunol, V55, P241
   Strauss EG, 2002, J VIROL, V76, P10188, DOI 10.1128/JVI.76.20.10188-10194.2002
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tellinghuisen TL, 1999, J VIROL, V73, P5309, DOI 10.1128/JVI.73.7.5309-5319.1999
   Tellinghuisen TL, 2001, J VIROL, V75, P2810, DOI 10.1128/JVI.75.6.2810-2817.2001
   Wang Wenyan, 2002, Methods Mol Biol, V182, P37
NR 45
TC 36
Z9 37
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
J9 J VIROL
JI J. Virol.
PD DEC
PY 2003
VL 77
IS 23
BP 12710
EP 12719
DI 10.1128/JVI.77.23.12710-12719.2003
PG 10
WC Virology
SC Virology
GA 744DM
UT WOS:000186612700032
PM 14610193
OA Green Published, Bronze
DA 2020-10-30
ER

PT J
AU Ferreira, D
   Hernandez, R
   Horton, M
   Brown, DT
AF Ferreira, D
   Hernandez, R
   Horton, M
   Brown, DT
TI Morphological variants of Sindbis virus produced by a mutation in the
   capsid protein
SO VIROLOGY
LA English
DT Article
ID NUCLEOCAPSID PROTEIN; DISULFIDE BONDS; MOSQUITO CELLS; CROSS-LINKING;
   MEMBRANE; GLYCOPROTEINS; ORGANIZATION; MUTANTS; MATURATION; ALPHAVIRUSES
AB Sindbis virus is a complex aggregate of RNA, protein and lipid. The virus is organized as two nested T = 4 icosahedral protein shells between which is sandwiched a lipid bilayer. The virus RNA resides within the inner protein shell. The inner protein shell is attached to the outer protein shell through contacts to proteins in the outer shell, which penetrate the lipid bilayer. The data presented in the following manuscript show that mutations in the capsid protein can result in the assembly of the virus structural proteins into icosahedra of different triangulation numbers. The triangulation numbers calculated, for these morphological variants, follow the sequence T = 4, 9, 16, 25 and 36. All fall into the class P = 1 of icosadeltahedra as was predicted by Caspar and Klug (1962). The data support their hypothesis that families of icosahedra would be developed by altering the distance between the points of insertion of the five-fold axis. This capsid protein defect also results in the incorporation of much of the capsid protein, into large cytoplasmic aggregates of protein and RNA. These observations support models suggesting that the geometry of a pre-formed nucleocapsid organizes the assembly of the virus membrane proteins into a structure of identical configuration and argues against models suggesting that assembly of the membrane glycoproteins directs the assembly of the nucleocapsid. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RP Brown, DT (corresponding author), N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.
RI Ferreira, Davis/D-9356-2014
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 42775] Funding Source: Medline
CR ANDERSON TF, 1954, P INT C ELECTRON MIC, P122
   ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991
   ANTHONY RP, 1992, VIROLOGY, V190, P330, DOI 10.1016/0042-6822(92)91219-K
   BONATTI S, 1984, EUR J BIOCHEM, V140, P499, DOI 10.1111/j.1432-1033.1984.tb08130.x
   Brown D. T., 1980, TOGAVIRUSES, P473
   BROWN DT, 1975, J VIROL, V15, P1262, DOI 10.1128/JVI.15.5.1262-1266.1975
   BROWN DT, 1973, J VIROL, V12, P1534, DOI 10.1128/JVI.12.6.1534-1539.1973
   BROWN DT, 1972, J VIROL, V10, P534
   Carleton M, 1996, J VIROL, V70, P5541, DOI 10.1128/JVI.70.8.5541-5547.1996
   CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005
   CHENG RH, 1995, CELL, V80, P621
   Choi HK, 1997, J MOL BIOL, V266, P633, DOI 10.1006/jmbi.1996.0827
   Choi HK, 1996, J MOL BIOL, V262, P151, DOI 10.1006/jmbi.1996.0505
   CONDREAY LD, 1988, J VIROL, V62, P346, DOI 10.1128/JVI.62.1.346-348.1988
   COOMBS K, 1987, J MOL BIOL, V195, P359, DOI 10.1016/0022-2836(87)90657-7
   COOMBS K, 1987, VIRUS RES, V7, P131, DOI 10.1016/0168-1702(87)90075-X
   Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081
   FRIEDMAN RM, 1972, J VIROL, V10, P504, DOI 10.1128/JVI.10.3.504-515.1972
   FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075
   GAEDIGKNITSCHKO K, 1991, VIROLOGY, V183, P206, DOI 10.1016/0042-6822(91)90133-V
   GAROFF H, 1974, P NATL ACAD SCI USA, V71, P3988, DOI 10.1073/pnas.71.10.3988
   GLIEDMAN JB, 1975, J VIROL, V16, P913, DOI 10.1128/JVI.16.4.913-926.1975
   GRIMLEY PM, 1968, J VIROL, V2, P1326, DOI 10.1128/JVI.2.11.1326-1338.1968
   Harrison S. C., 1986, TOGAVIRIDAE FLAVIVIR, P21
   LEE H, 1994, VIROLOGY, V204, P471, DOI 10.1006/viro.1994.1557
   LEE HR, 1994, VIROLOGY, V202, P390, DOI 10.1006/viro.1994.1355
   Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7
   LILIJESTROM P, 1991, J VIROL, V65, P147
   LIU N, 1993, J CELL BIOL, V120, P877, DOI 10.1083/jcb.120.4.877
   LIU N, 1993, VIROLOGY, V196, P703, DOI 10.1006/viro.1993.1527
   LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994
   LUO T, 1994, VIROLOGY, V200, P200, DOI 10.1006/viro.1994.1178
   MILLER ML, 1993, J GEN VIROL, V74, P293, DOI 10.1099/0022-1317-74-2-293
   MULVEY M, 1994, J VIROL, V68, P805, DOI 10.1128/JVI.68.2.805-812.1994
   PAREDES AM, 1992, VIROLOGY, V187, P329, DOI 10.1016/0042-6822(92)90322-G
   PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095
   Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6
   RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987
   Skoging-Nyberg U, 2001, J VIROL, V75, P4625, DOI 10.1128/JVI.75.10.4625-4632.2001
   STRAUSS EG, 1978, J VIROL, V28, P466, DOI 10.1128/JVI.28.2.466-474.1978
   STRAUSS EG, 1977, VIROLOGY, V82, P122, DOI 10.1016/0042-6822(77)90038-1
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tellinghuisen TL, 2000, J VIROL, V74, P4302, DOI 10.1128/JVI.74.9.4302-4309.2000
   Tellinghuisen TL, 1999, J VIROL, V73, P5309, DOI 10.1128/JVI.73.7.5309-5319.1999
   Tellinghuisen TL, 2001, J VIROL, V75, P2810, DOI 10.1128/JVI.75.6.2810-2817.2001
   VONBONSDORFF CH, 1978, J VIROL, V28, P578, DOI 10.1128/JVI.28.2.578-583.1978
   WALKER DH, 1970, J VIROL, V5, P765, DOI 10.1128/JVI.5.6.765-782.1970
   WILLIAMS RC, 1958, BIOCHIM BIOPHYS ACTA, V28, P464, DOI 10.1016/0006-3002(58)90507-9
   WIRTH DF, 1979, J CELL BIOL, V81, P154, DOI 10.1083/jcb.81.1.154
   Zhang W, 2002, J VIROL, V76, P7239, DOI 10.1128/JVI.76.14.7239-7246.2002
NR 50
TC 28
Z9 35
U1 1
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR 1
PY 2003
VL 307
IS 1
BP 54
EP 66
DI 10.1016/S0042-6822(02)00034-X
PG 13
WC Virology
SC Virology
GA 664FL
UT WOS:000182051000006
PM 12667814
DA 2020-10-30
ER

PT J
AU De Campos, RM
   Ferreira, DF
   Da Veiga, VF
   Rebello, MA
   Rebello, MCS
AF De Campos, RM
   Ferreira, DF
   Da Veiga, VF
   Rebello, MA
   Rebello, MCS
TI Effect of monensin on Mayaro virus replication in monkey kidney and
   Aedes albopictus cells
SO ACTA VIROLOGICA
LA English
DT Article
DE Mayaro virus; monensin; TC7 cells; Aedes albopictus cells; protein
   synthesis; virus morphogenesis
ID SEMLIKI-FOREST-VIRUS; INFLUENZA-A VIRUSES; ION-CHANNEL ACTIVITY; HUMAN
   DISEASE AGENT; INTRACELLULAR-TRANSPORT; INFECTED-CELLS; SINDBIS VIRUS;
   GOLGI-COMPLEX; M2 PROTEIN; HEMAGGLUTININ
AB The effect of a cationic ionophore, monensin, on the replication of Mayaro virus in monkey kidney TC7 and Aedes albopictus cells has been studied. Treatment of these cells with 1 mumol/l monensin during infection did not affect the virus protein synthesis but inhibited severely the virus replication. Electron microscopy of the cells infected with Mayaro, virus and treated with monensin revealed that the morphogenesis of Mayaro virus was impaired in TC7 but not in A. albopictus cells.
C1 Univ Fed Rio de Janeiro, Prof Paulo Goes Inst Microbiol, Dept Virol, BR-21941590 Rio De Janeiro, Brazil.
RP Rebello, MCS (corresponding author), Univ Fed Rio de Janeiro, Prof Paulo Goes Inst Microbiol, Dept Virol, BR-21941590 Rio De Janeiro, Brazil.
RI Azevedo, Renata/V-3130-2019; Ferreira, Davis/D-9356-2014; da Veiga
   Junior, Valdir Florencio/K-1013-2012
OI da Veiga Junior, Valdir Florencio/0000-0003-1365-7602
CR CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   CIAMPOR F, 1992, VIRUS RES, V22, P247, DOI 10.1016/0168-1702(92)90056-F
   CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D
   CONTRERAS A, 1979, J VIROL, V29, P114, DOI 10.1128/JVI.29.1.114-122.1979
   GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I
   GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835
   HAHN SE, 1992, BIOCHEM CELL BIOL, V70, P1339, DOI 10.1139/o92-182
   JAIN SK, 1991, J BIOL CHEM, V266, P5756
   JOHNSON DC, 1982, J VIROL, V43, P1102, DOI 10.1128/JVI.43.3.1102-1112.1982
   JOHNSON DC, 1980, VIROLOGY, V103, P407, DOI 10.1016/0042-6822(80)90200-7
   KAARIAINEN L, 1980, J CELL BIOL, V87, P783, DOI 10.1083/jcb.87.3.783
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MEZENCIO JMS, 1990, ARCH VIROL, V114, P229, DOI 10.1007/BF01310751
   MEZENCIO JMS, 1989, ARCH VIROL, V104, P299, DOI 10.1007/BF01315551
   MILLER ML, 1992, J VIROL, V66, P4180, DOI 10.1128/JVI.66.7.4180-4190.1992
   MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z
   NAIM HY, 1990, ARCH VIROL, V110, P221, DOI 10.1007/BF01311290
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   QUINN P, 1983, J CELL BIOL, V96, P851, DOI 10.1083/jcb.96.3.851
   REBELLO MCS, 1993, ACTA VIROL, V37, P223
   Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733
   SARIOLA M, 1995, J CELL SCI, V108, P2465
   SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   SUGRUE RJ, 1990, EMBO J, V9, P3469, DOI 10.1002/j.1460-2075.1990.tb07555.x
   SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M
   TAKEUCHI K, 1994, J VIROL, V68, P911, DOI 10.1128/JVI.68.2.911-919.1994
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6
NR 30
TC 2
Z9 2
U1 0
U2 1
PU SLOVAK ACADEMIC PRESS LTD
PI BRATISLAVA
PA PO BOX 57 NAM SLOBODY 6, 810 05 BRATISLAVA, SLOVAKIA
SN 0001-723X
J9 ACTA VIROL
JI Acta Virol.
PY 2003
VL 47
IS 2
BP 113
EP 119
PG 7
WC Virology
SC Virology
GA 717ZC
UT WOS:000185119800008
PM 14524478
DA 2020-10-30
ER

PT J
AU Ferreira, DF
   Santo, MPE
   Rebello, MA
   Rebello, MCS
AF Ferreira, DF
   Santo, MPE
   Rebello, MA
   Rebello, MCS
TI Weak bases affect late stages of Mayaro virus replication cycle in
   vertebrate cells
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID SINDBIS VIRUS; AMMONIUM-CHLORIDE; PROTEIN-SYNTHESIS; INHIBITION;
   INTERFERON; BHK-21-CELLS; ALPHAVIRUSES; CHLOROQUINE; EXPRESSION; AMINES
AB This paper describes the effect of two weak bases (ammonium chloride and chloroquine) on the morphogenesis of Mayaro virus. When Mayaro virus-infected TC7 (monkey kidney) cells were treated with these agents it was observed that weak bases caused a significant reduction in virus yield. Also, cellular protein synthesis, which is inhibited by Mayaro virus infection, recovered to nearly normal levels, However, the synthesis of Mayaro virus proteins was affected. These phenomena were dose-dependent. The process of Mayaro virus infection in vertebrate cells is very rapid, Virus precursors are not observed in cell cytoplasm and budding through the plasma membrane seems to be the only way of virus release. Electron microscopy of cells infected with Mayaro virus and treated with weak bases revealed an accumulation of virus structures in cell cytoplasm, The study also noted an inhibition of budding through the plasma membrane and the appearance of virus particles inside intracytoplasmic vacuoles. These observations indicate an impairment at the final stages of the virus replication cycle.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, BR-21941 Rio De Janeiro, Brazil.
RP Rebello, MCS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
RI Ferreira, Davis/D-9356-2014
CR BROWN DT, 1972, J VIROL, V10, P524, DOI 10.1128/JVI.10.3.524-536.1972
   CASALS J, 1957, AM J TROP MED HYG, V6, P1004, DOI 10.4269/ajtmh.1957.6.1004
   CASSELL S, 1984, J VIROL, V52, P857, DOI 10.1128/JVI.52.3.857-864.1984
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   CONTRERAS A, 1979, J VIROL, V29, P114, DOI 10.1128/JVI.29.1.114-122.1979
   DILLE BJ, 1982, J GEN VIROL, V62, P91, DOI 10.1099/0022-1317-62-1-91
   ELGIZOLI M, 1989, J VIROL, V63, P2921, DOI 10.1128/JVI.63.7.2921-2928.1989
   FROLOV I, 1994, J VIROL, V68, P1721, DOI 10.1128/JVI.68.3.1721-1727.1994
   KAARIAINEN L, 1984, ANNU REV MICROBIOL, V38, P91, DOI 10.1146/annurev.mi.38.100184.000515
   Koblet H, 1990, Adv Virus Res, V38, P343
   KOFF WC, 1979, J VIROL, V31, P261, DOI 10.1128/JVI.31.1.261-263.1979
   KOYAMA AH, 1989, VIRUS RES, V13, P271, DOI 10.1016/0168-1702(89)90073-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOPEZ S, 1994, J VIROL, V68, P1316, DOI 10.1128/JVI.68.3.1316-1323.1994
   MAHESHWARI RK, 1991, J GEN VIROL, V72, P2143, DOI 10.1099/0022-1317-72-9-2143
   MATLIN KS, 1986, J BIOL CHEM, V261, P5172
   MEZENCIO JMS, 1990, ARCH VIROL, V114, P229, DOI 10.1007/BF01310751
   MILLER DK, 1981, P NATL ACAD SCI-BIOL, V78, P3605, DOI 10.1073/pnas.78.6.3605
   OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327
   REBELLO MCS, 1993, ACTA VIROL, V37, P223
   SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291
   Singh AK, 1996, J INTERF CYTOK RES, V16, P725, DOI 10.1089/jir.1996.16.725
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
NR 23
TC 18
Z9 18
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-2615
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD APR
PY 2000
VL 49
IS 4
BP 313
EP 318
DI 10.1099/0022-1317-49-4-313
PG 6
WC Microbiology
SC Microbiology
GA 298RB
UT WOS:000086152000003
PM 10755624
OA Bronze
DA 2020-10-30
ER

PT J
AU Ferreira, DF
   Rebello, MCS
AF Ferreira, DF
   Rebello, MCS
TI Interferon selectively inhibits the synthesis of Mayaro virus
   glycoproteins
SO REVISTA DE MICROBIOLOGIA
LA English
DT Article
DE interferon alpha; Mayaro virus; glycoproteins; morphogenesis
ID HERPES-SIMPLEX VIRUS; INTRACELLULAR PH; REPLICATION
AB We have previously observed that interferon (recIFN alpha 2b) blocks the process of morphogenesis of Mayaro virus in TC7 cells (monkey kidney). In this work we show that IFNa inhibits preferentially virus glycoproteins and their precursors, and this effect is probably correlated to the alterations in the morphogenesis process previously observed.
C1 Inst Microbiol Prof Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
RP Rebello, MCS (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Mol Virol Lab, Ctr Ciencias Saude, Bloco G,Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil.
RI Ferreira, Davis/D-9356-2014
CR ANDERSON DR, 1954, AM J TROP MED HYG, V6, P1012
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   CHATTERJEE S, 1985, J VIROL, V56, P419, DOI 10.1128/JVI.56.2.419-425.1985
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MAHESHWARI RK, 1994, J INTERFERON RES, V14, P319, DOI 10.1089/jir.1994.14.319
   MAHESHWARI RK, 1991, J GEN VIROL, V72, P2143, DOI 10.1099/0022-1317-72-9-2143
   REBELLO MCS, 1993, ACTA VIROL, V37, P223
   REBELLO MCS, 1993, AN 22 REUN AN SOC BR, P6
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 0001-3714
J9 REV MICROBIOL
JI Rev. Microbiol.
PD JUL-SEP
PY 1998
VL 29
IS 3
BP 219
EP 221
DI 10.1590/S0001-37141998000300014
PG 3
WC Microbiology
SC Microbiology
GA 174YC
UT WOS:000079063300014
OA DOAJ Gold
DA 2020-10-30
ER

EF